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Ithaca 
When you start your journey to Ithaca, 
Then pray that the road is long, 
Full of adventure, full of knowledge, 
Do not fear the Lestrygonians 
And the Cyclopes and the angry Poseidon. 
You will never meet such as these on your path 
If your thoughts remain lofty, if a fine 
Emotion touches your body and your spirit. 
You will never meet the Lestrygonians, 
The Cyclopes and the fierce Poseidon, 
If you do not carry them within your soul, 
If your soul does not raise them up before you. 
 
Then pray the road is long. 
That the summer mornings are many, 
That you will enter ports seen for the first time 
With such pleasure, with such joy! 
Stop at Phoenician markets, 
And purchase fine merchandise, 
Mother-of-pearl and corals, amber and ebony, 
And pleasurable perfumes of all kinds, 
Buy as many pleasurable perfumes as you can; 
Visit hosts of Egyptian cities, 
To learn and learn from those who have knowledge. 
Always keep Ithaca fixed in your mind. 
To arrive there is your ultimate goal. 
But do not hurry the voyage at all. 
It is better to let it last for long years; 
And even to anchor at the isle when you are old, 
Rich withal that you have gained on the way, 
Not expecting that Ithaca will offer you riches. 
 
Ithaca has given you the beautiful voyage. 
Without her you would never have taken the road. 
But she has nothing more to give you. 
 
And if you find her poor, Ithaca has not defrauded you. 
With the great Wisdom you have gained, with so much experience, 
You must surely have understood by then what Ithaca means. 
 
C. P. Cavafy 
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1.1 Syntheses of Bicyclic Natural Products Having cis-Fused Furo[2,3-b]furan 
Structure: (Microreview): 
1.1.1 Abstract: Bicyclic natural products containing a cis-fused furo[2,3-b]furan 
framework are attractive synthetic targets, many with significant biological activity. The 
bicyclic framework has a distinct convex and a concave face. The former being easily 
accessible compared to the latter. Introducing functional groups on these bicycles 
selectively, especially on the concave face, poses therefore a major synthetic challenge. 
The objective behind this microreview is to provide various strategies for 
stereoselective syntheses of such natural products or their analogues. A special focus is 
given to application of different synthetic methodologies for the construction of the 
constrained bicyclic core. 
 
1.1.2 Introduction: The cis-fused dioxabicyclo[3.3.0]octane (Fig. 1) is an important 
structural component of a broad range of bicyclic natural products. Such compounds are 
extensively distributed in nature and have attracted much attention because of their 
unique structural properties and interesting biological activities. Generally, these natural 
products are highly functionalized, containing a number of asymmetric carbon centers. 
Therefore, from the viewpoint of synthetic organic chemistry, these natural products are 
challenging and interesting targets to test novel synthetic strategies in addition to 
exploring structure activity relationships within their biological profile. 
 
 
 
 
 
 
Figure 1 Basic structures of dioxabicyclo[3.3.0]octanes 
 
 This microreview details the various routes employed for the syntheses of 
bicyclic natural products containing cis-fused furo[2,3-b]furan (Type A) framework in 
the literature up until the end of 2005. 
1.1.3 Natural Products Having furo[2,3-b]furan Core (Type A): From the four 
possible isomeric core structures (Type A-D, Fig. 1), the furo[2,3-b]furans (Type A) are 
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convincingly prominent in nature. Along with distinct structural features, they also 
display a wide range of biological significance. 
 
 
Figure 2 Structures of spongiane diterpenoids 
 
Sponges are marine organisms expressing a large number of natural compounds, 
which display interesting biological properties such as antibacterial or cytotoxic 
activities. A scarcely explored sub-group of spongiane diterpenoids (Fig. 2) shares the 
structural motif of a cis-fused 5-oxofuro[2,3-b]furan unit (type A, Fig. 1), found in 
cheloviolene A (1) and B (2), dendrillolide A (3), dermatolactone (4), macfarlandin C 
(5), spongionellin (6), omriolide B (7) and norrisolide (8). A distinct structural feature 
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of all these natural products, with the exception of the cheloviolenes (1 and 2, Fig. 2) is 
the placement of a sterically bulky cyclic substituent on the concave face of the 
bicyclus. 
The isolation and biological profile of these natural products is listed in the 
following table: 
 
 
Entry Natural 
Product 
Natural  
Source 
Year of 
Isolation 
Biological 
Profile 
1 Cheloviolene A[1], 
[2] 
C. violacea 1993 unknown 
2 Cheloviolene B[1] C. violacea 1993 unknown 
Chromodoris norrisi 
[3] 
1984 unknown 3 
 
Dendrillolide A 
Chromodoris gleneii[4] 1991 unknown 
4 Dermatolactone[5] Basidiomycete Irpex 
lacteus 
1996 cytotoxic 
5 Macfarlandin C[6] Chromodoris 
macfarlandi 
1986 unknown 
6 Spongionellin[7] Spongionella gracilis 1986 unknown 
7 Omriolide B[8] Dictyodendrilla aff. 
Retiara 
2005 unknown 
8 Norrisolide[9] Chromodoris norrisi 1984 Golgi disrupting 
agent 
 
Table 1 Isolation and biological profile of 1-8 
 
 Despite of their abundance in nature, the synthesis as well as biological profile 
of these natural products is not much explored. Among these only norrisolide (8) has 
been recently synthesized having a unique property to irreversibly fragment the golgi 
apparatus in rat kidney cells. 
 The second class, having a comparable structural motif referred to as 
bis(tetrahydrofuran) belongs asteltoxin[10] (9, Fig. 3) and the clerodanes[11] (10-17, Fig. 
3). Asteltoxin is a mytotoxin isolated from toxic maize cultures, showing inhibitory  
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effect on oxidative phosphorylation on E.coli BF1-ATPase. On the other hand, the 
clerodanes are natural diterpenoids possessing interesting antifeedant properties. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Structures of other natural products having core of Type A 
 
 For the synthesis of these natural products, the major challenge to meet is the 
development of a flexible strategy for the construction of cis-fused furo[2,3-b]furan 
core in enantiomerically pure form that allows introduction of bulky groups especially 
on the concave face and ii) assembly as well as introduction of side chains possessing 
differently sized and functionalized bulk at the appropriate stage of synthesis on the 
desired face of the bicycle. 
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1.1.4 Norrisolide: Norrisolide (Fig. 4) was isolated in 1983 by Faulkner, Clardy and 
co-workers in a study of the chemical defense system of nudibranch molluscs. It is the 
first compound reported to vesiculate the golgi apparatus irreversibly.[12] Therefore 
norrisolide is of great use as a biological tool and could provide further information 
about dynamics and mechanism of Golgi apparatus. 
 
 
 
 
 
 
 
 
 
Figure 4 Structure of norrisolide 
 
1.1.4a Model Studies Towards Norrisolide: In 1999, Theodorakis and co-workers 
reported the synthesis of the cis-fused furo[2,3-b]furan motif of norrisolide.[13] As a key 
step, the ring expansion of appropriately substituted cyclopropyl esters was developed 
(Fig. 5). 
 
 
Figure 5 General scheme for ring expansion of substituted cyclopropyl ester 
 
 The idea behind this strategy was to utilize the ability of the anomeric bond in 18 
to undergo cleavage under mild acidic conditions. The transiently produced 1,3-dipolar 
synthon 19 could then cyclize at the anomeric center to produce desired bicyclus 20. 
 The dihydrofuran 22 was chosen as the starting point for this method which was 
synthesized from D-mannose 21 in four steps by applying the method reported by 
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cyclopropyl ester 23 as a mixture of diastereomers at C4 center (4:1 in favor of the exo 
adduct). The acid catalyzed cyclopropane ring opening of 23 yielded the compound 24. 
The 1,2-diol in 24 which was opened under the effect of acid was converted to methyl 
ketone 25 in three steps. The formation of cis-fused furo[2,3-b]furan 26 was then 
achieved by subjecting 25 to methanesulfonic acid. The cyclization underwent with 
complete diastereoelectivity. Finally, the O-acetyl functionality was installed at C2 
carbon of 26 to yield 27. 
 
 
Figure 6 Synthesis of the side-chain motif of norrisolide by Theodorakis 
 
 The cyclopropyl ester 23 could also be directly converted to cis-fused furo[2,3-
b]furan 28 in one pot using methanesulfonic acid/acetone combination (Fig. 7).[15] 
 
 
Figure 7 One pot ring expansion of cyclopropyl ring by Theodorakis 
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The benzyl ether functionality in 28 was easily converted to carbonyl group to 
yield 29 in two steps. However, attempts to further functionalize the C3 center in 28 or 
in 29 were unsatisfactory probably due to the steric hinderance imposed by the bicyclic 
system and also the reactivity of lactone. 
 Analogous to the aforementioned approach, Reiser and co-workers in 2005, 
reported a strategy for the enantioselective synthesis of cis-fused 5-oxofuro[2,3-b]furan 
derivatives (Fig. 8).[16] Inexpensive methyl-2-furoate 30 was used as a source for the 
1,2-cyclopropanecarboxylated furan substrates, which were to be subjected to the acid 
mediated one pot ring expansion of cyclopropane. 
 
 
Figure 8 One pot ring expansion of cyclopropyl ring by Reiser 
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 Methyl-2-furoate 30 was already reported to undergo an asymmetric 
cyclopropanation in the presence of copper (I) bis(oxazolines) to give rise to 2-oxo-
bicyclo[3.1.0]octane 31 with excellent regio-, enantio-, and diastereoselectivities.[17] 
Unlike the approach disclosed by Theodorakis, the introduction of the side-chain at C3 
center was achieved successfully by carrying out palladium catalyzed cross couplings 
on vinyl bromide 32, which in turn was prepared from 31 in two steps. After the 
catalytic hydrogenation of the double bond in the cross coupling products, the 1,2-
cyclopropanecarboxylated furan substrates 33, 34 and 37 were obtained. In the 
hydrogenation the side-chain was selectively oriented on concave face of the bicyclic 
system attaining the correct stereochemistry as in norrisolide. Upon acid mediated one 
pot ring expansion, 33, 34, and 37 yielded cis-fused furo[2,3-b]furans 35, 36 and 38 
respectively. In case of 37, the ring expansion yielded a diastereomeric mixture at the 
3a,6a ring junction. The diastereomeric ratio varied according to the reaction 
temperature. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9 Methods for O-acetylation at C2 center 
 
 Conversion of the carboxylic acid in 36 via Baeyer-Villiger oxidation yielded 
the O-acetyl derivative 39 as a single diastereomer. On the other hand, one step 
oxidative decarboxylation of 38a yielded the O-acetyl derivative 40 as a mixture of 
diastereomers, one of which was with the acetoxy group on convex face of the bicycle 
as in norrisolide, being the major diastereomer (Fig. 9). 
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The overall strategy was enantioselective and shorter than the one reported by 
Theodorakis. However, only aromatic side-chains were introduced at C3 center, while 
for the side-chain of norrisolide the perhydroindane core is required. 
1.1.4b Total Synthesis of Norrisolide by Theodorakis: In 2004 Theodorakis and co-
workers reported the first total synthesis of norrisolide (Fig. 10).[18, 19] The cis-fused 
furo[2,3-b]furan fragment 48 possessing the aldehyde functionality at C3 center was 
synthesized first using a Diels-Alder approach. 
Initially, vinyl iodide 42 was synthesized from the enantiomerically enriched 
enone 41 in 13 steps. 
 
 
Figure 10 First total synthesis of norrisolide by Theodorakis 
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 The synthesis of bicyclic motif 48 was started from butenolide 43 in which the 
desired stereochemistry at C2 center is already fixed. Diels–Alder reaction of 43 with 
butadiene 44, catalyzed by AlCl3 yielded 45 as a single diastereomer, in which the diene 
has approached the butenolide from the opposite side of the hydroxyl methyl group. 
Lactone reduction followed by oxidative cleavage of the double bond in 45 yielded the 
lactol 46 which was converted to the corresponding methyl ether 47 as a separable 1:1 
mixture of epimers at C3 center. Both the epimers were carried on in the subsequent 
sequence. The one carbon degradation at C3 center was carried out in five steps to give 
48. 
 The aldehyde 48 was then efficiently coupled with vinyl iodide 42 after lithium 
halogen exchange to yield a mixture of diastereomeric alcohols which was oxidized to 
the corresponding ketone followed by the selective hydrogenation of the double bond to 
give rise to 49. Further 8 steps, manipulating the TBDPS ether as well as the lactol 
functionality were required to furnish norrisolide 8 with complete retention of 
configuration. 
1.1.5 Asteltoxin: Asteltoxin (9, Fig. 11) was isolated in 1979 by Vleggaar and co-
workers during the investigation of toxic maize cultures of Aspergillus stellatus.[20] This 
mytotoxin is structurally related to aurovartin 50[21] and citreoviridin 51[22], compounds 
which have been used as inhibitors of oxidative phosphorylation.[23]  
 
 
Figure 11 Structures of asteltoxin, aurovertin and citreoviridin 
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Asteltoxin also happens to show similar inhibitory effect on the activity of E-coli 
BF1-ATPase.[24] It is also suggested that the bis(tetrahydrofuran) moiety is responsible 
for the inhibition and binding properties of asteltoxin. 
1.1.5a Schreiber`s Total Synthesis of Asteltoxin: In 1984, Schreiber and co-workers 
reported the first total synthesis of asteltoxin in a racemic form, using a convergent 
approach (Fig. 12).[25, 26] 
 
 
Figure 12 Schreiber`s total synthesis of racemic asteltoxin 
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 The aldehyde 58 was chosen as a key synthon which was prepared starting from 
3,4-dimethylfuran 52 in 10 steps. The Paterno-Büchi photocycloaddition of 52 and β-
benzyloxypropanal 53 afforded 54 in good yield, which was further functionalized to 
accomplish the synthesis of 58. Metalation of pentadienyl sulfoxide 59 with nBuLi and 
addition of aldehyde 58 followed by double [2, 3] sigmatropic rearrangement furnished 
an easily separable diastereomeric mixture of the diol 60, the desired isomer being 
major. The desired isomer of 60 was then cyclized in good yield to cis-fued furo[2,3-
b]furan 61 using camphorsulfonic acid. 
The introduction of pyrone ring 62 by cross aldol condensation with 61 followed 
by the selective dehydration of the less hindered alcohol attaining the trans geometry of 
the double bonds were the finishing steps to arrive at asteltoxin. 
1.1.5b Tadano`s Total Synthesis of (+)-Asteltoxin: Subsequent to Schreiber`s 
synthesis of racemic asteltoxin, Tadano and co-workers reported a total synthesis of (+)-
asteltoxin using D-glucose as an enantiomerically pure starting material (Fig. 13).[27, 28] 
 
 
Figure 13 Tadano`s total synthesis of (+)-asteltoxin 
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Synthesis of compound 63 was already reported from D-glucose by employing 
ortho ester Claisen rearrangement as a key step.[29] It already includes a 
stereochemically defined C3 carbon center in asteltoxin. The modification of the vinyl 
group in 63 to benzyl protected allyl ether 64 was achieved in seven steps. NaIO4 
oxidation of 64 afforded a pentasubstituted tetrahydrofuran 66 via the intermediate 65. 
The conversion of 66 into tetrahydrofuranone 67 was achieved in 12 steps. The 
sequential Grignard reaction, followed by the oxidation of the primary alcohol resulting 
due the deprotection of pivolyl ester during Grignard addition and Horner-Emmons 
reaction afforded unsaturated ester 68. Acid hydrolysis of 68 smoothly resulted in the 
cyclization of the second tetrahydrofuran ring to yield the cis-fused furo[2,3-b]furan 69. 
The total synthesis of (+)-asteltoxin was then completed in 4 steps from 69 using the 
aldol condensation strategy analogues to the one used by Schreiber and co-workers (61 
to asteltoxin 9, Fig. 12). 
Even though the synthesis of a single enantiomer of asteltoxin was 
accomplished, this strategy suffered from the lengthy synthesis of cis-fused furo[2,3-
b]furan 69 possessing the correct stereochemistry at all the asymmetric centers. 
1.1.5c Cha`s Total Synthesis of (+)-Asteltoxin: In 2003, Cha and co-workers, 
efficiently utilized a Lewis acid catalyzed pinacol type rearrangement of epoxy silyl 
ether 73 in order to synthesize (+)-asteltoxin (Fig. 14).[30],[31] This pivotal rearrangement 
strategy was analogous to the proposed biosynthetic pathway of asteltoxin. 
 The allylic alcohol 71 was synthesized from ester 70 in four steps. The Sharpless 
epoxidation of 71 furnished epoxy alcohol 72 in very good yield and with 94% 
diastereoselectivity. The epoxy silyl ether 73 was synthesized from 72 in three steps. 
The Pinacol type rearrangement of 73 was accomplished by the action of TiCl4 
providing aldehyde 74. Both the epimers of 73 smoothly underwent this acid catalyzed 
rearrangement. The diol 75 was then synthesized in 3 steps starting from 74. The 
treatment of 75 with methanolic hydrogen chloride followed by TIPS protection of the 
resulting alcohol gave fully protected acetal 76 as a single diastereomer. 
 Building up the left tetrahydrofuran ring was targeted in further sequence. The 
osmylation of 76 followed by oxidation of the primary alcohol in the resulting diol, and 
Grignard addition on the resulting aldehyde gave 77. A Lewis acid catalyzed cyclization 
of 77 afforded cis-fused furo[2,3-b]furan, which was then converted to 78 after the 
deprotection of TIPS ether. 
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 Finally, in order to achieve the total synthesis of (+)-asteltoxin, 78 was 
converted to aldehyde 79 in 8 steps. The union of α-pyrone phosphonate 80 with the 
aldehyde 79, followed by deprotection of silyl ethers furnished (+)-asteltoxin 9. 
 
 
Figure 14 Cha`s total synthesis of (+)-asteltoxin 
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1.1.5d Synthesis of cis-Fused Furo[2,3-b]furan fragment of Asteltoxin: Meanwhile, 
Yamamura and co-workers (1990) as well as Mulzer and co-workers (1994) reported 
the synthesis of the cis-fused furo[2,3-b]furan fragment 91 of asteltoxin. 
 The strategy reported by Yamamura and co-workers was based on branched 
chain D-xylohexofuranose derivative as a starting point (Fig. 15).[32] 
 
 
Figure 15 Yamamura`s synthesis of cis-fused furo[2,3-b]furan fragment of asteltoxin 
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and 86 were converted to 87 in 5 and 7 steps respectively in two different pathways. 
Compound 87 was then converted to the allyl benzyl ether 88 in two steps. Treatment of 
88 with OsO4 afforded a mixture of vicinal diols, which was subjected to acidic 
conditions to give chromatographically separable mixture of 89 and 90. Finally catalytic 
hydrogenation of the desired 90 provided hexahydrofuro[2,3-b]furan 91. 
 
 
Figure 16 Mulzer`s synthesis of cis-fused furo[2,3-b]furan fragment of asteltoxin 
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 The approach reported by Mulzer and co-workers started from 92 which is easily 
available from 2,3-dimethyl-1,3-butadiene (Fig. 16).[33] 
 Monoprotection of 92 as trityl ether and and Swern oxidation of the resulting 
alcohol yielded aldehyde 93. Diethylzinc was added to 93 under the conditions 
described by Soai.[34] Catalyst 94 furnished secondary alcohol 95 in 80 %ee, which was 
determined via the Mosher ester. Acylation of 95 led to the ester 96 which was 
smoothly rearranged to 97 as single diastereomer, using Burke and Kallmerten version 
of a Claisen type rearrangement. By recrystallization the optical purity of 97 was raised 
to >98 %ee. The stereoselectivity of rearrangement is remarkably hinged on the trityl 
protecting group. The newly formed 97 was cyclized to lactone 98. The lactone was 
then reduced to hemiketal 98 as an anomeric mixture. The deprotection of 98 with one 
equivalent of n-butyllithium followed by the addition of vinylmagnesium chloride 
yielded diol 99 as a single diastereomer via chelate Cram intermediate. Selective 
monobenzoylation of the secondary alcohol in 99 was accomplished in three steps to 
form 99, which was then submitted to Swern oxidation of the primary hydroxyl group 
and debenzoylation of the secondary one. The hydroxy aldehyde spontaneously cyclized 
to the lactol which was ketalized to give 101 as a 94:6 mixture of the β as well as α 
anomer. The controlled osmylation of vinyl group and glycol cleavage in 101 followed 
by reduction of aldehyde with LAH furnished alcohol 102 with less then 5% 
epimerization at C5 center in the aldehyde stage. The osmylation of 102 yielded 1.3:1 
mixture of anomeric diols 103 and 104 with >95:5 diastereoselectivity. Both anomers 
were treated separately with acid to close the second tetrahydrofuran ring by trans 
ketalization and finally debenzylation of the corresponding product furnished 91.  
1.1.6 Clerodanes (Dihydroclerodin and Lupulin C): Diterpenoids possessing the 
clerodane skeleton (10-17, Fig. 3) are widely distributed in nature and new members of 
this subclass of diterpenes continue to appear in the literature. Of the relatively few 
clerodanes that were tested for biological activity, many were found to possess 
interesting properties, which vary from antifeedant to antiviral, antitumour, antibiotic, 
antipeptic ulcer and piscicidal activity. 
1.1.6a Kato`s Stereocontrolled Synthesis of Clerodin homologue: In 1980, Kato and 
co-workers reported the stereoselective synthesis of clerodin homologue 110 (Fig. 
17).[35] 
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 The epoxy acetonide 106 was synthesized starting from hydroquinone 105 in 20 
steps. The reaction of 106 with lithium-di-(3-furyl)-cuprate⋅2-furyllithium-dimethyl 
complex yielded the desired furan alcohol 107 as a major product.  
 
 
Figure 17 Kato`s stereoselective synthesis of clerodin homologue 
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yield 113. Reduction of 113 followed by tosylation afforded diastereomeric mixture of 
114 and 115. Only 115 yielded the desired product 116 after heating with DBU. A 
better method to achieve the synthesis of 116 from 112 was based on Bamford-Stevens 
reaction.[37] 
 
 
Figure 18 Lallemand`s synthesis furofuranic model of clarodanes 
 
Later in 1983 Lallemand and co-workers reported a new preparation of furo[2,3-
b]furan derivatives by iodocyclization of unsaturated lactols (Fig. 19).[38] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19 Synthesis furo[2,3-b]furan derivatives via iodocyclization of lactols 
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 Lactols 118a and 118b were prepared from lactone 117 by using standard 
allylation protocol, followed by reduction using Dibal-H. The iodocyclization of 118 
was then carried out using iodine and sodium bicarbonate in acetonitrile to afford 119 in 
good yield. In order to perform some model reactions, 119a was transformed to 120a, 
121a, 122a respectively. 119b could be easily converted to 121b in a diastereomeric 
mixture of three possible isomers. 
 In 1991, Lallemand and co-workers also reported a model study aimed at the 
total synthesis of clerodin 10. The tricyclic furo[2,3-b]furan moiety 133 was prepared. 
This approach was based on Claisen rearrangement between a cyclohexanol and a 
cyclic orthoester (Fig. 20).[39] 
 
 
Figure 20 Lallemand`s model study aimed at the total synthesis of clerodin 
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crude mixture gave diol 125 which was selectively converted to lactone 128 with 
Fetizon`s reagent. The sequential allylation and Dibal-H reduction afforded lactol 129. 
Ozonolysis of terminal double bond in 129 and treatment with excess 
triphenylphosphine provided inseparable mixture of diastereomeric mixture of bicyclic 
lactol 130. Phenyl selenylation of the lactol 130 led to the separable selenyl derivatives 
131 and 132 in 2:1 ratio, which underwent an oxidation elimination step to afford model 
133. 
1.1.6c Furstoss` Synthesis of Subunit of Clerodane Derivatives: In 1995, Furstoss 
and co-workers reported the seven step synthesis of (1S,5R)-2,8-
dioxabicyclo[3.3.0]octane-3-one from its (1R,5S) antipode prepared by 
microbiologically mediated Baeyer-Villiger oxidation of the corresponding bicyclic 
precursor (Fig. 21).[41] This lactone could be a valuable building block for the synthesis 
of clerodane derivatives. 
 
 
Figure 21 Furstoss` synthesis of a subunit of clerodane derivatives 
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excess of 99% and 86% respectively. The lactone 136 was the wrong enantiomer as 
compared to the absolute configuration of the natural clerodane moeity. 
In order to achieve the synthesis of the desired enantiomer, lactone 136 was 
reduced using Dibal-H to the corresponding separable epimeric ethers 137. The 
successful oxidation of this ether to the corresponding lactone was achieved using 
ruthenium oxide and sodium periodate combination, delivering a mixture of monocyclic 
lactone 138 and the desired bicyclic lactone 139. The enantiomeric excess of 139 was 
improved by crystallization in n-hexane to 97%. This bicyclic lactone 139 was further 
transformed into the corresponding phenylselenium derivative which underwent an 
oxidation/elimination sequence when reacted with Davis reagent to afford the olefinic 
lactone 140 in 80 %ee, which is the furofuran subunit of clerodane derivatives. This 
lactone 140 was then smoothly hydrogenated to afford 141, the saturated (1S,5R) 
enantiomer of 136. 
1.1.6d Groot`s Total Synthesis of Dihydroclerodin and Lupulin C: In 1989 Groot 
and co-workers reported the first total synthesis of the natural enantiomer of 
dihydroclerodin and lupulin C starting from (R)-(−)-carvone (Fig. 22).[42]  
For enantioselective synthesis of 2-methoxyhexahydrofuro[2,3-b]furan 144, the 
racemic ester 142 was chosen as a starting point. Enzymatic trans esterification of 142 
with butanol resulted in a mixture of (R)-methyl- and (S)-butylesters that could be 
separated by preparative gas chromatography. 142 was then converted to 143 in five 
steps, which could be then transformed into 144 by reduction and transacetalization in 
62% yield. 
 In order to find a shorter route to obtain 144, enol ether 145 was converted to 
lactone 146 in one step which was then transfromed to racemic 144 by reduction and 
transacetalization. This could be carried out in multigram scale and the other advantage 
of this method was, Mukiyama aldol of this compound with silylenol ether 146 proved 
to be remarkably diastereoselective. Mukiyama aldol was applied as a key step for 
introduction of bulky side chain on less hindered convex face of the bicycle. Silylenol 
ether 146 was prepared from (R)-(−)-carvone. It was then subjected to aldol reaction 
with 144 in presence of TrClO4. 147 and 148 were the only two of possible eight 
diastereomers formed, which could be separated easily by crystallization of 148 by 
diisopropyl ether. The desired diastereomer 147 remained in solution. The 
diastereoselectivity of Mukiyama reaction could be explained by an approach of 
silylenol ether to the less hindered convex face of both enantiomers of the 
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hexahydrofuro[2,3-b]furan cation, which leads to the formation of 147 and 148. Thus 
Mukiyama approach proved to be the best method to build up the correct configuration 
at C9, C11, C13 and C16 stereocenters. 
 
 
Figure 22 Groot`s total synthesis of dihydroclerodin and lupulin C 
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C6 and C4 were introduced. The m-CPBA epoxidation of 149 gave 1:1 mixture of 
epoxides and acylation of this mixture yielded dihydroclerodin 11 (26%) and 4-epi-
dihydroclerodin 150 (25%). Acylation of diol 149 yielded the natural clerodane lupulin 
C 17. 
1.1.7 Conclusions: Several de novo strategies towards cis-fused furo[2,3-b]furan 
frameworks have been developed in recent years, making use of readily available 
starting materials that allow great functional diversity. Although most of these 
approaches are target driven aiming at a specific class of natural products containing 
this unique structural motif, many of the strategies reported clearly demonstrate their 
broad scope, which should make them attractive in the future for the rarely explored 
synthesis of biologically important natural products like clerodin (10, Fig. 3) and also 
scarcely explored sub-group of spongiane diterpenoids which shares the structural motif 
of a cis-fused 5-oxofuro[2,3-b]furan unit (1-7, Fig. 2). 
 In conclusion, this microreview has detailed several methods for the construction 
of uncommon cis-fused furo[2,3-b]furan frameworks as well as the total syntheses of 
natural products containing this core. It also highlights the stereoselective introduction 
of bulky side-chains on the concave or convex face of this bicycle at appropriate stages 
of the syntheses. 
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1.2 Background: During the studies directed towards the mysterious molluscan 
chemical defences, Faulkner and co-workers in 1983 reported the structure of an 
architecturally novel diterpenoid norrisolide (8, Fig. 2, 1.1.3), isolated from the skin 
extracts of the nudibranch Chromodoris norrisi (Fig. 23).[1] These mulluscs are 
populary called as Clown Nudibranch due to their brilliant coloration pattern and known 
to be ranging throughout the Gulf of California. They secrete norrisolide, which is 
probably the result of modification of chemicals obtained from their sponge prey. 
 
 
Figure 23 Chromodoris norrisi and norrisolide 
 
Almost two decades after the structure elucidation, Theodorakis and co-workers 
reported the first total synthesis of norrisolide and also disclosed its effects on the 
vesiculation of the golgi apparatus.[2-4] Meanwhile, meticulous studies established that 
norrisolide belongs to a family of rearranged spongiane diterpenes also including 
cheloviolene A and B, dendrillolide A, dermatolactone, macfarlandin C, spongionellin 
and omriolide B (1-8, Fig. 2, 1.1.3), which shares a common structural motif 
highlighted by a cis-fused furo[2,3-b]furan framework attached to a hydrophobic core. 
The combination of fascinating structural features and rather unexplored biological 
profile of these compounds continues to foster immense interest in their design and 
synthesis. 
 
 
Figure 24 Theodorakis` approach for the synthesis of cis-fused furo[2,3-b]furans 
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Earlier, Theodorakis and co-workers developed a synthesis of such cis-fused 
furo[2,3-b]furans 152 based on ring expansion of a fused cyclopropyl ester 151 which 
was synthesized starting from a carbohydrate derivative D-mannose 21 (Fig. 24).[5] This 
methodology offers the advantage from inexpensive chiral starting material but suffers 
limited options for the control of stereochemistry and functional groups that can be 
introduced. Moreover, attempts to homologate the C3 center in 152 were unsatisfactory 
due to the difficulties stated before (section 1.1.4a). 
 
 
Figure 25 Retrosynthetic analysis of norrisolide by Theodorakis 
 
Even so, Theodorakis et al. reported the first total synthesis of norrisolide using 
tBuLi mediated coupling of bis(tetrahydrofuran) fragment 48 and vinyl iodide 42 
containing perhydroindane core in a key step (Fig. 25).[6] 
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1.3 Aim of This Work: Taking into consideration all the facts concerning synthesis 
and biological activity of this class of spongiane diterpenoids, this thesis is aimed 
especially at the stereoselective synthesis of a cis-fused furo[2,3-b]furan intermediates 
which can be broadly applied for the synthesis of spongiane diterpenoids such as 
norrisolide. 
The synthesis of intermediate 162 is envisioned starting from furan derivative 
154 which is commercially available and can also be prepared easily using methyl 
chloroacetate and acetylacetaldehyde-dimethylacetal in two steps. The retrosynthetic 
strategy is illustrated in Fig. 26. In the synthetic direction, the plan will entail the 
asymmetric cyclopropanation of 154 in the presence of copper-(I)-bisoxazolines to yield 
155, followed by introduction of an extensive range of functionalities at C3 position to 
get hold of the dihydrofuran derivatives 156. 1,2-cyclopropanecarboxylated furanoids 
157 are anticipated to be formed by the hydrogenation of the double bond, which is 
expected to orient the substituents at C3 center on the concave face of the bicycle as 
observed in the majority of the spongiane diterpenoids containing cis-fused furo[2,3-
b]furan structure. 
 
 
Figure 26 Retrosynthetic analysis of furo[2,3-b]furan intermediate 162 
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A Lewis acid mediated rearrangement of these furanoids 157 is to be a key step 
in the construction of carboxylic acids 158 containing this unique bicyclic framework. 
The choice of appropriate protecting group for carboxylic acid functionality in 158 is 
crucial, as there might be a possibility of lactonization after nucleophilic addition on the 
aldehyde 159. Therefore, O-benzyl which is not a very good leaving group will be the 
suitable choice. The later operations will be the nucleophilic additions on the aldehyde 
159 followed by oxidation of the resulting alcohol 160 to obtain ketone 161. The 
oxidative decarboxylation of carboxylic acid functionality in 161, in order to achieve 
the O-acetylation at C2 center and ketone olefination to accomplish the synthesis of 162 
will be the finishing point. 
 The implementation of this strategy, culminating in the stereoselective synthesis 
of a range of versatile building blocks for the synthesis of marine natural products such 
as norrisolide will be described in detail in the following chapter. 
 Furthermore, applications of 1,2-cyclopropanecarboxylated furanoids 157 in a 
variety of cyclopropane rearrangements are investigated as an additional part of this 
work in the subsequent chapters. 
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2 Towards the Total Synthesis of Norrisolide: 
2.1 Asymmetric Cyclopropanation of Furan Derivatives: 
2.1.1 Introduction: The first synthesis of a cyclopropane derivative was reported in 
1884 by William Henry Perkin.[7] Nearly 123 years after, cyclopropane chemistry still 
offers for the chemists of 21st century significant challenges in this distinctive class of 
three membered ring compounds. Investigations on how far we can get a carbon atom 
and its homologues to bend their preferred bonding angles and accommodate unusual 
bonding situations are still on the way. In course of time, modern synthetic 
methodology has made it possible to deal with these extremely strained cycloalkanes in 
the perspective of their synthesis and applications. As a result cyclopropane derivatives 
are frequently employed as multipurpose building blocks in organic synthesis.[8] 
 
 
 
 
Figure 27 Cyclopropanation using metal-catalyzed decomposition of diazoalkanes 
 
 The cyclopropanation of olefins using the transition metal-catalyzed 
decomposition of diazoalkanes (Fig. 27) is one of the most extensively studied 
methods.[9] Both inter- and intramolecular versions of this reaction have been 
developed. The nature of the starting diazo reagent as well as the type of the reaction 
(inter- or intramolecular), plays a key role in the appropriate selection of the most 
efficient catalyst for a given transformation. 
 
 
 
 
 
 
Figure 28 Structures of α-diazoesters 
 
 α-diazoesters are the most profoundly studied diazo reagents for intermolecular 
cyclopropanation. Many other reagents, all containing at least one electron withdrawing 
group have been used to prepare cyclopropanes (Fig. 28). The simple α-diazoesters can 
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be prepared on gram scale and reacted in the presence of the metal catalyst and 
alkenes.[10] 
 Among a wide range of metal catalysts, the ones derived from Cu, Rh, Ru and 
Os are known to react faster with electron-rich alkenes, whereas Pd metal carbenes are 
optimal for electron-deficient alkenes. In most of these cases, the mechanism of the 
transition metal-catalyzed decomposition of α-diazocarbonyl compounds is believed to 
proceed via formation of the illustrious metal carbene complex. [11] 
 
 
Figure 29 Decomposition of α-diazoesters by chiral transition metal complex 
 
 A pre-eminent approach practised for the asymmetric cyclopropanation is the 
decomposition of α-diazoesters by chiral transition metal complexes to cyclopropanate 
achiral alkenes in an intermolecular fashion (Fig 29). 
 The most effective catalysts for the preparation of the trans isomer with the 
widest reaction scope are copper-based catalysts. The catalysts based on other transition 
metals are also very effective, but they generally produce lower enantio- and 
diastereoselectivites and have a narrower scope. 
 
 
Figure 30 The first enantioselective cyclopropanation by Nozaki 
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 The first example of an enantioselective copper-based intermolecular 
cyclopropanation was reported by Nozaki in 1966.[12] A copper-catalyzed 
decomposition of ethyl diazoacetate in the presence of an N-benzylethylamine-based 
chiral salicylaldimino complex gave about 6% enantiomeric excess of the 
corresponding cis and trans cyclopropanecarboxylates (Fig. 30). 
Though the enantiomeric ratios were very low, this exercise led to a class of 
catalysts which further proved to be quite effective in the synthetic tasks then going on 
in Nozaki group. 
 As a consequence of this enantioselective transformation, several hundred chiral 
ligands have been synthesized and tested in copper catalyzed processes in the past four 
decades. Most of these ligands comprise the structural variations of the basic types 
including substituted salicylaldimines, semicorrins, bis(oxazolines), bipyridines and 
many others. 
 The copper (I) complex of bis(oxazoline) 163, disclosed by Evans in the early 
1990s,[13, 14] is still a standard to which new bis(oxazoline) ligands are compared. The 
catalyst 163 has been extensively used in cyclopropanation reactions of some cyclic as 
well as acyclic enol ethers[15] of protected allylic alcohols[16] and of vinyl fluorides[17]. 
 
 
Figure 31 Structures of bis(oxazoline) ligands and cyclopropanation of 30 
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cyclopropanation of furans using Cu (I) complex of these ligands has been reported.[19, 
20] 
 The structures of Evans bis(oxazoline) 163, the modified bis(oxazoline) ligands 
164 and 165 synthesized in our group and their applications in enantioselective 
cyclopropanation of furan derivative 30 is shown in Fig 31. 
 The initial part of the present work was designed towards the improvements in 
the synthesis of bis(oxazoline) ligand 164 and its application to the enantioselective 
cyclopropanation of furan derivatives possessing substituents at different positions. 
2.1.2 Synthesis of (S,S)-bis(4-isopropyloxazoline) 164: The commercially available 
tert-butyl-substituted bis(oxazoline) 163 often gives rise to the highest selectivities. A 
number of applications have been developed in which the bis(4-isopropyloxazoline) 164 
gives similar or even superior results. Furthermore, for the synthesis of tert-butyl-
substituted bis(oxazoline) 163, the unnatural and therefore expensive amino acid tert-
leucine is required. As an alternative, bis(4-isopropyloxazoline) 164, available as either 
enantiomer prepared from inexpensive (S)- or (R)-valine 166, is an attractive ligand for 
large scale applications if equally good enantioselectivity can be achieved. 
 
 
Figure 32 Synthesis of (S,S)-bis(4-isopropyloxazoline) 164 
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increases the cost effectiveness.[22] It was then converted to dimethylmalonyl dichloride 
169 using oxalyl chloride in dichloromethane. 
The subsequent acylation mediated by triethylamine yielded dihydroxy 
malonodiamide 170 in 84% yield after two crystallizations. The dihydroxy 
malonodiamide 170 was cyclized to bis(oxazoline) 164 via the bis(tosyl chloride) in 
83% yield (Fig. 32). 
2.1.3 Synthesis of Furan Derivatives: As a simple selection of substrates for the 
asymmetric cyclopropanation, furan derivatives shown in Fig. 33 were chosen. 
 
 
Figure 33 Structures of furan derivatives 
 
171 was synthesized from 3-methyl-furfural 173 in two simple steps (Fig. 34). 
NaClO2 oxidation of 173 yielded the acid which was then converted to the 
corresponding methyl ester 171. The derivative 172 was commercially available. 
 
 
Figure 34 Syntheses of furan derivatives 171 and 154 
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 To accomplish the synthesis of 3-methyl-2-furoic ester 154 proved to be an 
interesting task. The two step synthesis of 154 via the Darzens glycidic ester 
condensation reported by Burness was followed (Fig. 34).[23] 
 The Darzen reaction of 174 proceeded effectively, yielding the glycidic ester 
175 quantitatively. The addition of catalytic amounts p-toluenesulfonic acid in the 
rearrangement of glycidic ester 175 helped to get the conversion to the product 154 at 
130 oC instead of 160 oC as reported by Burness. Moreover, the yield was improved 
from 70% to 88%. It is also noteworthy that in the reported procedure the thermal 
rearrangement of 175 is carried out without the addition of acid. However, no formation 
of the product 154 was observed even at the higher temperature, when this protocol was 
followed. 
2.1.4 Cyclopropanation: The furan derivative 171 did not react at all in copper 
catalyzed cyclopropanation reaction with ethyl diazoacetate. Also 172 gave extremely 
low conversion towards the cyclopropanated products. Further attempts to optimize the 
reaction conditions were not carried out. 
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Figure 35 Cyclopropanation of 3-methyl-2-furoic ester 
 
 In contrast, the cyclopropanation of 3-methyl-2-furoic ester 154 was quite 
successful as compared to that of other substrates (Fig. 35). The reaction proceeded 
regioselectively, as only the less substituted double bond was cyclopropanated. The 
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complete diastereoselection was the other special feature of in course of this reaction, as 
the ester functionality was oriented exclusively on the convex face of the bicyclic 
framework. Not even a trace amount of the corresponding endo isomer was observed. 
The yield of the reaction was quite agreeable ranging from 60% to 72%, depending on 
the choice of reaction parameters. The equivalents of ethyl diazoacetate (4 equiv.) 
employed was probably the most important factor regarding the improved yields. Even 
though excess ethyl diazoacetate resulted in the formation of diethyl maleate, diethyl 
fumarate and a trimer[24] resulting from the [3+2] cycloddition reaction, it was well 
compensated by the improved yields of the desired cyclopropanated product 176. 
 
 
Figure 36 The stereochemical investigation of the cyclopropanation of 3-methyl-2-
furoic ester 154 
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bis(oxazoline) 164 yielded comparable enantioselectivity as the Evans` standard system. 
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the enantiomeric excess. The option to attain the pure enantiomeric form of 176 will be 
discussed in the next section 2.2. 
 The stereoselectivity of the cyclopropanation can be explained by means of the 
model proposed by Pfaltz (Fig. 36).[25] Due to the C2 symmetry in bis(oxazoline), two 
opposite quadrants are sterically blocked. The ligand forms a plane which is 
perpendicular to the plane formed by the trigonal carbenoid atom. The less substituted 
and electron-rich double bond of the furoic ester can attack either from Re-face (favored 
path) or from Si-face (disfavored path). 
The interactions of olefin with the carbenoid atom change its hybridization to sp3 
arranging it in tetrahedral geometry. As shown in B, the path B results in repulsive 
interaction between the ester group at the formerly carbenoid center and on β-alkyl 
group at the stereocenter on the oxazoline ring. Moreover, the α-alkyl group blocks the 
attack of furan from Si-face as in path B. These types of interactions will not appear on 
attack from Re-face, forming the corresponding product as a major outcome. This is in 
accordance with the experimental results, principally based on the transition state A. 
2.2 Allylic Bromination (Wohl-Ziegler Bromination): 2-oxobicyclo[3.1.0]hexene 
derivative 176 was envisioned as a suitable substrate for allylic bromination in order to 
have the versatile functionalities at C3 carbon center. Indeed, it yielded the 
corresponding allyl bromide 177 in a satisfactory yield, when subjected to AIBN and 
NBS in CCl4 at reflux temperature. After the recrystallization from n-hexane, the 
enantiomeric excess was enhanced to more than 99% (Fig. 37). 
 
 
Figure 37 Allylic bromination and improvement in enantiomeric excess 
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shown in Fig. 38. The mechanism clearly reveals the fact that it would not be viable to 
avoid the formation of this furan derivative during the allylic bromination. 
 
 
Figure 38 Mechanism for the formation of furan derivative 178 
 
 Another interesting fact observed during this reaction was that on larger scale 
(20 g.) even at reflux temperature, the reaction was not initiated. After careful literature 
search explaining a general survey of reaction conditions, water was employed as an 
additive. Disappointingly, the reaction yielded major amount of furan derivative 178 
rather than the desired allyl bromide product 177. Nevertheless, the employement of 
molecular bromine in catalytic amount accelerated the reaction considerably, also 
minimizing the formation of the side product to 20%.  
 
 
 
Figure 39 ORTEP drawing of 177 
 
Finally, the absolute configuration of 177 was unambiguously proven by X-ray 
structure analysis. The ORTEP diagram is shown in Fig. 39. 
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 Upon catalytic hydrogenation, 177 underwent de-bromination to yield 176 back. 
Thus, allylic bromination proves as a practical method to obtain 176 in enantiopure 
form. What's more, enantiomerically pure allyl bromide 177 could prove as a versatile 
intermediate, as a number of constructive conversions of this moiety are well known. 
2.3 Functionalization at C3 Carbon Center: Having enantiopure cyclopropyl 
derivatives 176 with methyl and 177 with bromomethyl functionality at C3 carbon in 
hand, the synthesis of the derivatives having a wide range of other functionalities was 
envisioned. 
 Initially, 177 was exposed to Mg in THF or diethyl ether in order to form the 
corresponding Grignard reagent. However, these experiments were not successful. The 
effort to form a Wittig salt by reacting 177 with triphenyl phosphine gave very low 
yields. 
 Moreover, the substitution of bromide in 177 with O-acetyl also proceeded only 
in very low yields. 
 
 
Figure 40 Functionalization at C3 carbon center 
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bromomethyl derivative 177 was transformed into aldehyde 181 in three steps (Fig. 40). 
177 was exposed to the mixture of K2CO3 and p-methoxy phenol in acetone to afford 
the p-methoxy phenyl ether 179 in very good yield. Ceric ammonium nitrate mediated 
oxidative cleavage of p-methoxy phenyl ether 179 yielded the allylic alcohol 180. This 
was then oxidized to aldehyde 181 using activated MnO2. 
 
 
Figure 41 Side-chain introduction and oxidation sequence 
 
 The model reactions for side-chain introduction tried on aldehyde 181, were 
Sakurai allylation with allyl silane and Mukiyama aldol reaction with cyclic enol ether 
183 (Fig. 41). Both yielded the respective products 182 and 184 in good yield as a 
mixture of diastereomers. The diastereomeric ratios were not determined. Subsequent 
oxidation of the resulting alcohols failed entirely under various conditions, most likely 
caused by the steric hinderance of the cyclopropyl moiety plus the possible interactions 
between methyl ester and hydroxy functionality. 
The aldehyde functionality in 181 was also protected effectively as cyclic (185) 
as well as acyclic (186) acetal. 181 was subjected to p-toluene sulfonic acid and 
ethylene glycol at reflux temperature, in Dean-Stark condenser to yield cyclic acetal 185 
in very good yield. The synthesis of acyclic acetal 186 was achieved also in good yield 
by reacting 181 with triethyl orthoformate in the presence of the catalytic amount of (+)-
camphorsulfonic acid (Fig 42). 
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 Thus, a small library of cyclopropane derivatives was synthesized productively, 
the members of which possess different functionalities at C3 carbon center such as 
methyl, bromomethyl, alkoxymethyl, hydroxymethyl, aldehyde and acetal protected 
aldehyde. 
 
 
Figure 42 Protection of aldehyde as cyclic and acyclic acetal 
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derivatives was the next assignment to complete. However, this reaction proved to be 
quite substrate dependant.  
The methyl derivative 176 upon catalytic hydrogenation unpredictably yielded a 
diastereomeric mixture of optically inactive diester 187. The furan ring as well as 
cyclopropane ring underwent the hydrogenation to yield this completely saturated 
entity. The bromomethyl derivative 177 afforded the methyl derivative 176 under a 
range of hydrogenation conditions. This proved to be an easy way to get 
enantiomerically pure methyl derivative 176 as stated before. The hydroxymethyl 
derivative 180 underwent hydrogenolysis under various conditions also yielding the 
methyl derivative 176. The formyl derivative 181 yielded hydroxymethyl derivative 180 
under various hydrogenation conditions (Fig. 43). 
 These results proved to be a major restriction of the strategy, as they reduced the 
number of possible derivatives possessing diverse functionalities ready to be subjected 
to the acid mediated rearrangement in order to form cis-fused furo[2,3-b]furans. 
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Compound Catalyst (a) Time A B C (187) 
a) Pd/C 3 h - - 65% 
b) Pt/C 3 h - - 63% 
c) Pd/BaSO4 48 h - - - 
d) Wilkinson`s 
catalyst 
48 h - - - 
 
 
 
176 
e) 
Pd/cyclohexadiene
48 h - - - 
R2 = CH3 a) or b) or c) 30 min - 
Quantitative. 
- 
 
 
177 
d) or e) 48 h - - - 
R2 = CH3 a) or b) or c) 30 min - 
Quantitative. 
-  
180 
d) or e) 48 h - - - 
R2 = 
CH2OH 
a) or b) or c) 30 min - 
Quantitative. 
-  
181 
d) or e) 48 h - - - 
 
(a) All the reactions were carried out at 25 oC and balloon (atm.) pressure. 
 
Figure 43 Substrate dependant hydrogenation 
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Nevertheless, the hydrogenation of 179 yielded less than 30% hydrogenation 
product 188 together with a number of other unidentified products. Conversely, acetals 
185 and 186 underwent smooth hydrogenation when subjected to Palladium on charcoal 
under the hydrogen atmosphere yielding 189 and 190 respectively (Fig. 44). 
 
 
Figure 44 Synthesis of 1,2-cyclopropanecarboxylated furanoids 
 
 In all the successful cases, hydrogenation occured exclusively from the convex 
face of the bicyclus, resulting in highly congested derivatives in which the functional 
group at C3 carbon as well as methyl ester are forced on the concave face. The possible 
reason for this could be the steric hinderance created by cyclopropyl group which 
allowed the hydrogen addition only from the more accessible convex face. 
 
 
 
Figure 45 ORTEP drawing of 189 
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X-ray analysis of 189 (Fig. 45) and NOE experiments explicitly proved these 
structural assignments. 
2.5 Trans-thioacetalization: The cyclic as well as acyclic acetals are known to be 
acid senstitive. For that reason, considering the possibility of concomitant acetal 
deprotection during the acid mediated rearrangement of 1,2-cyclopropanecarboxylated 
furanoids 189 and 190, the preparation of such a furanoid derivative possessing the 
acid-stable masking group of aldehyde was the next intention. The dithioacetal 
protecting group which was thought to be a better alternative is, in most cases, cleaved 
by reaction with Hg(II) salts or oxidation; acid hydrolysis is known to be inadequate. 
 As a first option to accomplish the synthesis of such a derivative, α,β-
unsaturated aldehyde 181 was protected as a dithioacetal quantitatively. But, the 
catalytic hydrogenation of the double bond failed completely, most likely due to the 
potential poisoning of the catalyst by sulfur part present in the substrate. Trans-
thioacetalization of 190 proved to be the perfect alternative to overcome this problem. 
 
 
Figure 46 BF3⋅Et2O-mediated trans-thioacetalization 
 
 A combination of BF3⋅OEt2/1,3-propane dithiol proved to be the best, yielding 
the corresponding dithioacetal 191 as the exclusive product in an excellent yield (Fig. 
46). Thus, along with O,O-acetals 189 and 190, S,S-acetal 191 was also prepared as the 
potential substrate for the acid mediated rearrangement. The other benefit of this 
derivative could be that it also creates the prospect to form a quaternary center on the 
side-chain in later stages by performing the reactions involving an umpolung of 
reactivity, as many of the target spongiane diterpenoids hold such a quaternary center. 
2.6 Synthesis of Furo[2,3-b]furan Motif via Acid-Mediated One-Pot Ring 
Expansion of Cyclopropane Rings: As expected, O,O-acetals 189 and 190 on 
treatment with acid yielded a series of anonymous products, most likely due to the 
simultaneous acetal deprotection, ester hydrolysis and cyclopropane rearrangement. 
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 Nonetheless, S,S-acetal 191 on the treatment with 6 M (aq.) HCl in 1,4-dioxane 
yielded the straightforwardly separable mixture of cis-fused furo[2,3-b]furans 192 and 
193 in reasonable yield. The complete conversion to acid 193 could not be observed 
even after stirring the reaction at room temperature for 96 hours, perhaps due to the 
steric hinderance produced by six-membered thioacetal ring. The slight increase in 
reaction temperature helped in hydrolyzing the methyl ester completely affording 193 as 
an exclusive product in 69% yield (Fig. 47). 
 
 
Figure 47 HCl-mediated rearrangements of 191 
 
 As expected, the presence of both electron withdrawing and electron donating 
substituents at vicinal positions of the cyclopropyl ring of 191 allowed the cleavage of  
 
 
Figure 48 Mechanism of HCl-mediated rearrangement 
 
anomeric bond to occur under acidic conditions. The transiently produced 1,3-dipolar 
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bicyclic ring system of methyl ester 192, along with the acid 193. The complete 
conversion to acid 193 was then achieved at elevated temperature under the effect of aq. 
HCl (Fig. 48). 
 An important advantage of this strategy was that only one diastereomer was 
obtained, retaining the stereochemistry at all the carbon centers producing the 
substantially strained system in which methyl ester as well as thioacetal ring are 
oriented on the concave face of the bicycle. 
 The structures of 192 and 193 were unequivocally proved by NOE experiments 
particularly performed on methyl ester 192 (Fig 49).  
 
 
ppm
2.62.83.03.23.43.63.84.04.24.44.64.8 ppm
2.6
2.8
3.0
3.2
3.4
3.6
3.8
4.0
4.2
4.4
4.6
4.8
 
 
 
Figure 49 NOE spectrum of methyl ester 192 
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 The key NOE signals which establish the stereochemistry as exposed in Fig. 50 
are, H-2 to H-3, H-3 to H-3a and H-3a to HA-4. 
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Figure 50 Key NOE signals of methyl ester 192 
 
 As both methyl ester 192 and acid 193 could be isolated in good yields 
depending upon the reaction conditions, it broadened the choice for the next 
manipulations by exploiting the chemoselectivity of different reagents towards both the 
functional groups. However, reduction of the methyl ester in 192 as well as carboxylic 
acid in 193 selectively to the corresponding primary alcohol was not successful.  
 
 
Figure 51 Benzyl protection and dithioacetal deprotection 
 
Therefore, the benzyl protection of the carboxylic acid was anticipated as a 
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secondary alcohol resulting from nucleophilic additions of the side-chains on demasked 
aldehyde at C3 carbon center, as O-benzyl is not as good leaving group as O-methyl. 
193 was converted to benzyl ester 195 in excellent yield (Fig. 51). As a final 
point, the deprotection of dithioacetal was the critical objective. The early attempts 
running this reaction with some metals that are commonly used to catalyze the 
hydrolysis (oxidation) of dithioacetal, namely, HgCl2/CdCO3, AgNO3/AgO, FeCl3/CuO 
or other reagents like NBS, BTI, DMP failed completely. For this reason, dithioacetal 
195 was converted to the corresponding dimethyl acetal 196 using NBS in methanol. 
The hydrolysis of 196 was achieved using formic acid in dichloromethane affording the 
aldehyde 197 in 50% yield over two steps. 
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Figure 52 NOE spectrum of aldehyde 197 
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However, after the NOE experiments it was revealed that the stereocenter 
bearing aldehyde functionality in 197 was epimerized possibly as a result of acidity of 
the reaction medium.  The structure of 197 was unambiguously assigned by NOE 
experiments as shown in Fig. 53. 
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Figure 53 Key NOE signals of aldehyde 197 
 
The key NOE signals which prove the stereochemistry as given in Fig. 53 are, 
aldehyde-H to H-3a and aldehyde-H to H-2. These studies demonstrated that the 
aldehyde functionality was oriented on the convex face of the bicylic system. 
2.7 Conclusions and Outlook: In summary, the stereoselective synthesis of cis-
fused furo[2,3-b]furan intermediates was achieved, which can be broadly applied for the 
synthesis of norrisolide as well as various spongiane diterpenoids containing this 
distinctive bicyclic framework. The strategy described is predominantly based on acid-
mediated one-pot ring expansion of the corresponding cyclopropanes and also allows 
the introduction of versatile functionalities on C3 carbon center such as dithioacetal, 
dimethyl acetal or aldehyde. These functionalities can be utilized with the intention of 
introducing the bulky side-chains on either concave or convex face of the bicyclus. 
 Moreover, the compact and sterically cumbersome structure of cis-fused 
furo[2,3-b]furans as well as cyclopropane precursors led to several ineffective reactions 
and numerous modifications of the overall strategy. Nonetheless, exploration of each 
strategy led to conclusions that were decisive in designing the successful strategy. 
 This strategy can also be utilized as groundwork for the synthesis of potential 
insect antifeedant clerodin (Fig. 3). Furoic ester 30 could be transformed into 198 in 
four steps (Fig. 54), which could be used as a substrate for Mukiyama aldol reaction 
with the silyl enol ether 146 derived from carvone. The addition of enol ether might 
take place from the convex face directed by steric hinderance caused by lactone ring 
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giving the intermediate 199. After the lactone reduction and protection of resulting 
lactol, the intermediate 200 could be obtained. 
 
 
Figure 54 Proposed Synthesis of clerodin 
 
The protocol followed by Groot and co-workers in the total synthesis of 
dihydroclerodin[26] could be used in order to achieve the annulation of the second ring 
and introducing the other structural features in order to accomplish the total synthesis of 
clerodin 10. 
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3.1 Donor-Acceptor Substituted Cyclopropanes: The diverse functionality and 
reactivity present in the cyclopropanes makes them attractive substrates for the chemical 
development in modern organic synthesis.[1, 2] While unactivated cyclopropanes have 
been directly employed for certain useful chemical transformations[3, 4], most of the 
cyclopropane based methodologies have relied on derivatives substituted by electron 
donor and acceptor groups. Since electronic relationship of these substituents effect the 
activation of the cyclopropanes and a high versatility of the products after ring cleavage, 
they are particularly suitable for synthetic applications. Following are the general 
structures of geminally and vicinally donor-acceptor (DA) substituted cyclopropanes. 
 
 
Figure 55 General structures of donor-acceptor (DA) cyclopropanes. 
 
Only a few examples for the use of geminally DA-substituted cyclopropanes 
(201, Fig. 55) are known, since substituents do not act in a synergistic (push-pull) 
manner. However, vicinally DA-substituted cyclopropanes (202, Fig. 55) which serve as 
1,3-dipolar synthons (203, Fig. 55) are used in many synthetically valuable 
transformations.[5, 6] 
 
 
Figure 56 Reactions of vicinally substituted donor-acceptor (DA) cyclopropanes 
Don
AccR
Don AccR Don Acc
201 202 203
R1 OR3
R2
Lewis acid
R1 OR3
HR
2
O
OEt
LA
O
R1
R2
OEt
O
R3
LA
O
R1
R2
OEt
O
R3
LA
reagents
204
OR3
R1
R2
CO2Et
H  transfer
205
O
R1
R2
CO2Et
protonolysis and
loss of R3
206
O
R1
R2
CO2Et
E  trap
207
E OR3
R1
R2
CO2Et
Nu  addition
208
Nu
[3+2]cycloaddition
(E  and Nu  )
[3+2]cycloaddition
209
R4 X Y R5
CO2Et
H
Y
X
R2
R3O
R1
R4
R5
CO2Et
Section 3. Donor-Acceptor Substituted Cyclopropanes and Their Rearrangements 55 
 
 Generally, the nature of reaction conditions directs the ultimate outcome of the 
1,3-zwitterion and the intermediates react in an intramolecular fashion by hydride[7, 8] or 
proton transfers to give γ-alkoxy α,β-unsaturated esters 205 or saturated γ-oxoesters 206 
(Fig. 56). Siloloxy substituted DA cyclopropanes are particularly susceptible to give 
simple protonolysis products 206. Intermolecular reactions can occur at just one or both 
sites of the dipole. Examples of α-addition from electrophilic trapping of enolates to 
afford 207 and nucleophilic addition to the intermediate oxocarbenium ions to give 208 
are both known. Combining the dual reactivity of the 1,3-dipole results in formal [3+2] 
cycloadditions furnishing highly functionalized carbon or heterocyclopentane 
derivatives 209. These latter transformations involving DA substituted cyclopropanes 
are synthetically powerful methods for accessing products often not readily available 
through traditional routes. 
 The stereoselective cyclopropanation of furans reported in the preceding section 
affords unique bicyclic structures combining the high reactivity of cyclopropanes 
together with the extreme optical purity and functional diversity associated with them. 
The electron donating effect from the furan ring oxygen conveniently helps to drive a 
variety of rearrangement as well as ring enlargement reactions of these DA substituted 
cyclopropane derivatives. 
 Therefore, the studies investigating the utilization of already synthesized 1,2-
cyclopropanecarboxylated furanoids in such rearrangements and their applications 
towards the synthesis of unnatural amino acids, dihydro- and tetrahydrofurans as well as 
γ-butyrolactones are envisioned as an additional part of this work. 
3.2 NBS-Promoted Ring Opening of 1,2-Cyclopropanecarboxylated Furanoids: 
Synthesis of Enantiomerically Pure Amino Acid Containing 2,3,4,5-
Tetrasubstituted THF Ring in the Molecular Backbone: 
3.2.1 Introduction: In recent years the interest in a rational design of amino acid and 
peptide mimetics has steadily grown due to the pharmacological limitations of bioactive 
peptides. The biological relevance of unnatural amino acids continues to promote 
enormous attention to their design and synthesis.[9]  
The cation-binding ability of ether subunits as well as the synthetic and 
conformational potential of amino acids are the foremost reasons which has caused the 
great interest in the synthesis of amino acids containing ether functionalities in the side-
chain and/or the molecular backbone.[10] 
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Examples of naturally occurring ether amino acids are neuraminic acid (210, 
Fig. 57) found as subunits of oligosaccharides, muraminic acid (211, Fig. 57) found in 
cell-walls of bacteria.[11] 
 
 
 
 
 
 
 
 
Figure 57 Naturally occuring ether amino acids 
 
Most contributions to the field of synthetic ether amino acids start from 
carbohydrates. Sugar amino acids (SAA) were developed by Kessler et al.[12] (212, 213 
Fig. 58), Lansbury et al.[13] (214, Fig. 58), Dondoni et al.[14, 15], Wessel et al.[16] and 
Ichikawa et al.[17] Sugar derived THF amino acids of type 215 (Fig. 58) have been 
synthesized by several groups.[18, 19] THF peptides made out of 215 show remarkable 
secondary structures.[20] 
 
 
 
 
 
 
 
 
 
 
 
Figure 58 Sugar-derived synthetic THP and THF amino acids. 
 
The approach to THF amino acids in the present work started with already 
synthesized 1,2-cyclopropanecarboxylated furanoid scaffolds as a chiral pool source. 
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The diastereoselective ring opening of cyclopropane sugar derivatives was already 
demonstrated by Danishefsky and co-workers[21] as well as by Chandrasekaran and co-
workers.[22]  
 
 
Figure 59 Diastereoselective ring opening of cyclopropane sugars 
 
 During the studies towards the synthesis of Epothilone A, Danishefsky and co-
workers reported that 216, when subjected to oxidative opening with N-iodosuccinimide 
(NIS) afforded 217 (A, Fig. 59). The idea behind this was to acquire the geminal 
dimethyl groups. Later Chandrasekaran and co-workers followed the same strategy, 
treating 218 with NIS/MeOH (28 °C, 8 h) yielding 219 in 75% yield as a single 
diastereomer (B, Fig. 59). 219 was then efficiently applied for the synthesis of 2-C-
branched glyco-amino acid derivatives. 
 
 
 
 
 
Figure 60 General scheme for the ring opening of cyclopropane 
 
3.2.2 NBS-Promoted Cyclopropane Ring Opening: In accordance with the 
aforementioned results, 1,2-cyclopropanecarboxylated furanoid 189 was envisioned as a 
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suitable synthon for the diastereoselective ring opening of the cyclopropane, utilizing its 
ability to undergo, in the presence of a protic solvent, electrophilic ring opening assisted 
by adjacent oxygen (Fig. 60). 
 However, taking into consideration the low stability of iodo-derivatives, N-
bromosuccinimide (NBS) was preferred as an electrophile. Acetic acid as well as 
methanol was chosen as the appropriate protic solvent. Additionally azide was also 
examined as a potential nucleophile with the intention of introducing the amine 
functionality at the anomeric center. The results obtained are summarized in Fig. 61. 
 
 
 
 
 
 
 
 
 
Nucleophile 
 
Solvent 
 
Temp. 
 
Time 
 
Yield 
Diastereomeric
Ratio (a) 
 
MeOH 25 oC 24 h 78% 90:10 OMe 
OMe MeOH 15 oC 36 h 86% 100:0 
OAc AcOH 25 oC 3 h Decomposition - 
MeOH(b) 25 oC 48 h No reaction - N3 
N3 MeOH(b) Reflux (c) 24 h No reaction - 
 
(a) Diastereomeric ratio was determined according to the stereochemistry at the 
anomeric center. 
(b) NBS was not used in this reaction. 
(c) NaN3 in MeOH: the trans-esterification was observed. 
 
Figure 61 Results for the ring opening of cyclopropane in 189 
 
 Initially, when the reaction was carried out in the presence of light, very low 
yields were obtained. Moreover, the formation of unidentified side-products was also 
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observed. Hence, the subsequent experiments were carried out under exclusion of light. 
In case of the acetic acid, decomposition of the substrate was observed probably due to 
the concomitant deprotection of the cyclic acetal. When sodium azide was used as a 
nucleophile at room temperature, there was no formation of the product. However, at 
higher temperature only trans-esterification was observed. 
 Nevertheless, the treatment of 189 with NBS in MeOH under exclusion of light 
for 24 hours furnished the desired product 220. The temperature of the reaction played a 
significant role for the diastereomeric ratio with respect to the configuration at the 
anomeric center. While the reaction was carried out at 25 oC, the diastereomeric ratio 
obtained was 90:10, the one bearing the β-OMe group as a major diastereomer. 
However, at slightly lower temperature, complete β-diastereoselectivity could be 
attained. Even though the reaction time was longer (36 hours) in this case, it was well 
compensated by excellent diastereoselectivity as well as very good yield. Thus, two new 
stereocenters could be introduced in a single reaction, with complete 
diastereoselectivity. 
 
 
 
Figure 62 ORTEP diagram of 220 
 
 The structure and the absolute configuration of the α-bromo ester derivative 220 
was unambiguously established by NOE experiments and X-ray structure analysis. The 
ORTEP diagram is shown in Fig. 62. The crystal structure of 220 was in agreement with 
the stereochemical assignment for the ring opening products on the basis of NOE 
experiments. 
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On the basis of all these studies, it was confirmed that the anomeric bond in the 
strained cyclopropane ring in 189 underwent cleavage mediated by NBS under the 
effect of a protic solvent methanol (Fig. 63). 
 
 
Figure 66 Mechanism of the ring opening of cyclopropane in 189 
 
The simultaneous cleavage of the cyclopropane ring and trapping of the 
electrophilic bromine clearly followed the SN2 pathway. The resulting oxo-carbenium 
ion 221 is then attacked by methoxide acting as the nucleophile to yield the α-bromo 
ester 220. The attack occured exclusively from the β-face, probably because of the 
steric hinderance created by acetal ring as well as methyl ester functionality. 
3.2.3 Synthesis of Amino Acid Containing 2,3,4,5-Tetrasubstituted THF Ring in 
the Molecular Backbone: The conversion of α-bromo ester 220 into the amino acid 
scaffold was the next objective which was accomplished in three steps (Fig. 64). 
 
 
Figure 64 Conversion of 220 to amino acid scaffold 
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The SN2 substitution of bromine in 220 was achieved in excellent yield using 
sodium azide. Catalytic hydrogenolysis of the resulting azido ester 222 in the presence 
of Boc2O afforded the corresponding N-Boc-amino ester 223. The in situ protection of 
the amine functionality was carried out to in order to avoid the possible cyclization of 
amine with methyl ester. Finally, the differentiation between the two esters was the 
decisive task to complete. In fact, the methyl ester in 223 could be selectively 
hydrolyzed to the corresponding acid 224, when carefully subjected to 1 equivalent of 
lithium hydroxide at low temperature. 
 
 
 
 
 
 
 
Figure 65 The probable chelation responsible for the selective ester hydrolysis 
 
 The selective hydrolysis of the methyl ester was achieved successfully probably 
assisted by the tetrahydrofuran ring oxygen by forming a five membered chelate ring 
with the Li+ ion and the carbonyl oxygen of the methyl ester (Fig. 65). 
3.2.4 Conclusions and Outlook: In conclusion, the NBS-promoted cyclopropane ring 
opening of 1,2-cyclopropanecarboxylated furanoid in presence of a protic solvent was 
achieved with complete diastereoselectivity. This method was applied efficiently for the 
synthesis of a enantiomerically pure amino acid containing 2,3,4,5-tetrasubstituted THF 
ring in the molecular backbone. This amino acid can be further functionalized (e.g. 
chemoselective ring opening of the cyclic acetal and exploiting the reactivity of the 
resulting aldehyde) in order to acquire a library of THF amino acids. Also, the THF 
amino acids are interesting candidates as peptidomimetics or for the assembly of 
artificial ion channels. 
 This strategy can also be utilized as groundwork for the synthesis of γ- and δ-
lactone amino acids as shown in Fig. 66. Furan derivative 30 can be converted to 224 in 
6 steps via NBS-promoted ring opening. The treatment of 224 with 1,3-propane dithiol 
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the amino ester 225. A Lewis acid catalyzed cyclization of 225 would afford the δ-
lactone 226. 
 
 
Figure 66 The proposed scheme for synthesis of γ- and δ-lactone amino acids 
 
 Alternatively, the benzyl protection of the secondary alcohol in 225 followed by 
the deprotection of dithio acetal would provide the aldehyde 227. The NaBH4 reduction 
of 227 should afford the primary alcohol which is anticipated to cyclize in situ 
furnishing the γ-lactone amino acid 228. On the other hand, nucleophilic addition on 
227 would provide 229 which would further cyclize to form 230. 
3.3 Silica Catalyzed Ring Opening of Cyclopropane Ring in 1,2-
cyclopropanecarboxylated Furanoid: A New Entry to Functionalized 2,3,5-
Trisubstituted 2,5-Dihydro- And Tetrahydrofuran Derivatives: 
3.3.1 Introduction: The widespread occurrence of 2,5-dihydrofuran units in a number 
of natural products has led to increased interest in versatile and stereoselective methods 
for preparing such compounds.[23] 2,5-dihydrofurans represent pivotal structural 
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elements of a wide variety of different biologically active molecules. For instance, 2,5-
dihydrofurans can be found in mycotoxins, polyether antibiotics, spiroketals and even 
amino acids.[24-28] Examples in nature include 2,5-dihydrofurans 231 and 232, which are 
found in hops and similar spirans occur in the Santalina species (Fig 67).[29] 
 
 
 
 
 
Figure 67 Structures of naturally occurring 2,5-dihydrofurans 
 
 Similarly, saturated five membered ring heterocyclics such as tetrahydrofuran 
appear in a number of natural products. For example kumausynes (233 and 234)[30], 
kumausallene (235)[31] and laurefucin (236)[32, 33] (Fig. 68), found in the secondary 
metabolites of red algae of the genus Laurencia, growing in the costal waters around 
Japan. 
 
 
Figure 68 Structures of the natural products containing tetrahydrofuran 
 
 Despite the fact that dihydro- and especially tetrahydrofurans are found in the 
molecular backbone of many natural products, synthesis of this class of compounds 
with desired substituents in a stereoselective manner remains to be a significant 
challenge. 
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 For the synthesis of tetrahydrofurans,[34] reduction (catalytic hydrogenation) of 
furans represents one approach, which has the advantage that a variety of substituents 
can be introduced in the precursor furans, often regioselectively, via electrophilic 
substitution. However, this approach generally lacks stereoselectivity. Starting from 
ribose or deoxy-ribose is another common approach, which offers the advantage of 
inexpensive chiral starting materials but suffers from limited option of stereochemistry 
and functional groups that can be introduced. A variety of methodologies have also 
been developed for forming the DHF or THF rings from the acyclic precursors. These 
include cyclodehydration of 1,4-diols under acid catalysis or Mitsunobu conditions, 
cycloetherification of 5-hydroxy-olefins (5-exo cyclization) or 4-hydroxy olefins (5-
endo-cyclization) induced by halogens, mercury, selenium or transition metals and atom 
transfer radical cyclization of acyclic ethers. 
3.3.2 Silica Catalyzed Cyclopropane Ring Opening: During the investigation 
directed towards synthesis of norrisolide, the synthesis of 2,3,5-trisubstituted 2,5-
dihydrofuran intermediate 239 in enantiomerically and diastereomerically pure form 
was developed (Fig. 69). 
 
 
Figure 69 Synthesis of 239 
 
 With the intention of exploring the reactivity of the acetals in 189 and 190, as 
well as of the aldehyde 237 resulting after the deprotection of these acetals, attempts to 
deprotect 189 were carried out. Being sterically hindered and also comprising the 
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possibility of concomitant cyclopropane rearrangement, 189 did not respond 
satisfactorily to the various deprotection conditions tried e.g. p-TsOH, PPTS, HCl (1.5 
M), CAN, amberlyst-15, Montmorillonite-K10, TFA and I2. Nevertheless, the 190 was 
deprotected quantitatively when it was subjected to formic acid in dichloromethane for 
5 minutes. The structure and absolute configuration of the resulting aldehyde 237 was 
explicitly established by NOE experiments. 
 During the purification of 237 by silica gel chromatography the rearrangement 
of 237 into the mixture of the epimerized aldehyde 238 and the rearranged 239 was 
observed. Slow and repeated purification gave the unsaturated aldehyde 239 as an 
exclusive product. Alternatively, the aldehyde 239 was obtained exclusively in good 
yield, when crude 237 was stirred with silica gel in diethyl ether for 72 hours at 25 oC. 
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Figure 70 NOE spectrum of aldehyde 239 
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 In order to establish the structure and stereochemistry of 239, NOE experiments 
were carried out (Fig 70). The key NOE signals observed were H-5 to CH2CO2Et, H-4 
to CHO and CHO to H-2. But the interesting fact observed was that unlike other NOE 
signals, the protons H-2 and H-5 did not show any NOE signal (Fig 71). On the basis of 
this observation, one could assume that these protons are trans to each other. 
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Figure 71 Key NOE signals of aldehyde 239 
 
 The improved force field molecular mechanics calculations (MM2) of the 
structure were preformed in order to get an estimate for the distance between 2-H and 5-
H (Fig. 72).  
 
 
 
Figure 72 The minimum energy conformation of 239 
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These calculations revealed that in case of the minimum energy conformation of 
239, the distance between 2-H and 5-H is 3.682 Å, where as the maximum distance 
between which the two protons exhibit the NOE signal is 3.2 Å. Due to this, the 
corresponding NOE signal is not seen. 
 
 
 
 
 
 
 
Figure 73 Oxidation of 239 
 
 To confirm the assignment of the structure in 239, the aldehyde functionality 
was oxidized using NaClO2 in a very good yield affording the acid 240 as a white 
crystalline solid (Fig. 73). After recrystallization of 240, it was subjected to X-ray 
crystallography analysis. The ORTEP diagram of 240 is shown in Fig. 74, which 
confirms that both the hydrogens 2-H and 5-H are on the α-face. This proves that the C-
5 center did not epimerize during the silica catalyzed rearrangement of 237. 
 
 
 
Figure 74 ORTEP diagram of the acid 240 
 
 The combination of all the aforementioned studies helped to propose the 
mechanism for the silica catalyzed ring opening of cyclopropane ring in 237 (Fig. 75). 
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 Due to the acidity of silica gel the aldehyde present at C3 center of 237 
undergoes epimerization forming the β-aldehyde 238. Under the effect of acid, 238 
enolizes to form the intermediate 241, which then undergoes ring opening via 242 to 
form 239. 
 
 
Figure 75 Mechanism of the silica catalyzed cyclopropane ring opening of 237 
 
 The efforts to carry out this rearrangement in the presence of other Lewis acids 
e.g. p-TsOH, amberlyst-15, etc. were unsatisfactory. 
 
 
Figure 76 Microwave acceleration of the rearrangement of 237 
 
To accelerate the reaction rate, it was also carried out under microwave 
irradiations on silica support. Indeed, the complete conversion to the product was 
observed on TLC as well as on 1H NMR in 3 hours in quantitative yield (Fig. 76). 
3.3.3 Synthesis of Dihydro- And Tetrahydrofuran Derivatives: Attempts to carry 
out 1,4 addition of azide as well as alkyl nucleophile on the unsaturated aldehyde in 239 
with the intention of forming tetrasubstituted tetrahydrofuran derivatives were not 
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satisfactory. In order to synthesize the corresponding trisubstituted tetrahydrofuran 
derivative, 239 was hydrogenated to afford 243 as a single diastereomer orienting the 
aldehyde on β-face (Fig. 77). 
 
 
 
 
 
 
 
Figure 77 Derivatization of 239 
 
3.3.4 Conclusions and Outlook: In conclusion, a practical synthesis of 2,3,5-
trisubstituted 2,5-dihydro and tetrahydrofuran derivatives was developed. This approach 
is principally based on the silica catalyzed rearrangement of 1,2-
cyclopropanecarboxylated furanoid 237 being accessible in the enantiomerically pure 
form, which undergoes a completely diastereoselective cyclopropane rearrangement. It 
is conceivable that 239 can be a valuable intermediate for the synthesis of structurally 
more complex compounds. 
3.4 Ozonolysis of 1,2-cyclopropanecarboxylated Dihydrofurans: A Synthetic 
Strategy Towards Structurally Diverse γ-butyrolactone Scaffolds: 
3.4.1 Introduction: γ-Butyrolactones are a very common structural element in organic  
compounds present in about 10% of all natural products. A wide variety of naturally 
occurring mono-, di- and trisubstituted monocyclic γ-butyrolactones are known, but 
they are also found as part of more complex frameworks, especially in bicyclic and 
tricyclic ring systems. They display a broad biological profile including strong 
antibiotic, antihelmitic, antifungal, antitumor, antiviral, antiinflammatory and cytostatic 
properties, which makes them interesting lead structures for new drugs. Consequently, 
several methods for the stereoselective synthesis of γ-butyrolactone scaffold are 
continuously evolving.[35] 
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Figure 78 Stereoselective Synthesis of γ-butyrolactones by Reiser et. al. 
 
 Recently our group has reported the stereoselective synthesis of anti-
disubstituted γ-butyrolactones 244 in either enantiomeric form using the 1,2-
cyclopropanecarboxylated dihydrofuran 31 as a starting point. The strategy was 
predominantly based on the ozonolysis of 31 followed by the addition of allyl 
nucleophiles on the resulting aldehyde and subsequent lactonization. 
In the resulting lactones 244, the aldehyde functionality was readily transformed 
by alkenylation, allylation or amination reactions, while the allyl group was used in 
cross-metathesis (CM) and ring closing metathesis (RCM) or radical cyclization 
reactions. Thereby, paraconic acids or a variety of bi- (5.6 or 5.7) and tricyclic (5.6.5, 
5.6.6, 5.7.5, or 5.7.6) scaffolds, being commonly found in elemanolides, 
eudesmanolides, xanthanolides or guaianolides, were accessible in only a few steps 
(Fig. 78).[36-40] 
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The 1,2-cyclopropanecarboxylated dihydrofurans synthesized in the preceding 
sections were envisioned as the suitable substrates for the abovementioned ozonolysis 
strategy. These substrates were expected to form the corresponding γ-butyrolactones 
with a quaternary center caused by the substituent at C3 center. 
 
 
Figure 79 Attempted ozonolysis strategy 
 
3.4.2 Ozonolysis and Lactonization: As expected, the ozonolysis of 176 was quite 
successful yielding 250 in good yield (Fig. 79). However, various attempts to add a 
nucleophile on the ketone functionality in 250 failed completely. The possible reason 
behind this could be the reduced electrophilicity of the ketone functionality because of 
which the oxalyl ester got cleaved before the nucleophile could add on the ketone in all 
the attempts. 
 Consequently, the bromomethyl derivative 251 was chosen as an alternative 
substrate, which was synthesized by cleaving the double bond in 177 oxidatively via 
ozonolysis. The carbonyl carbon in 251 was anticipated to be more electrophilic due to 
the –I effect exerted by the bromine atom. Indeed, the allyl nucleophile could be added 
without difficulty on the bromoketone 251 using allyl-tri-butyl tin in the presence of 
BF3.OEt2. The product was obtained as a diastereomeric mixture of the corresponding 
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alcohol 252. However, lactonization of these alcohols under the effect of base was not 
successful probably due to the side reactions caused by the halohydrin functionality 
present in 252. 
 
 
Figure 80 Plan for the synthesis of γ-butyrolactone with a quaternary center 
 
3.4.3 Conclusions and Outlook: In conclusion, the attempt towards development of a 
new asymmetric strategy to γ-butyrolactones containing a quaternary center was carried 
out. The resulting lactones were envisioned as versatile building blocks for the natural 
product syntheses. However, due the reasons discussed above the result was not fairly 
satisfying. 
Nevertheless, an alternative to achieve this synthesis could be as shown in Fig. 
80. Protection of the primary alcohol in 180 with appropriate protecting group will 
result in the ether 254 which might serve as a better starting point for the ozonolysis, 
nucleophilic addition and lactonization sequence to yield the desired product 257. 
References: 
[1] H.-U. Reissig, R. Zimmer, Chemical Reviews (Washington, DC, United States) 
2003, 103, 1151. 
[2] M. Yu, B. L. Pagenkopf, Tetrahedron 2005, 61, 321. 
[3] A. de Meijere, S. I. Kozhushkov, A. F. Khlebnikov, Topics in Current 
Chemistry 2000, 207, 89. 
[4] Z. Rappoport, Chemistry of the Cyclopropyl Group. A 2-Volume Set, 1987. 
[5] E. Wenkert, Heterocycles 1980, 14, 1703. 
[6] E. Wenkert, Accounts of Chemical Research 1980, 13, 27. 
O
MeO2C
H
H
CO2Et
180
CO2Et
OCOCO2Me
O
255
PGO
OH
CO2Et
OCOCO2Me
OH
256
PGO
OO
CHO
OPG
257
O
MeO2C
H
H
CO2Et
254
OPG
Section 3. Donor-Acceptor Substituted Cyclopropanes and Their Rearrangements 73 
 
[7] M. P. Doyle, J. H. Griffin, V. Bagheri, R. L. Dorow, Organometallics 1984, 3, 
53. 
[8] H. U. Reissig, Tetrahedron Letters 1985, 26, 3943. 
[9] A. K. Ghosh, C.-X. Xu, S. S. Kulkarni, D. Wink, Organic Letters 2005, 7, 7. 
[10] A. Schrey, F. Osterkamp, A. Straudi, C. Rickert, H. Wagner, U. Koert, B. 
Herrschaft, K. Harms, European Journal of Organic Chemistry 1999, 2977. 
[11] E. G. von Roedern, E. Lohof, G. Hessler, M. Hoffmann, H. Kessler, Journal of 
the American Chemical Society 1996, 118, 10156. 
[12] E. Graf von Roedern, H. Kessler, Angewandte Chemie 1994, 106, 684. 
[13] J. P. McDevitt, P. T. Lansbury, Jr., Journal of the American Chemical Society 
1996, 118, 3818. 
[14] A. Dondoni, M.-C. Scherrmann, A. Marra, J.-L. Delepine, Journal of Organic 
Chemistry 1994, 59, 7517. 
[15] A. Dondoni, M.-C. Scherrmann, Journal of Organic Chemistry 1994, 59, 6404. 
[16] H. P. Wessel, C. M. Mitchell, C. M. Lobato, G. Schmid, Angewandte Chemie, 
International Edition in English 1996, 34, 2712. 
[17] Y. Suhara, J. E. K. Hildreth, Y. Ichikawa, Tetrahedron Letters 1996, 37, 1575. 
[18] M. D. Smith, D. D. Long, T. D. W. Claridge, G. W. J. Fleet, D. G. Marquess, D. 
G. Marquess, Chemical Communications (Cambridge) 1998, 2039. 
[19] T. K. Chakraborty, S. Jayaprakash, P. V. Diwan, R. Nagaraj, S. R. B. Jampani, 
A. C. Kunwar, Journal of the American Chemical Society 1998, 120, 12962. 
[20] M. D. Smith, T. D. W. Claridge, G. W. J. Fleet, G. E. Tranter, M. S. P. Sansom, 
Chemical Communications (Cambridge) 1998, 2041. 
[21] P. Bertinato, E. J. Sorensen, D. Meng, S. J. Danishefsky, Journal of Organic 
Chemistry 1996, 61, 8000. 
[22] P. R. Sridhar, K. C. Ashalu, S. Chandrasekaran, Organic Letters 2004, 6, 1777. 
[23] T. G. Kilroy, T. P. O'Sullivan, P. J. Guiry, European Journal of Organic 
Chemistry 2005, 4929. 
[24] B. Franck, H. P. Gehrken, Angewandte Chemie (International ed. in English) 
1980, 19, 461. 
[25] M. Ganguli, L. T. Burka, T. M. Harris, Journal of Organic Chemistry 1984, 49, 
3762. 
[26] U. Koert, M. Stein, H. Wagner, Chemistry--A European Journal 1997, 3, 1170. 
Section 3. Donor-Acceptor Substituted Cyclopropanes and Their Rearrangements 74 
 
[27] F. Perron, K. F. Albizati, Chemical Reviews (Washington, DC, United States) 
1989, 89, 1617. 
[28] M. P. VanBrunt, R. F. Standaert, Organic Letters 2000, 2, 705. 
[29] A. W. Burgstahler, G. N. Widiger, Journal of Organic Chemistry 1973, 38, 
3652. 
[30] T. Suzuki, K. Koizumi, M. Suzuki, E. Kurosawa, Chemistry Letters 1983, 1643. 
[31] T. Suzuki, K. Koizumi, M. Suzuki, E. Kurosawa, Chemistry Letters 1983, 1639. 
[32] A. Furusaki, E. Kurosawa, A. Fukuzawa, T. Irie, Tetrahedron Letters 1973, no. 
46, 4579. 
[33] A. Fukuzawa, E. Kurosawa, T. Irie, Tetrahedron Letters 1972, 3. 
[34] G. T. Wang, S. Wang, Y. Chen, R. Gentles, T. Sowin, Journal of Organic 
Chemistry 2001, 66, 2052. 
[35] M. Seitz, O. Reiser, Current Opinion in Chemical Biology 2005, 9, 285. 
[36] E. Jezek, A. Schall, P. Kreitmeier, O. Reiser, Synlett 2005, 915. 
[37] B. Nosse, R. B. Chhor, W. B. Jeong, C. Boehm, O. Reiser, Organic Letters 
2003, 5, 941. 
[38] R. B. Chhor, B. Nosse, S. Sorgel, C. Bohm, M. Seitz, O. Reiser, Chemistry--A 
European Journal 2003, 9, 260. 
[39] C. Boehm, O. Reiser, Organic Letters 2001, 3, 1315. 
[40] C. Bohm, M. Schinnerl, C. Bubert, M. Zabel, T. Labahn, E. Parisini, O. Reiser, 
European Journal of Organic Chemistry 2000, 2955. 
 
 
 
 
 
 
 
 
 
 
 
 
Section 4. Summary 75 
 
4 Summary: 
The overall goal of the present thesis was the further development of copper-(I)-
bisoxazoline catalyzed cyclopropanation of furans as a key step towards furanoids as 
found in a range of marine natural products.  
In this context, an improved procedure for the synthesis of bis(4-
isopropyloxazoline) 164 was developed. This procedure resembles the previously 
reported protocols for 163. The main differences can be found in the workup conditions, 
which accommodate the quite different solubility and crystallization properties of 
intermediates and final ligand 164. 
 
 
 
 
The asymmetric cyclopropanation of the substituted furan derivative 154 was 
developed with excellent regio-, diastereo- and enantioselectivity. 
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Conversion of the 1,2-cyclopropanecarboxylated dihydrofuran 176 to 177 
allowed to enhance the enantiomeric excess to >99% ee. Moreover, the allylic bromide 
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is a versatile functionality, which could be further manipulated towards the synthesis of 
various 1,2-cyclopropanecarboxylated dihydrofurans (e.g. 191). 
 
 
 
 
The stereoselective synthesis of cis-fused furo[2,3-b]furans was achieved as an 
application of these derivatives, which gave intermediates 193-197, relevant for the 
synthesis of norrisolide 8 as well as various spongiane diterpenoids containing 
distinctive furo[2,3-b]furan framework. 
 
 
 
 
The strategy followed is predominantly based on acid-mediated one-pot ring 
expansion of the corresponding cyclopropanes. The main advantage of the strategy is 
the orientation of the functional group in such a way that the side-chains could be 
introduced on concave as well as convex face of the bicycle. 
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NBS-promoted ring opening of 1, 2 cyclopropanecarboxylated furanoid 189 was 
another application which provided the stereocontrolled 4 steps access to unnatural 
THF-containing α-amino acid 224 with multiple stereocenters. 
 
 
 
 
 
 
 
 
 
Silica catalyzed ring opening of 1,2-cyclopropanecarboxylated furanoid 237 
yielding the enantiomerically pure dihydrofuran derivative 239 was further studied in 
the course of these investigations. This intermediate can be used in the synthesis of 
substituted tetrahydrofurans (e.g. 243), being found in many natural products. 
 
 
 
 
The ozonolysis, nucleophilic addition and base catalyzed lactonization sequence in 
order to build up γ-butyrolactones of the type 258 containing quaternary center was not 
successful due to various reasons as stated before. 
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In conclusion, the stereoselective synthesis of 1,2-cyclopropanecarboxylated 
furanoids and their applications in the preparation of marine natural products and 
unnatural amino acids was carried out. 
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5 Experimental part  
5.1 Instruments and general techniques: 
1H NMR: Bruker ARX 400 (400 MHz), Bruker Avance 300 (300 MHz). The 
chemical shifts are reported in δ (ppm) relative to chloroform (CDCl3, 7.26 ppm), 
dimethylsulfoxide (DMSO-d6, 2.50 ppm), methanol (CD3OD, 3.31 ppm) and 
tetramethylsilane (TMS, 0 ppm). The spectra were analyzed by first order, the coupling 
constants are reported in Hertz (Hz). Characterization of signals: s = singlet, d = 
doublet, t = triplet, q = quartet, m = multiplet, bs = broad singlet, dd = double of a 
doublet, dt = double of a triplet, dq = double of a quartet, ddd = double of a doublet of a 
doublet, dddd = doublet of a doublet of a doublet of a doublet, Integration is determined 
as the relative number of atoms. Diastereomeric ratios were determined by comparing 
the integrals of corresponding protons in the 1H NMR spectra. 
13C NMR: Bruker ARX 400 (100.6 MHz), Bruker Avance 300 (75.5 MHz). The 
chemical shifts are reported in δ (ppm) relative to chloroform (CDCl3, 77.16 ppm), 
dimethylsulfoxide (DMSO-d6, 36.52 ppm), methanol (CD3OD, 49.0 ppm) and 
tetramethylsilane (TMS, 0 ppm). 13C NMR resonance assignment were aided by the use 
of the DEPT 135 (DEPT = distortionless enhancement by polarization transfer) 
technique to determine the number of hydrogens attached to each carbon atom and is 
declared as: + = primary or tertiary (positive DEPT signal intensity), − = secondary 
(negative DEPT signal) and quat = quaternary (no DEPT signal intensity) carbon atoms. 
In some cases DEPT 90 spectra were recorded to distinguish between primary and 
tertiary carbon atoms. This is marked with the CH or CH3 notation at the corresponding 
signal. 
2D-NMR: Bruker DRX-500 spectrometer operating at a basic 1H frequency of 
500 MHz at 298 oK. The spectra were recorded at 280 oK, using the solvent line 
(CD3OH, 1 H δ 3.31) for referencing. DQF-COSY, 80 ms-TOCSY and 500 ms-ROESY 
standard experiments were performed with suppression of the methanol OH line by 
low-power presaturation. 
IR-spectra: were recorded with an ATI Mattson Genesis Series FT-IR or a Bio-
Rad Excalibur series FT-IR. 
MS-spectra: masspectroscopy department of the University of Regensburg, 
Varian Mat 311 A. 
Elemental analysis: microanalytical department of the University of 
Regensburg. 
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Melting points: (m.p.) were determined with a Buchi SMP 20 and are 
uncorrected. 
Thin layer chromatography: (TLC) was performed on alumina plates coated 
with silica gel (Merck silica gel 60 F 254, layer thickness 0.2 mm). Visualization was 
accomplished by UV light (wavelenght λ = 254 nm) and a vanillin/sulphuric acid 
solution or Mostain. 
Optical rotations: were measured on a Perkin-Elmer-Polarimeter 241 with 
sodium lamp at 589 nm in the specified solvent. The optical rotation was calculated 
with the following formula: 
 
[ ]20Dα  = ([α]exp x 100)/ (c x d) 
 
20 = temperature (°C) 
[α]exp = measured value 
c = concentration (g/100 ml) 
d = length of the cuvette 
 
Column chromatography: was performed on silica gel Geduran SI 60 (70-230 
mesh) purchased from Merck and flash chromatography on flash-silica gel 60 (230-400 
mesh ASTM) purchased from Merck. Solvents were purified according to standard 
laboratory methods. THF, diethyl ether and toluene were distilled over 
sodium/benzophenone before use. Dichloromethane, DMSO and DMF were distilled 
over calcium hydride and acetonitrile over P2O5. Methanol was refluxed 2 h over 
magnesia, distilled and stored under nitrogen over 4 Å molecular sieves. The hexanes 
used had a boiling point of 40-60 °C. All solvents were distilled before use. Other 
chemicals were purchased from commercial suppliers and used as received. 
All reactions with oxygen or moisture sensitive reactants were performed under 
nitrogen atmosphere. 
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5.2  Synthesis of compounds 
 
 
(–)-(S,S)-N,N'-Bis(1-hydroxymethyl-2-methylpropyl)-2,2-dimethyl-malonamide 
(170): An oven-dried 250 mL, 3-necked round-bottom flask equipped with a stirring bar 
and two 50 mL pressure-equalizing addition funnels connected to a mineral oil bubbler 
was purged with nitrogen and charged with (L)-valinol 167 (5.13 g, 0.050 moles). The 
flask was immersed in an ice bath at 0 °C and triethylamine (17.4 mL, 0.124 moles) was 
added dropwise via the first addition funnel. 2,2-Dimethylpropanedioyl dichloride 169 
(3.3 mL, 0.25 moles) in abs. dichloromethane (25 mL) was then added dropwise over 
25 minutes via the second addition funnel. The internal temperature increased from 0 °C 
to 10 °C during the addition.  Subsequently, the ice bath was removed and the reaction 
mixture was allowed to warm to room temperature. Stirring was continued for 45 min, 
resulting in a colorless precipitate that was dissolved by addition of abs. 
dichloromethane (120 mL). After addition of aqueous HCl (1N, 30 mL), the aqueous 
layer was separated and extracted with dichloromethane (3 x 15 mL). The combined 
organic layers were washed with saturated NaHCO3 solution (30 mL) and brine (30 
mL), dried over MgSO4, filtered and concentrated in vacuo to afford crude 170 as a pale 
yellow solid. Recrystallization of the crude product from ethyl acetate (40 mL) yielded 
170 (4.30 g, 14.2 mmol, 57%) as white crystals. The mother liquor was concentrated 
and the residue recrystallized from ethyl acetate (10 mL) to yield a second crop of 170 
(1.60 g, 5.27 mmol, 21%); the process was repeated to yield a third crop of 170 (0.440 
g, 1.45 mmol, 6%, total yield: 6.40 g, 21.1 mmol, 84%). 
 
Rf = 0.25 (SiO2, EtOAc/MeOH, 95:5); m.p. = 98−99 °C; [ ]20Dα  = −6.0 (c = 0.50, 
CH2Cl2); 1H NMR (300 MHz, CDCl3): δ = 0.92 (d, J = 6.8 Hz, 6 H), 0.96 (d, J = 6.8 
Hz, 6 H), 1.50 (s, 6 H), 1.82 (oct, J = 6.8 Hz, 2 H), 2.66 (bs, 2 H), 3.52 (m, 2 H), 
3.69−3.86 (m, 4 H), 6.41 (d, J = 8.6 Hz, 2 H); 13C NMR (75 MHz, CDCl3): δ = 18.8, 
19.6, 23.7, 29.1, 50.2, 57.1, 63.5, 174.5; IR (KBr): ~ν  = 3349, 3380, 2962, 2886, 1658, 
1530, 1049, 1033 cm-1; MS (ES) m/z (%) = 405.2 (20), 325.2 ([M+Na]+, 100), 285.2 
(10); HRMS (ES) calcd. for C15H30N2O4Na 325.2103, found 325.2084; elemental 
OH
N
H
O
N
H
O
OH
Section 5. Experimental Part 82 
 
analysis calcd (%) for C15H30N2O4 (302.41): C 59.57, H 10.00, N 9.26; found: C 59.01, 
H 10.12, N 9.11. 
 
 
(–)-(S,S)-Bis(4-isopropyloxazoline) (164): An oven-dried 500 mL, 2-necked round-
bottom flask equipped with a stirring bar and a 50 mL, pressure-equalizing addition 
funnel connected to a mineral oil bubbler was purged with nitrogen and charged with (–
)-(S,S)-N,N'-bis-(1-hydroxymethyl-2-methylpropyl)-2,2-dimethylmalonamide 170 (5.5 
g, 18.4 mmol), 4-dimethylaminopyridine (0.204 g, 1.67 mmol) and abs. 
dichloromethane (130 mL). The flask was immersed in a water bath at room 
temperature and triethylamine (10.25 mL, 73.4 mmol) was added slowly via syringe. 
Subsequently, tosyl chloride (7.10 g, 37 mmol, 2.0 equiv.), dissolved in abs. 
dichloromethane (15 mL), was added dropwise over 30 minutes via the addition funnel. 
After completion of the addition, the funnel was rinsed with abs. dichloromethane (2.5 
mL) and the reaction mixture was stirred for an additional 27 hours at room 
temperature. The reaction mixture was treated with saturated NH4Cl solution (70 mL) 
followed by water (40 mL). The aqueous layer was separated and extracted with 
dichloromethane (3 x 55 mL), and the combined organic layers were dried over MgSO4. 
The organic solution was filtered and concentrated under vacuum. The oily residue was 
treated with hot pentane (40 mL), stirred for 5 min and the supernatant liquid was 
decanted. This procedure was repeated three times and the collected pentane layers were 
combined and concentrated under vacuum to yield 164 (4.05 g, 15.2 mmol, 83%) as 
colorless oil.  
 
Rf =  0.25 (SiO2, CH2Cl2/MeOH, 19:1); [ ]α D20  = −107.5 (c 1.0, CH2Cl2); 1H NMR (300 
MHz, CDCl3): δ = 0.85 (d, J = 6.8 Hz, 6 H), 0.91 (d, J = 6.8 Hz, 6 H), 1.51 (s, 6 H), 
1.88−1.73 (m, 2 H), 4.06−3.93 (m, 4 H), 4.26−4.15 (m, 2 H); 13C NMR (75 MHz, 
CDCl3): δ = 17.3, 18.5, 24.4, 32.2, 38.5, 69.9, 71.5, 168.7; IR (film) ~ν  = 3308, 2960, 
2874, 1746, 1525, 1353, 1303, 1037, 1017, 895, 815, 714 cm-1; MS (EI) m/z (%) 266 
(M+, 15), 265 (30), 223 (100), 195 (30), 155 (65), 137 (97), 110 (50); HRMS (EI) calcd 
O
N N
O
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for C15H26N2O2 266.1994, found 266.1987; elemental analysis calcd (%) for 
C15H26N2O2 (266.38): C 67.63, H 9.84, N 10.52; found C 66.65, H 9.81, N 10.08. 
 
 
 
 
5-Methyl-furan-2-carboxylic acid methyl ester (171): A solution of NaClO2 (2.715 g, 
30 mmol, 3 equiv.) in water (1 mL) was added dropwise to a stirred mixture of 5-
methyl-furfural 173 (1.1 g, 10 mmol, 1 equiv.) in acetonitrile (20 mL), KH2PO4 (1.293 
g, 9.5 mmol, 0.95 equiv.) in water (10 mL) and of 30% H2O2 (1.54 mL, 15 mmol, 1.5 
equiv.), keeping the temperature at 0 oC. Oxygen evolved from the solution until the end 
of the reaction (12 hours) with a bubbler connected to the apparatus. A small amount of 
Na2SO3 (1.89 g, 15 mmol, 1.5 equiv.) was added to destroy the unreacted HOCl and 
H2O2. After acidification with 6N HCl, the mixture was extracted with dichloromethane 
(3 × 30 mL). The combined organic layers were washed with water (1 × 10 mL), dried 
over anhydrous Na2SO4 and concentrated in vacuo. The crude acid was dissolved in 
methanol (10 mL) and then Conc. H2SO4 (0.2 mL) was added to it. The solution was 
refluxed for 24 hours. Methanol was removed under vacuo and the residue was taken 
into dichloromethane (10 mL). This was washed with saturated NaHCO3 (1 × 5 mL), 
brine (1 × 5 mL) and dried over anhydrous MgSO4 and filtered. The dichloromethane 
was removed under vacuo. The residue was purified by column chromatography on 
silica (hexanes/ethyl acetate 9:1) to provide 171 as colorless oil (0.84 g, 60%). 
 
Rf = 0.25 (SiO2, hexanes/ethyl acetate, 9:1); 1H NMR (300 MHz, CDCl3): δ = 2.37 (s, 3 
H, CH3), 3.86 (s, 3 H, CO2Me), 6.10 (dd, J = 0.89, 3.36 Hz, 1 H, 4-H), 7.08 (dd, J = 
3.36 Hz, 1 H, 3-H); 13C NMR (75 MHz, CDCl3): δ = 14.1 (+, CH3), 51.9 (+, CO2Me), 
108.6 (+, C-4) 119.6 (+, C-3), 143.1 (Cquat, C-2) 157.3 (Cquat, C-5), 159.3 (Cquat, 
CO2Me). 
 
 
3-(2,2-dimethoxy-ethyl)-3-methyl-oxirane-2-carboxylic acid methyl ester (175): A 
2-L. three-necked flask was equipped with a sealed centrifugal stirrer, a thermometer 
OMe
MeO
CH3
O
CO2Me
O CH3
MeO2C
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inserted through an adapter with a side arm connected to a source of dry nitrogen, and a 
250-mL Erlenmeyer addition flask. The apparatus was dried with a free flame in a slow 
stream of nitrogen; from this point the reaction was conducted in an atmosphere of 
nitrogen. A mixture of 4,4-dimethoxy-2-butanone 174 (94.373 g, 0.714 moles, 1 
equiv.), methyl chloroacetate (124 g, 1.143 moles, 1.6 equiv.), and 570 mL of abs. ether 
was placed in the reaction flask, then sodium methoxide (61.719 g, 1.143 moles, 1.6 
equiv.) was placed in the addition flask. The solution was cooled in an ice-salt bath to –
10 oC, and then sodium methoxide was added gradually at a rate such that a temperature 
below –5 oC could be maintained (about 2 hours). The mixture was stirred for an 
additional 2 hours and then allowed to warm to room temperature. It was then stirred at 
the same temperature for 48 hours. It was cooled again to 0 oC and made slightly acidic 
by the addition of 8 mL of glacial acetic acid in 120 mL of water. The ether was 
decanted and the residual slurry was extracted with ether (3 × 100 mL). The combined 
ether solutions were washed with 50 mL of sat. NaCl solution to which was added 1 g 
portions of NaHCO3 until the washings were no longer acidic. Finally ether layer was 
washed with sat. NaCl solution and then dried over anhydrous MgSO4. The ether was 
removed in vacuo. The residual glycidic ester was distilled through a 15-cm vigreux 
column to yield (148.85 g, 97%) of colorless oil as the product 175. 
 
b.p. = 113-122 oC/8 mm; 1H NMR (300 MHz, CDCl3): δ = 1.36 (d, J = 15.4 Hz, 3 H), 
1.95 (m, 2 H), 3.24 (d, J = 8.5Hz, 3 H), 3.27(d, J = 7.96 Hz, 3 H), 3.72 (d, J = 4.39 Hz, 
3 H), 3.39 (s, 1 H), 4.45 (m, 1 H). 
 
 
 
 
 
3-Methyl-furan-2-carboxylic acid methyl ester (154): 175 (148.85 g, 0.73 moles, 1 
equiv.) was taken in a flask which was connected to a distillation condenser. Toluene-4-
sulfonic acid monohydrate (2.773 g, 0.015 moles, 2.0 mol%) was added to it. The 
mixture was then heated. When the liquid temperature reached 130 oC, MeOH began to 
distill. The heating was continued until the distillation of MeOH essentially ceased. 
After the heating bath had been allowed to cool, the product was distilled at reduced 
O
MeO2C
H3C
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pressure (b.p. = 72-78 oC/8mm). The crude product 154 was recrystallized in EtOH to 
yield a white crystalline solid (85.1 g., 88%). 
 
m.p. = 36.5-37 oC; 1H NMR (300 MHz, CDCl3): δ = 2.35 (s, 3 H, CH3), 3.89 (s, 3 H, 
CO2Me), 6.35 (d, J = 1.65 Hz, 1 H, 4-H), 7.43 (d, J = 1.65 Hz, 1 H, 5-H); 13C NMR 
(75.5 MHz, CDCl3): δ = 11.6 (+, CH3), 51.7 (+, CO2Me), 115.2 (+, C-4), 131.3 (Cquat, 
C-3), 140.3 (Cquat, C-2), 145.0 (+, C-5), 160.1 (Cquat, CO2Me); MS (EI, 70 eV): m/z (%) 
= 140.0 (65) [M+], 125.0 (11) [M+ − CH3], 109.0 (100) [M+ − OCH3]. 
 
 
 
 
 
(1S,5R,6S)-(−)-4-Methyl-2-oxa-bicyclo[3.1.0]hex-3-ene-3,6-dicarboxylic acid 6-ethyl 
ester 3-methyl ester (176): Phenylhydrazine (0.34 mL, 3.25 mmol, 1.2 mol%) was 
added under nitrogen at 0 oC to a solution of 154 (40.00 g, 0.285 moles, 1.0 equiv.), 
Cu(OTf)2 (1.032 g, 2.85 mmol, 1 mol%) and (−)-164 (1.901 g, 7.14 mmol, 2.5 mol%) in 
CH2Cl2 (20 mL). After 20 min, a solution of ethyl diazoacetate (132.30 g, 1.142 moles, 
4 equiv.) in CH2Cl2 (800 mL) was added through a dropping funnel over 10 days. The 
reaction mixture was filtered through a short pad of basic alumina and solvent was 
removed in vacuo. The residue was purified by column chromatography on silica 
(hexanes/ethyl acetate 19:1) to provide 176 as colorless oil (46.79 g, 72%, 91% ee). 
 
Rf = (SiO2, hexanes/ethyl acetate 4:1) = 0.24; [ ]α D20  = −215.2 (c 1.0, CH2Cl2); 1H NMR 
(300 MHz, CDCl3): δ = 1.18 (dd, J = 2.64, 1.06 Hz, 1 H, 6-H), 1.27 (t, J = 7.15 Hz, 3 H, 
CH2CH3), 2.21 (d, J = 0.58 Hz, 3 H, 4-CH3), 2.79 (ddq, J = 0.58, 5.32, 2.64 Hz, 1 H, 5-
H), 3.81 (s, 3 H, CO2Me), 4.15 (m, 2 H, CH2CH3), 4.82 (dd, J = 5.32, 1.06 Hz, 1 H, 1-
H); 13C NMR (75.5 MHz, CDCl3): δ = 12.8 (+, 4-CH3), 14.4 (+, CH2CH3), 21.8 (+, C-
6), 37.2 (+, C-5), 52.0 (+, CO2Me), 61.2 (−, CH2CH3), 65.4 (+, C-1), 130.0 (Cquat, C-4), 
141.5 (Cquat, C-3), 160.7 (Cquat, CO2Me), 172.1 (Cquat, CO2Et); IR (film): ~ν  = 2955, 
1715, 1639, 1441, 1284, 1162, 1047, 998, 833, 776 cm-1; MS (EI, 70 eV): m/z (%) = 
226.0 (13) [M+], 181.0 (7) [M+ − OCH2CH3], 153 (100) [M+ − CO2CH2CH3], 139 (26), 
111 (21), 93 (7); MS (HR-EI, 70 eV): 226.0840 (C11H14O5: calc. 226.0841 [M+]). 
O
MeO2C
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(1S,5R,6S)-(−)-4-Bromomethyl-2-oxa-bicyclo[3.1.0]hex-3-ene-3,6-dicarboxylic acid 
6-ethyl ester 3-methyl ester (177): 176 (20.00 g, 88.4 mmol, 1 equiv.), AIBN (1.452 g, 
8.8 mmol, 10 mol%) and NBS (16.52 g, 92.8 mmol, 1.05 equiv.) were refluxed in CCl4 
(400 mL) for 3 hours (TLC control). The drop of molecular bromine was used to initiate 
the reaction. The solution was cooled to 0 oC overnight and filtered. The organic layer 
was then washed with water (3 × 100 mL), dried over anhydrous MgSO4 and filtered. 
The CCl4 was removed in vacuo. The residue was purified by column chromatography 
on silica (hexanes/ethyl acetate 19:1) to provide 177 as colorless oil (16.60 g, 62%). The 
product was then recrystallized in n-hexane to obtain a white crystalline solid (12.14 g, 
45%, >99% ee). 
 
Rf = (SiO2, hexanes/ethyl acetate 4:1) = 0.22; m.p. = 42 oC; [ ]α D20  = −75.1 (c 1.0, 
CH2Cl2); 1H NMR (300 MHz, CDCl3): δ = 1.28 (dd, J = 2.73, 1.08 Hz, 1 H, 6-H), 1.28 
(t, J = 7.13 Hz, 3 H, CH2CH3), 2.99 (dd, J = 5.44, 2.73 Hz, 1 H, 5-H), 3.86 (s, 3 H, 
CO2Me), 4.17 (dq, J = 7.13, 1.53 Hz, 2 H, CH2CH3), 4.55 (d, J = 10.36 Hz, 1 H, 
CH2Br), 4.68 (d, J = 10.36 Hz, 1 H, CH2Br), 4.89 (dd, J = 5.44, 1.08 Hz, 1 H, 1-H); 13C 
NMR (75.5 MHz, CDCl3): δ = 14.3 (+, CH2CH3), 21.9 (+, C-6), 25.0 (−, CH2Br), 34.5 
(+, C-5), 53.0 (+, CO2Me), 61.4 (−, CH2CH3), 65.8 (+, C-1), 128.1 (Cquat, C-4), 143.4 
(Cquat, C-3), 159.8 (Cquat, CO2Me), 171.5 (Cquat, CO2Et); IR (KBr): ~ν  = 2989, 2360, 
1712, 1628, 1439, 1385, 1358,1300, 1210, 1186, 1124, 1070, 1029, 995,927, 899, 
826,784, 742 cm-1; MS (CI, NH3): m/z (%) = 323.9 (100) ) [M+ + NH4+], 322 (96) [M+ 
+ NH4+], 306.9 (8) [MH+], 305.0 (7) [MH+], 244.1 (4) [M+ − CO2Me], 242.1 (4) [M+ − 
CO2Me], 225.1 (10) [M+ − Br]; elemental analysis calcd (%) for C11H13BrO5 (305.12): 
C 43.30, H 4.29, Br 26.19, O 26.22; found C 43.31, H 4.32.  
 
 
 
 
O
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4-(Bromo-ethoxy-carbonyl-methyl)-3-methyl-furan-2-carboxylic acid methyl ester 
(178): After the column chromatography, of the residue of the reaction for 177, the 
white crystalline solid was obtained as a side product (5.395 g, 20%). 
 
Rf = (SiO2, hexanes/ethyl acetate 4:1) = 0.23; m.p. = 42 oC; 1H NMR (300 MHz, 
CDCl3): δ = 1.32 (t, J = 7.14 Hz, 3 H, CH2CH3), 2.33 (s, 3 H, 3-CH3), 3.89 (s, 3 H, 
CO2Me), 4.30 (dq, J = 7.14, 2.42 Hz, 2 H, CH2CH3), 5.41 (s, 1 H, CHBrCO2Et), 6.65 (s, 
1 H, Ar-H); 13C NMR (75.5 MHz, CDCl3): δ = 11.7 (+, C(CH3)), 14.0 (+, CH2CH3), 
36.8 (+, CHBrCO2Et), 51.9 (+, CO2Me), 63.1 (−, CH2CH3), 116.0 (+, C-5), 132.4 (Cquat, 
C-4), 140.8 (Cquat, C-3), 150.2 (Cquat, C-2), 159.7 (Cquat, CO2Me), 166.1 (Cquat, CO2Et); 
IR (KBr): ~ν  = 3470, 3400, 2959, 2579, 2509, 2241, 1895, 1749, 1611, 1539, 1440, 
1380, 1096, 949, 733 cm-1; MS (EI, 70 eV): m/z (%) = 304.1 (3) [M+], 225.0 (100), 
179.9 (12), 153.0 (35), 93.0 (14), 64.9 (11), MS (HR-EI, 70 eV): 303.9947 
(C11H13BrO5: calc. 303.9946 [M+]). elemental analysis calcd (%) for C11H13BrO5 
(305.12): C 43.30, H 4.29, Br 26.19, O 26.22; found C 43.31, H 4.32.  
 
 
 
 
 
 
 
 
(1S,5R,6S)-(−)-4-(4-Methoxy-phenoxymethyl)-2-oxa-bicyclo[3.1.0]hex-3-ene-3,6-
dicarboxylic acid 6-ethyl ester 3-methyl ester (179): A mixture of 4-Methoxyphenol 
(3.753 g, 30.2 mmol, 1.025 equiv.) and anhydrous K2CO3 (5.096 g, 36.9 mmol, 1.25 
equiv.) in acetone (100 mL) was stirred at 0 oC for 15 min. To this mixture was added a 
solution of 177 (9.0 g, 29.5 mmol, 1 equiv.) in acetone (50 mL) dropwise over a period 
of 30 min., reaction mixture being maintained at 0 oC during the addition. After the 
O
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addition reaction mixture was slowly allowed to come to room temperature, stirred for 
24 hours. The inorgainc salts were then filtered off and acetone was distilled off. The 
residue was taken up in ether (80 mL). The ether extract was washed with 2N NaOH (2 
× 30 mL), water (2 × 30 mL), dried over anhydrous MgSO4 and filtered. The ether was 
removed in vacuo. The residue was purified by column chromatography on silica 
(hexanes/ethyl acetate 4:1) to provide 179 as colorless oil (9.15 g, 89%). 
 
Rf = (SiO2, hexanes/ethyl acetate 4:1) = 0.21; [ ]α D20  = −116.6 (c 1.0, CH2Cl2); 1H NMR 
(300 MHz, CDCl3): δ = 1.11 (dd, J = 2.69, 1.11 Hz, 1 H, 6-H), 1.26 (t, J = 7.14 Hz, 3 H, 
CH2CH3), 3.06 (dd, J = 5.35, 2.69 Hz, 1 H, 5-H), 3.77 (s, 3 H, OCH3), 3.85 (s, 3 H, 
CO2Me), 4.13 (dq, J = 7.14, 4.91 Hz, 2 H, CH2CH3), 4.88 (dd, J = 5.33, 1.11 Hz, 1 H, 
1-H), 5.04 (d, J = 13.69 Hz, 1 H, CH2Ar), 5.15 (d, J =13.69 Hz, 1 H, CH2Ar), 6.85 (m, 4 
H, Ar); 13C NMR (75.5 MHz, CDCl3): δ = 14.3 (+, CH2CH3), 21.5 (+, C-6), 34.0 (+, C-
5), 52.5 (+, CO2Me), 55.8 (+, C-1), 61.2 (−, CH2CH3), 62.9 (−, CH2Ar), 66.1 (+, OMe), 
114.8 (+, Ar), 116.1 (+, Ar), 130.0 (Cquat, C-4), 143.0 (Cquat, C-3), 152.2 (Cquat, Ar), 
154.4 (Cquat, Ar), 160.1 (Cquat, CO2Me), 171.7 (Cquat, CO2Et); IR (film): ~ν  = 3419, 2985, 
2838, 1726, 1636, 1589, 1506, 1462, 1440, 1377, 1355, 1300, 1227, 1167, 1137, 1088, 
1039, 1016, 924, 896, 829, 771 cm-1; MS (CI, NH3): m/z (%) = 366.2 (100) [M + 
NH4+], 349.2 (7) [MH+], 331.2 (31) [MH+ − H2O], 242.1 (35), 225.1 (19); MS (HR-EI, 
70 eV): 348.1205 (C18H20O7: calc. 348.1209 [M+]). 
 
 
 
 
 
 
(1S,5R,6S)-(−)-4-Hydroxymethyl-2-oxa-bicyclo[3.1.0]hex-3-ene-3,6-dicarboxylic 
acid 6-ethyl ester 3-methyl ester (180): Ceric ammonium nitrate (43.20 g, 78.8 mmol, 
3 equiv.) was added in a single portion to the 179 (9.15 g, 26.3 mmol, 1 equiv) in 
acetonitrile : water (300 : 75 mL) at –5 oC under an atmosphere of nitrogen. The 
reaction mixture was stirred for an additional ca. 20 minutes (TLC control) and 
partitioned between ethyl acetate and water. The combined organic phases were washed 
with saturated NaHCO3 (3 × 75 mL), water (3 × 75 mL), dried over anhydrous MgSO4 
O
H
H
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and filtered. The solvent was removed in vacuo. The residue was purified by flash 
column chromatography on silica (hexanes/ethyl acetate 4:1) to provide 180 as colorless 
oil (5.22 g, 82%). 
 
Rf = (SiO2, hexanes/ethyl acetate 1:1) = 0.18; [ ]α D20  = −184.7 (c 1.0, CH2Cl2); 1H NMR 
(300 MHz, CDCl3): δ = 1.22 (dd, J = 2.69, 1.05 Hz, 1 H, 6-H), 1.27 (t, J = 7.14 Hz, 3 H, 
CH2CH3), 3.00 (dd, J = 5.33, 2.69 Hz, 1 H, 5-H), 3.03 (bs, 1 H, -OH), 3.85 (s, 3 H, 
CO2Me), 4.13 (q, J = 7.14 Hz, 2 H, CH2CH3), 4.63 (s, 2 H, -CH2OH), 4.89 (dd, J = 
5.33, 1.05 Hz, 1 H, 1-H); 13C NMR (75.5 MHz, CDCl3): δ = 14.3 (+, CH2CH3), 21.6 (+, 
C-6), 34.6 (+, C-5), 52.6 (+, CO2Me), 57.4 (−, CH2OH), 61.3 (−, CH2CH3), 65.8 (+, C-
1), 133.5 (Cquat, C-4), 142.6 (Cquat, C-3), 160.9 (Cquat, CO2Me), 171.8 (Cquat, CO2Et); IR 
(film): ~ν  = 3457, 3444, 3069, 2984, 2957, 2199, 2089, 2013, 1890, 1712, 1633, 1440, 
1402, 1354, 1301, 1134, 1085, 1044, 1014, 953, 923, 893, 837, 813, 755 cm-1; MS (CI, 
NH3): m/z (%) = 260.1 (100) [M + NH4+], 242.1 (32) [MH+], 225.1 (69); MS (HR-EI, 
70 eV): 242.0792 (C11H14O6): calc. 242.0790  [M+•]). 
 
 
 
 
 
(1S,5R,6S)-(−)-4-Formyl-2-oxa-bicyclo[3.1.0]hex-3-ene-3,6-dicarboxylic acid 6-
ethyl ester 3-methyl ester (181): To a solution of 180 (4.91 g, 20.3 mmol, 1 equiv.) in 
CH2Cl2 (250 mL) was added manganese dioxide (26.43 g, 30.4 mmol, 15 equiv.) at 
room temperature and the mixture was stirred for 3 hours. The reaction mixture was 
then filtered through a short celite pad. The solvent was removed in vacuo. The residue 
obtained was crystallized in n-pentane to provide 181 as a white crystalline solid (4.2 g, 
86%). 
 
Rf = (SiO2, hexanes/ethyl acetate 4:1) = 0.23; m.p. = 71oC; [ ]α D20  = −221.6 (c 1.0, 
CH2Cl2); 1H NMR (300 MHz, CDCl3): δ = 1.24 (dd, J = 2.92, 1.01 Hz, 1 H, 6-H), 1.28 
(t, J = 7.15 Hz, 3 H, CH2CH3), 3.27 (ddq, J = 0.46, 5.39, 2.92 Hz, 1 H, 5-H), 3.94 (s, 3 
H, CO2Me), 4.17 (q, J = 7.15 Hz, 2 H, CH2CH3), 5.05 (dd, J = 5.39, 1.01 Hz, 1 H, 1-H), 
10.33 (s, 1 H, CHO); 13C NMR (75.5 MHz, CDCl3): δ = 14.3 (+, CH2CH3), 21.2 (+, C-
O
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5), 29.5 (+, C-6), 53.4 (+, CO2Me), 61.6 (−, CH2CH3), 67.4 (+, C-1), 129.9 (Cquat, C-4), 
155.2 (Cquat, C-3), 158.4 (Cquat, CO2Me), 170.6 (Cquat, CO2Et), 186.5 (+, CHO); IR 
(KBr): ~ν  = 3064, 3009, 2960, 2886, 2729, 1703, 1654, 1610, 1466, 1134, 1078, 1045, 
1005, 930, 874, 821, 769 cm-1; MS (CI, NH3): m/z (%) = 258.1 (100.0) [M + NH4+], 
241.1 (76.8) [MH+], 167.0 (2.1); elemental analysis calcd (%) for C11H12O6 (240.21): C 
55.00, H 5.04; found C 54.94, H 5.05. 
 
 
 
 
 
 
 
(1S,5R,6S)-4-(1`-Hydroxy-but-3`-enyl)-2-oxa-bicyclo[3.1.0]hex-3-ene-3,6-
dicarboxylic acid 6-ethyl ester 3-methyl ester (182): A solution of 181 (100 mg, 0.4 
mmol, 1 equiv.) in abs. CH2Cl2 (5 mL) was treated with BF3⋅OEt2 (57 μL, 0.45 mmol, 
1.1 equiv.) at −78 oC. After 10 minutes, allyltrimethylsilane (72 μL, 0.45 mmol, 1.1 
equiv.) was added and stirring was continued for 24 hours. The reaction was quenched 
with saturated NaHCO3 (2 mL). The layers were separated and organic layer was 
washed with brine (1 × 2 mL) and dried over anhydrous MgSO4 and filtered. The 
solvent was removed in vacuo. The residue was purified by column chromatography on 
silica (hexanes/ethyl acetate 4:1) to provide 182 as colorless oil (89 mg, 76%). 
 
Rf = (SiO2, hexanes/ethyl acetate 4:1) = 0.13; 1H NMR (300 MHz, CDCl3): δ (minor 
diastereomer) = 1.14 (dd, J = 1.03, 2.71 Hz, 1 H, 6-H), 1.24 (t, J = 7.14 Hz, 3 H, 
CH2CH3), 2.39-2.58 (m, 2 H, 2`-H), 2.92 (dd, J = 5.32, 2.71 Hz, 1-H, 5-H), 3.80 (s, 3 H, 
CO2Me), 4.04-4.17 (m, 2 H, CH2CH3), 4.82 (dd, J = 1.03, 5.32 Hz, 1 H, 1-H), 4.95-4.99 
(m, 1 H, 1`-H), 5.10-5.13 (m, 2 H, 4`-H); 5.72-5.89 (m, 1 H, 3`-H); δ (major 
diastereomer) = 1.18 (dd, J = 1.03, 2.71 Hz, 1 H, 6-H), 1.25 (t, J = 7.14 Hz, 3 H, 
CH2CH3), 2.39-2.58 (m, 2 H, 2`-H), 3.07 (dd, J = 5.32, 2.71 Hz, 1-H, 5-H), 3.81 (s, 3 H, 
CO2Me), 4.04-4.17 (m, 2 H, CH2CH3), 4.85 (dd, J = 1.03, 5.32 Hz, 1 H, 1-H), 4.95-4.99 
(m, 1 H, 1`-H), 5.10-5.13 (m, 2 H, 4`-H); 5.72-5.89 (m, 1 H, 3`-H); 13C NMR (75.5 
MHz, CDCl3): δ (minor diastereomer) = 14.3 (+, CH2CH3), 21.7 (+, C-5), 32.6 (+, C-
6), 40.8 (−, C-2`), 52.5 (+, CO2Me), 61.3 (−, CH2CH3), 65.6 (+, C-1), 66.0 (+,C-1`), 
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118.7 (−, C-4`), 133.5 (+, C-3`), 135.4 (Cquat, C-4) 141.7 (Cquat, C-3), 160.5 (Cquat, 
CO2Me), 171.8 (Cquat, CO2Et); δ (major diastereomer) = 14.3 (+, CH2CH3), 21.8 (+, 
C-5), 33.7 (+, C-6), 41.1 (−, C-2´), 52.7 (+, CO2Me), 61.3 (−, CH2CH3), 65.7 (+, C-1), 
67.1 (+,C-1`), 118.8 (−, C-4`), 133.6 (+, C-3`), 136.6 (Cquat, C-4) 142.1 (Cquat, C-3), 
161.0 (Cquat, CO2Me), 171.8 (Cquat, CO2Et); IR (film): ~ν  = 3496, 3077, 2955, 2909, 
1734, 1629, 1441, 1175, 1032, 921, 894, 838, 757, 736 cm-1. 
 
 
 
 
 
 
(1S,5R,6S)-(−)-4-[1´,3´]Dioxolan-2´-yl-2-oxa-bicyclo[3.1.0]hex-3-ene-3,6-
dicarboxylic acid 6-ethyl ester 3-methyl ester (185): 181 (1.20 g, 5 mmol, 1 equiv.) in 
benzene (70 mL) was treated with p-toluene sulfonic acid hydrate (0.048 g, 0.25 mmol, 
5 mol%) and ethylene glycol (0.56 mL, 10 mmol, 2 equiv.) and then heated at reflux in 
a Dean-Stark condenser, under nitrogen up to 5 hours (with TLC monitoring). It was 
then cooled to room temperature. After addition of water (10 mL), the mixture was 
extracted with CH2Cl2 (3 × 30 mL) which was washed with saturated NaHCO3 (3 × 30 
mL) and then water (3 × 30 mL). The organic phase was then dried over anhydrous 
MgSO4 and filtered. The solvent was removed in vacuo. The residue was purified by 
column chromatography on silica (hexanes/ethyl acetate 4:1) to provide 185 as colorless 
oil (1.24 g, 87%).  
 
Rf (SiO2, hexanes/ethyl acetate 4:1) = 0.21; [ ]α D20  = −107.5 (c 1.0, CH2Cl2); 1H NMR 
(300 MHz, CDCl3): δ = 1.26 (m, 1 H, 6-H), 1.27 (t, J = 7.15 Hz, 3 H, CH2CH3), 3.04 
(dd, J = 5,49, 2.74 Hz, 1 H, 5-H), 3.84 (s, 3 H, CO2Me), 3.94 – 4.23 (m, 6 H, CH2CH3 
and –OCH2CH2O-), 4.88 (dd, J = 5.49, 0.93 Hz, 1 H, 1-H), 6.19 (s, 1 H, 2`-H); 13C 
NMR (75.5 MHz, CDCl3): δ = 14.3 (+, CH2CH3), 21.1 (+, C-5), 31.4 (+, C-6), 52.6 (+, 
CO2Me), 61.2 (−, CH2CH3), 65.7 (−, -OCH2CH2O-), 65.8 (−, -OCH2CH2O-), 66.2 (+, 
C-1), 97.3 (+, C-2`), 128.6 (Cquat, C-4), 145.7 (Cquat, C-3), 159.5 (Cquat, CO2Me), 171.8 
(Cquat, CO2Et); IR (film): ~ν  = 3066, 2983, 2957, 2894, 1737, 1642, 1553, 1440, 1396, 
1358, 1304, 1290, 1174, 1142, 1084, 1036, 999, 948, 897, 846, 818, 778, 735, 703 cm-1; 
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MS (CI, NH3): m/z (%) = 302.3 (21) [M + NH4+], 285.2 (100) [MH+], 240.2 (7); MS 
(HR-EI, 70 eV): 284.0898 (C13H16O7: calc. 284.0896  [M+]). 
 
 
 
 
 
 
(1S,5R,6S)-(−)-4-Diethoxymethyl-2-oxa-bicyclo[3.1.0]hex-3-ene-3,6-dicarboxylic 
acid 6-ethyl ester 3-methyl ester (186): 181 (8.0 g, 33 mmol, 1 equiv.) in Et2O (180 
mL) was treated with (+)-Camphor-10-sulfonic acid (0.8 g, 10% wt/wt) and triethyl 
orthoformate (16.5 mL, 100 mmol, 3 equiv.) and then stirred at room temperature for 48 
hours. Then the mixture was poured into 5% aq. ammonium hydroxide solution (40 
mL). The layers were separated and the aqueous layer was extracted with Et2O (3 × 50 
mL). The combined organic layers were washed with brine (3 × 30 mL). The organic 
phase was then dried over MgSO4 and filtered. The solvent was removed in vacuo. The 
residue was purified by column chromatography on silica (hexanes/ethyl acetate 9:1) to 
provide 186 as colorless oil (9.239 g, 89%). 
 
Rf (SiO2, hexanes/ethyl acetate 4:1) = 0.25; [ ]α D20  = −148.4 (c 1.0, CH2Cl2); 1H NMR 
(300 MHz, DMSO-d6): δ = 1.1-1.21 (m, 9 H, 1 -CO2CH2CH3 and 2 -OCH2CH3), 1.22 
(dd, J = 2.61, 1.10 Hz, 1 H, 6-H), 2.89 (dd, J = 5.49, 2.61 Hz, 1 H, 5-H), 3.42-3.70 (m, 4 
H, 2 -OCH2CH3), 3.75 (s, 3 H, CO2Me), 4.09 (d, J = 7.14 Hz, 2 H, -CO2CH2CH3), 5.04 
(dd, J = 5.49, 1.10 Hz, 1 H, 1-H), 5.70 (s, 1 H, CH(OEt)2); 13C NMR (75.5 MHz, 
DMSO-d6): δ = 14.1 (+, CH2CH3), 15.0 (+, -OCH2CH3), 15.1 (+, -OCH2CH3), 20.4 (+, 
C-5), 31.4 (+, C-6), 52.2 (+, CO2Me), 60.7 (−, -OCH2CH3), 61.8 (−, -OCH2CH3), 62.5 
(−, -CO2CH2CH3), 65.1 (+, C-1), 95.5 (+, CH(OEt)2), 129.1 (Cquat, C-4), 143.0 (Cquat, C-
3), 159.2 (Cquat, CO2Me), 171.0 (Cquat, CO2Et); IR (film): ~ν  = 3427, 2979, 1722, 1641, 
1553, 1440, 1398, 1352, 1288, 1164, 1141, 1062, 994, 930, 893, 843, 820, 776, 733 cm-
1; MS (EI, 70 eV): m/z (%) = 314.2 (5) [M+•], 269.2 (85), 241.1 (73), 197.1 (84), 181.1 
(100); MS (HR-EI, 70 eV): 314.1368 (C15H22O7: calc. 314.1366 [M+•]). 
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2-Hydroxy-3-methyl-heptanedioic acid 7-ethyl ester 1-methyl ester (187): A 
solution of 176 (1.00 g, 4.4 mmol, 1 equiv.) in EtOAc (80 mL) was treated with 10 % 
Pd/C (100 mg) and purged with hydrogen for 10 minutes followed by vigorous stirring 
in an atmosphere of hydrogen (via balloon) for 2 h (TLC control). The reaction mixture 
was filtered through a pad of celite. The solvent was removed in vacuo. The residue was 
purified by column chromatography on silica (hexanes/ethyl acetate 4:1) to provide 187 
as a white crystalline solid (0.667 g, 65%). 
 
Rf (SiO2, hexanes/ethyl acetate 4:1) = 0.10; 1H NMR (300 MHz, CDCl3): δ (minor 
diastereomer) = 0.98 (d, J = 6.93 Hz, 3 H, 3-CH3), 1.22 (t, J = 7.15 Hz, 3 H, -
CH2CH3), 1.27-1.94 (m, 5 H, 3-H, 4-CH2 and 5-CH2), 2.22-2.31 (m, 2 H, 6-CH2), 2.80 
(d, J = 5.57 Hz, 1 H, -OH, exchanged in D2O), 3.76 (s, 3 H, CO2Me),4.04-4.15 (m, 2 H, 
-CH2CH3), 4.16 (dd, J = 5.57, 2.83 Hz, 1 H, 2-H); δ (major diastereomer) = 0.80 (d, J 
= 6.86 Hz, 3 H, 3-CH3), 1.22 (t, J = 7.15 Hz, 3 H, -CH2CH3), 1.27-1.94 (m, 5 H, 3-H, 4-
CH2 and 5-CH2), 2.22-2.31 (m, 2 H, 6-CH2), 2.75 (d, J = 5.66 Hz, 1 H, -OH, exchanged 
in D2O), 3.76 (s, 3 H, CO2Me),4.04-4.15 (m, 2 H, -CH2CH3), 4.16 (dd, J = 5.57, 2.83 
Hz, 1 H, 2-H); 13C NMR (75.5 MHz, CDCl3): δ (minor diastereomer) = 14.3 (+, 
CH2CH3), 15.9 (+, 3-CH3), 22.7 (−, C-5), 30.5 (−, C-4), 34.5 (−, C-6), 37.1 (+, C-3), 
52.5 (+, CO2Me), 60.4 (−, CH2CH3), 74.9 (+. C-2), 173.6 (Cquat, CO2Me), 175.3 (Cquat, 
CO2Et); δ (major diastereomer) = 14.3 (+, CH2CH3), 13.5 (+, 3-CH3), 22.8 (−, C-5), 
32.6 (−, C-4), 34.5 (−, C-6), 36.6 (+, C-3), 52.6 (+, CO2Me), 60.4 (−, CH2CH3), 73.2 (+. 
C-2), 173.7 (Cquat, CO2Me), 175.6 (Cquat, CO2Et); MS (CI, NH3): m/z (%) = 250.1 (100) 
[M + NH4+], 233.2 (41) [MH+], 204.1 (8). 
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(1S,3R,4R,5R,6S)-(−)4-(4`-Methoxy-phenoxymethyl)-2-oxa-bicyclo[3.1.0]hexane-
3,6-dicarboxylic acid 6-ethyl ester 3-methyl ester (188): A solution of 179 (1.00 g, 
2.9 mmol, 1 equiv.) in MeOH (80 mL) was treated with 10% Pd/BaSO4 (0.100 g) and 
purged with hydrogen for 10 minutes followed by vigorous stirring in an atmosphere of 
hydrogen (via balloon) for 24 h (TLC control). The reaction mixture was filtered 
through a pad of celite. The solvent was removed in vacuo. The residue was purified by 
column chromatography on silica (hexanes/ethyl acetate 4:1) to provide 188 as colorless 
oil (0.281 g, 28%). 
 
Rf (SiO2, hexanes/ethyl acetate 4:1) = 0.19; [ ]α D20  = −12.1 (c 1.0, CH2Cl2); 1H NMR 
(300 MHz, CDCl3): δ = 1.24 (t, J = 7.14 Hz, 3 H, CH2CH3), 2.35 (ddd, J = 5.66, 5.51, 
4.20 Hz, 1 H, 5-H), 2.58-2.59 (m, 1 H, 6-H), 3.43-3.53 (m, 1 H, 4-H), 3.59 (s, 3 H, 
CO2Me), 3.76 (s, 3 H, OCH3), 3.97-4.18 (m, 4 H, CH2CH3 and 1`-CH2), 4.33 (dd, J = 
0.79, 5.66 Hz, 1-H), 4.88 (d, J = 10.43 Hz, 1 H, 3-H), 6.77-6.86 (m, 4 H, Ar); 13C NMR 
(75.5 MHz, CDCl3): δ = 14.3 (+, CH2CH3), 25.7 (+, C-6), 28.5 (+, C-5), 43.1 (+, C-4), 
52.4 (+, CO2Me), 55.8 (+, OCH3), 60.7 (−, CH2CH3), 66.3 (−, 1`-CH2), 66.4 (+, C-1), 
80.1 (+, C-3), 114.7 (+, Ar), 115.5 (+, Ar), 152.5 (Cquat, Ar), 154.3 (Cquat, Ar), 170.6 
(Cquat, CO2Me), 171.8 (Cquat, CO2Et); IR (film): ~ν  = 3453, 3449, 2954, 2836, 1717, 
1638, 1508, 1467, 1413, 1369, 1301, 1233, 114, 1068, 1039, 930, 826, 755 cm-1; MS 
(CI, NH3): m/z (%) = 368.2 (100) [M + NH4+], 351.1 (27) [MH+], 227.1 (11).; MS (HR-
EI, 70 eV): 350.1363 (C18H22O7: calc. 350.1366 [M+•]). 
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(1S,3R,4S,5S,6S)-(+)-4-[1´´,3´´]Dioxolan-2´-yl-2-oxa-bicyclo[3.1.0]hexane-3,6-
dicarboxylic acid 6-ethyl ester 3-methyl ester (189): A solution of 185 (1.24 g, 4.4 
mmol, 1 equiv.) in EtOAc (80 mL) was treated with 10% Pd/C (0.186 g) and purged 
with hydrogen for 10 minutes followed by vigorous stirring in an atmosphere of 
hydrogen (via balloon) for 2 h (TLC control). The reaction mixture was filtered through 
a pad of celite. The solvent was removed in vacuo. The residue was purified by column 
chromatography on silica (hexanes/ethyl acetate 4:1) to provide 189 as a white 
crystalline solid (0.937 g, 75%). 
 
Rf (SiO2, hexanes/ethyl acetate 4:1) = 0.20; m.p. = 52 oC; [ ]α D20  = +16.4 (c 1.0, 
CH2Cl2); 1H NMR (300 MHz, CDCl3): δ = 1.25 (t, J = 7.14 Hz, 3 H, CH2CH3), 2.27 
(ddd, J = 5.56, 5.66, 4.15 Hz, 1 H, 5-H), 2.70 (ddd, J = 4.15, 1.06, 0.55 Hz, 1 H, 6-H), 
3.23 (dddd, J = 10.63, 5.56, 5.28, 0.55 Hz, 1 H, 4-H), 4.07 (dq, J = 10.78, 7.14 Hz, 1 H, 
CH2CO2Et), 4.13 (dq, J = 10.78, 7.14 Hz, 1 H, CH2CO2Et), 3.82-4.16 (m, 4 H, -
OCH2CH2O-), 4.29 (dd, J = 5.66, 1.06 Hz, 1 H, 1-H), 4.83 (d, J = 10.63 Hz, 1 H, 3-H), 
5.09 (d, J = 5.28 Hz, 1 H, 4`-H); 13C NMR (75.5 MHz, CDCl3): δ = 14.2 (+, CH2CH3), 
25.3 (+, C-5), 26.7 (+, C-6), 47.4 (+, C-4), 52.3 (+, CO2Me), 60.5 (−, CH2CH3), 65.3 (−, 
-OCH2CH2O-), 65.6 (−, -OCH2CH2O-), 66.0 (+, C-1), 79.2 (+, C-3), 102.5 (+, C-4´), 
170.5 (Cquat, CO2Me), 171.7 (Cquat, CO2Et); IR (KBr): ~ν  = 3073, 2982, 2955, 2894, 
2772, 2255, 2053, 2200, 1747, 1720, 1603, 1414, 1367, 1302, 1211, 1179, 1117, 1059, 
979, 939, 879, 854, 814, 733 cm-1; MS (CI, NH3): m/z (%) = 304.3 (100) [M + NH4+], 
287.2 (17) [MH+]; elemental analysis calcd (%) for C13H18O7 (286.28): C 54.54, H 
6.34, O 39.12; found C 54.26, H 6.22. 
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(1S,3R,4S,5S,6S)-(+)-4-Diethoxymethyl-2-oxa-bicyclo[3.1.0]hexane-3,6-dicarboxylic 
acid 6-ethyl ester 3-methyl ester (190): A solution of 186 (1.00 g, 3.18 mmol, 1 
equiv.) in EtOAc (80 mL) was treated with 10% Pd/C (0.100 g) and purged with 
hydrogen for 10 minutes followed by vigorous stirring in an atmosphere of hydrogen 
(via balloon) for 2 h (TLC control). The reaction mixture was filtered through a pad of 
celite. The solvent was removed in vacuo. The residue was purified by column 
chromatography on silica (hexanes/ethyl acetate 4:1) to provide 190 as a low melting 
solid (0.755 g, 75%). 
 
Rf (SiO2, hexanes/ethyl acetate 4:1) = 0.24; [ ]α D20  = +4.1 (c 1.0, CH2Cl2); 1H NMR 
(300 MHz, DMSO-d6): δ = 1.02-1.12 (m, 7 H, 5-H and 2 -OCH2CH3), 1.17 (t, J = 7.10 
Hz, 3 H, CH2CH3), 2.11 (ddd, J = 5.70, 5.65, 4.21 Hz, 1 H, 6-H), 2.60 (m, 1 H, 4-H), 
3.27-3.70 (m, 4 H, 2 -OCH2CH3), 3.63 (s, 3 H, CO2Me), 4.04 (q, J = 7.10 Hz, 2 H, 
CH2CH3), 4.27 (dd, J = 0.82, 5.65, 1 H, 1-H), 4.48 (d, J = 10.43 Hz, 1 H, 3-H) , 4.72 (d, 
J = 8.23 Hz, 1 H, 1`-H); 13C NMR (75.5 MHz, DMSO-d6): δ = 14.1 (+, CH2CH3), 14.9 
(+, -OCH2CH3), 15.3 (+, -OCH2CH3), 25.2 (+, C-5), 27.3 (+, C-6), 46.4 (+, C-4), 52.0 
(+, CO2Me), 60.1 (−, -CO2CH2CH3), 61.7 (−, -OCH2CH3), 62.0 (−, -OCH2CH3), 65.8 
(+, C-1), 79.5 (+, C-3), 101.6 (+, C-1`), 169.6 (Cquat, CO2Me), 171.4 (Cquat, CO2Et); IR 
(KBr): ~ν  = 3059, 2981, 1713, 1371, 1307, 1209, 1173, 1114, 1001, 922, 854, 705 cm-1; 
MS (EI, 70 eV): m/z (%) = 271.2 (16) [M-•OEt], 210.2 (48), 196.1 (51), 157.1 (100), 
143.1 (55); elemental analysis calcd (%) for C15H24O7 (316.35): C 56.95, H 7.65, O 
35.40; found C 56.68, H 7.36. 
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(1S,3R,4S,5S,6S)-(−)4-[1`,3`]Dithian-2-yl-2-oxa-bicyclo[3.1.0]hexane-3,6-
dicarboxylic acid 6-ethyl ester 3-methyl ester (191): To a solution of 190 (1.00 g, 
3.16 mmol, 1 equiv.) and 1,3-propanedithiol (0.42, 3.49 mmol, 1.2 equiv.) in 
dichloromethane (50 mL) under nitrogen atmosphere at −78 °C was added boron 
trifluoride diethyl etherate (0.9 mL, 6.25 mmol, 2.2 equiv.) over 10 min. The mixture 
was stirred for 4 hours, allowed to warm to room temperature over 15 hours, poured 
into cold saturated aqueous sodium bicarbonate (10 mL), and extracted with diethyl 
ether (2 x 20 mL). The combined organic phase was successively washed with saturated 
sodium bicarbonate (2 x 20 mL) and brine (2 x 20 mL). The organic phase was then 
dried over anhydrous MgSO4 and filtered. The solvent was removed in vacuo. The 
residue was purified by column chromatography on silica (hexanes/ethyl acetate 4:1) to 
provide 191 as a white crystalline solid (1.00 g, 95%). 
 
Rf (SiO2, hexanes/ethyl acetate 4:1) = 0.24; m.p. = 86-87 oC; [ ]α D20  = −19.7 (c 1.0, 
CH2Cl2); 1H NMR (300 MHz, CDCl3): δ = 1.25 (t, J = 7.20 Hz, 3 H, CH2CH3), 1.83-
2.12 (m, 2 H, 5`-CH2); 2.42 (ddd, J = 5.50, 4.23, 5.50 Hz, 1 H, 5-H), 2.80-2.90 (m, 5 H, 
6-H and 4` and 6`-CH2), 3.44 (ddd, J = 10.09, 10.09, 5.50, 1 H 4-H), 3.70 (s, 3 H, 
CO2Me), 4.04-4.16 (m, 2 H, CH2CH3), 4.25-4.28 (m, 2 H, 1-H and 3-H), 4.76 (d, J = 
10.09 Hz, 1 H, 4`-H); 13C NMR (75.5 MHz, CDCl3): δ = 14.3 (+, CH2CH3), 25.42 (+, 
C-6), 25.44 (−, C-5`), 28.9 (+, C-5), 29.4 (−, C-4` or C-6`), 29.6 (−, C-4` or C-6`), 45.7 
(+, C-4), 48.4 (+, C-2`), 52.6 (+, CO2Me), 60.8 (−, CH2CH3), 66.9 (+, C-1), 80.5 (+, C-
3), 170.4 (Cquat, CO2Me), 171.2 (Cquat, CO2Et); IR (KBr): ~ν  = 3436, 3078, 2986, 1721, 
1413, 1374, 1317, 1281, 1248, 1209, 1109, 1009, 954, 876, 760 cm-1; MS (EI, 70 eV): 
m/z (%) = 332.1(2) [M+•], 204.1 (33), 203.1 (60), 115.0 (100); MS (HR-EI, 70 eV): 
332.0749 (C14H20O5S2: calc. 332.0752 [M+•]); elemental analysis calcd (%) for 
C14H20O5S2 (332.44): C 50.58, H 6.06, O 24.06, S 19.29; found C 50.39, H 5.92, S 
19.43. 
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(2R,3S,3aR,6aR)-(−)-3-[1`,3`]Dithian-2-yl-5-oxo-hexahydro-furo[2,3-b]furan-2-
carboxylic acid methyl ester (192): To a solution of 191 (1.16 g., 3.49 mmol, 1 equiv.) 
in 1,4-dioxane (40 mL), 6M aq. HCl (40 mL) was added and was stirred at room 
temperature for 24 hours. The reaction mixture was then extracted with 
dichloromethane (3 × 30 mL). The combined organic layers were washed with saturated 
sodium bicarbonate (3 × 30 mL) and dried over anhydrous MgSO4 and filtered. The 
solvent was removed in vacuo. The residue was purified by column chromatography on 
silica (hexanes/ethyl acetate 1:1) to provide 192 as a white crystalline solid (0.467 g, 
44%). 
 
Rf (SiO2, hexanes/ethyl acetate 1:1) = 0.24; m.p. = 159 oC; [ ]α D20  = −25.5 (c 1.0, 
CH2Cl2); 1H NMR (300 MHz, DMSO-d6): δ = 1.77-1.99 (m, 2 H, 5`-CH2), 2.52-2.80 
(m, 2 H, 4-CH2), 2.82-3.0 (m, 4 H, 4` and 6`-CH2), 3.30-3.42 (m, 2 H, 3-H and 3a-H), 
3.63 (s, 3 H, CO2Me), 4.15 (d, J = 12.04 Hz, 1 H, 2`-H), 4.68 (d, J = 7.12 Hz, 1 H, 2-H), 
6.11 (d, J = 5.56 Hz, 1 H, 6a-H); 13C NMR (75.5 MHz, DMSO-d6): δ = 25.2 (−, C-4), 
26.4 (−, C-4` or C-6`), 26.7 (−, C-4` or C-6`), 29.2 (−, C-5`), 40.0 (+, C-3a) 41.2 (+, C-
3), 46.9 (+,C-2`), 52.2 (+, CO2Me), 79.7 (+,C-2), 108.4 (+,C-6a), 170.3 (Cquat, CO2Me), 
176.0 (Cquat, C-5); IR (KBr): ~ν  = 3445, 2955, 1788, 1734, 1421, 1381, 1279, 1164, 
1082, 947, 883, 772 cm-1; MS (EI, 70 eV): m/z (%) = 304.0 (25) [M+•], 203.0 (100), 
160.9 (67), 118.9 (34); MS (HR-EI, 70 eV): 304.0434 (C12H16O5S2: calc. 304.0439 
[M+•]); elemental analysis calcd (%) for C12H20O5S2 (304.38): C 47.35, H 5.30, O 
26.28, S 21.07; found C 47.16, H 5.26, S 20.98. 
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(2R,3S,3aR,6aR)-(−)-3-[1`,3`]Dithian-2-yl-5-oxo-hexahydro-furo[2,3-b]furan-2-
carboxylic acid (193): To a solution of 191 (1.16 g., 3.49 mmol, 1 equiv.) in 1,4-
dioxane (40 mL), 6M aq. HCl (40 mL) was added and was stirred at 40 oC for 36 hours. 
The reaction mixture was then extracted with dichloromethane (3 × 30 mL). The 
combined organic layers were dried over anhydrous MgSO4 and filtered. The solvent 
was removed in vacuo. The crude acid was washed with chloroform (20 mL) to obtain 
purified 193 as a white crystalline solid (0.699 g, 69%), which was used without further 
purification for the next reaction. 
 
Rf (SiO2, CH2Cl2/MeOH 5:1) = 0.24; m.p. = 227 oC; [ ]α D20  = −8.0 (c 1.0, CH2Cl2); 1H 
NMR (300 MHz, DMSO-d6): δ = 1.83-1-94 (m, 2 H, 5`-CH2), 2.5-3.0 (m, 6 H, 4, 4` 
and 6`-CH2), 3.19-3.39 (m, 2 H, 3-H and 3a-H), 4.23 (d, J = 12.04 Hz, 1 H, 2`-H), 4.56 
(d, J = 7.44 Hz, 1 H, 2-H), 6.10 (d, J = 5.90 Hz, 1 H, 6a-H), 13.09 (s, 1 H, CO2H); 13C 
NMR (75.5 MHz, DMSO-d6): δ = 25.2 (−, C-4), 26.6 (−, C-4` or C-6`), 27.0 (−, C-4` or 
C-6`), 29.4 (−, C-5`), 40.0 (+, C-3a), 41.6 (+, C-3), 46.5 (+, C-2`), 79.9 (+,C-2), 108.3 
(+,C-6a), 171.2 (Cquat, CO2H), 175.9 (Cquat, C-5); IR (KBr): ~ν  = 3316, 2905, 1751, 
1730, 1403, 1334, 1267, 1201, 1114, 1079, 967, 867, 760 cm-1; MS (EI, 70 eV): m/z 
(%) = 289.9 (36) [M+•], 188.9 (100), 161.0 (78), 118.9 (74); MS (HR-EI, 70 eV): 
290.0289 (C11H14O5S2: calc. 290.0283 [M+•]); elemental analysis calcd (%) for 
C11H14O5S2 (290.36): C 45.50, H 4.86, O 27.55, S 22.09; found C 45.36, H 4.88, S 
21.84. 
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(2R,3S,3aR,6aR)-(+)-3-[1`,3`]Dithian-2-yl-5-oxo-hexahydro-furo[2,3-b]furan-2-
carboxylic acid benzyl ester (195): BnBr (0.46 mL, 3.90 mmol, 1.1 equiv.) in acetone 
(20 mL) was added to a cooled solution of 193 (1.030 g, 3.55 mmol, 1 equiv.), Et3N 
(0.54 mL, 3.55 mmol, 1.1 equiv.), and DMAP (22 mg, 0.18 mmol, 0.05 equiv.) in 
acetone (40 mL). After being stirred at room temperature overnight, the acetone was 
removed in vacuo and the residue was taken in CH2Cl2. The CH2Cl2 phase was washed 
with H2O (3 × 30 mL), brine (3 × 30 mL) and dried over anhydrous MgSO4. After 
removal of the solvent in vacuo, the resulting residue was purified by silica gel 
chromatography (hexane/ethyl acetate, 4:1) to give 195 as a white crystalline solid 
(1.282 g, 95%). 
 
Rf (SiO2, hexanes/ethyl acetate 4:1) = 0.5; m.p. = 138 oC; [ ]α D20  = +3.7 (c 1.0, CH2Cl2); 
1H NMR (300 MHz, DMSO-d6): δ = 1.74-1-95 (m, 2 H, 5`-CH2), 2.5-2.95 (m, 6 H, 4, 
4` and 6`-CH2), 3.29-3.42 (m, 2 H, 3-H and 3a-H), 4.09 (d, J = 12.01 Hz, 1 H, 2`-H), 
4.73 (d, J = 7.55 Hz, 1 H, 2-H), 5.12 (d, J = 12.18 Hz, 1 H, CH2Ph), 5.19 (d, J = 12.32 
Hz, 1 H, CH2Ph), 6.12 (d, J = 5.69 Hz, 1 H, 6a-H), 7.30-7.41 (m, 5 H, Ar); NMR (75.5 
MHz, DMSO-d6): δ = 25.1 (−, C-4), 26.8 (−, C-4` or C-6`), 27.0 (−, C-4` or C-6`), 29.3 
(−, C-5`), 40.1 (+, C-3a), 41.5 (+, C-3), 47.1 (+, C-2`), 66.5 (−, CH2Ph), 79.8 (+,C-2), 
108.4 (+,C-6a), 128.3 (+, Ar), 128.4 (+, Ar), 128.5 (+, Ar), 135.4 (Cquat, Ar), 169.8 
(Cquat, CO2Bn), 176.0 (Cquat, C-5); IR (KBr): ~ν  = 3551, 3449, 2905, 2361, 1786, 1736, 
1495, 1359, 1296, 1179, 1084, 914, 855, 752 cm-1; MS (EI, 70 eV): m/z (%) = 380.1 (5) 
[M+•], 289.0 (100), 91.1 (79); MS (HR-EI, 70 eV): 380.0749 (C18H20O5S2: calc. 
380.0752 [M+•]); elemental analysis calcd (%) for C18H20O5S2 (380.48): C 56.82, H 
5.30, O 21.03, S 16.86; found C 56.15, H 5.28, S 16.73. 
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(2R,3S,3aR,6aR)-(−)-3-Dimethoxymethyl-5-oxo-hexahydro-furo[2,3-b]furan-2-
carboxylic acid benzyl ester (196): To a solution of 195 (0.200 g, 0.52 mmol, 1.0 
equiv.) in MeOH (20 mL) NBS (0.280 g, 1.57 mmol, 3.0 equiv.) was added at 0 oC and 
stirred at the same temperature for 3 hours. Then saturated solution of Na2SO3 was 
added to this mixture. The resulting white slurry was extracted with CH2Cl2 (3 × 10 
mL). The combined organic layers were washed with brine (3 × 10 mL), dried over 
anhydrous MgSO4 and filtered. The CH2Cl2 was removed in vacuo. The residue was 
purified by column chromatography on silica (hexanes/ethyl acetate 1:1) to provide 196 
as colorless oil (0.117 g, 66%). 
 
Rf (SiO2, hexanes/ethyl acetate 1:1) = 0.5; [ ]α D20  = −4.1 (c 1.0, CH2Cl2); 1H NMR (300 
MHz, DMSO-d6): δ = 2.54-2.70 (m, 2 H, 4-CH2), 3.0-3.38 (m, 2 H, 3-H and 3a-H), 
3.11 (s, 3 H, -OMe), 3.28 (s, 3 H, -OMe), 4.45 (d, J = 8.61, 1 H, 2-H), 4.61 (d, J = 8.61 
Hz, 1 H, CH(OMe)2, 5.15 (s, 2 H, CH2Ph), 6.11 (d, J = 5.93 Hz, 1 H, 6a-H), 7.32-7.42 
(m, 5 H, Ar); NMR (75.5 MHz, DMSO-d6): δ = 29.1 (−, C-4), 38.7 (+, C-3a) 45.9 (+, 
C-3), 52.4 (+, OMe), 54.2 (+, OMe), 66.6 (−, CH2Ph), 79.8 (+,C-2), 101.7 (+, 
CH(OMe)2), 108.7 (+,C-6a), 128.4 (+, Ar), 128.5 (+, Ar), 128.7 (+, Ar), 135.4 (Cquat, 
Ar), 170.5 (Cquat, CO2Bn), 176.1 (Cquat, C-5); IR (film): ~ν  = 3536, 3348, 3244, 2835, 
1787, 1382, 1349, 1291, 1177, 1000, 945, 825, 750 cm-1; MS (EI, 70 eV): m/z (%) = 
336.0 (1) [M+•], 202.0 (14), 168.9 (43), 140.9 (41); MS (HR-EI, 70 eV): 336.1203 
(C17H20O7: calc. 336.1209 [M+•]). 
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 (2R,3R,3aR,6aR)-(−)-3-Formyl-5-oxo-hexahydro-furo[2,3-b]furan-2-carboxylic 
acid benzyl ester (197): To a solution of 196 (100 mg, 0.30 mmol, equiv.) in CH2Cl2 (2 
mL) was added at room temperature formic acid (1.1 mL, 29.7 mmol, 100 equiv.). After 
being stirred for 3 hours, the mixture was neutralized with solid Na2CO3 (mg.) and 
diluted with saturated Na2CO3 solution. The layers were separated and the aqueous 
phase was extracted with Et2O (3 × 5 mL). The combined organic layers were dried 
over anhydrous MgSO4 and filtered. The solvent was removed in vacuo. The residue 
was purified by column chromatography on silica (hexanes/ethyl acetate 1:1) to provide 
197 as colorless oil (29 mg, 34%). 
 
Rf (SiO2, hexanes/ethyl acetate 1:1) = 0.3; [ ]α D20  = −50.8 (c 1.0, CH2Cl2); 1H NMR 
(300 MHz, CDCl3): δ = 2.46 (dd, J = 18.76, 3.70 Hz, 1 H, 4-CH2), 2.88, (dd, J = 18.76, 
10.87 Hz, 1 H, 4-CH2), 3.40 (dd, J = 2.57, 2.37 Hz, 1 H, 3-H), 3.65 (dddd, J = 10.87, 
5.80, 3.70, 2.57 Hz, 1 H, 3a-H), 5.05 (d, J = 2.37 Hz, 1 H, 2-H), 5.19 (d, J = 11.94 Hz, 1 
H, CH2Ph), 5.27 (d, J = 11.94 Hz, 1 H, CH2Ph), 6.10 (d, J = 5.80 Hz, 1 H, 6a-H), 9.70 
(s, 1 H, CHO); 13C NMR (75.5 MHz, CDCl3): δ = 34.2 (−, C-4), 38.1 (+, C-3a), 60.1 (+, 
C-3), 68.5 (−, CH2Ph), 78.2 (+, C-2), 108.4 (+, C-6a), 128.9 (+, Ar), 129.0 (+, Ar), 
134.6 (+, Ar), 134.8 (Cquat, Ar), 170.1 (Cquat, CO2Bn), 173.7 (Cquat, C-5), 195.7 (+; 
CHO); IR (film): ~ν  = 3358, 2890, 1800, 1732, 1348, 1256, 1176, 1126, 1001, 946, 826, 
752 cm-1; MS (EI, 70 eV): m/z (%) = 289.9 (1) [M+•], 183.9 (11), 108.9 (15),91.0 (100); 
MS (HR-EI, 70 eV): 290.0787 (C15H14O6: calc. 290.0790 [M+•]). 
 
 
 
 
 
 
 
 
O
BnO2C
OHC
O
H
H
O
Section 5. Experimental Part 103 
 
 
 
 
 
 
 
(1`S,2R,3S,4R,,5R)-(−)-4-(Bromo-ethoxycarbonyl-methyl)-3-[1´´,3´´]dioxolan-2´´-
yl-5-methoxy-tetrahydro-furan-2-carboxylic acid methyl ester (220): A mixture of 
189 (0.600 g, 2.10 mmol, 1.0 equiv.) and NBS (1.119 g, 6.28 mmol, 3.0 equiv.) in 
MeOH (30 mL) was stirred at 15 oC for 36 hours, in the dark. Then saturated solution of 
Na2SO3 was added to this mixture. The resulting white slurry was extracted with 
CH2Cl2 (3 × 15 mL). The combined organic layers were washed with brine (3 × 15 mL), 
dried over anhydrous MgSO4 and filtered. The CH2Cl2 was removed in vacuo. The 
residue was purified by column chromatography on silica (hexanes/ethyl acetate 7:3) to 
provide 220 as a white crystalline solid (0.713 g, 86%). 
 
Rf (SiO2, hexanes/ethyl acetate 1:1) = 0.39; m.p. = 78 oC; [ ]α D20  = −69.8 (c 1.0, 
CH2Cl2); 1H NMR (300 MHz, CDCl3): δ = 1.31 (t, J = 7.15 Hz, 3 H, CH2CH3), 3.05 
(ddd, J = 11.32, 6.82, 5.65 Hz, 1 H, 4-H), 3.10 (ddd, J = 6.83, 4.53, 3.48 Hz, 1 H, 3-H), 
3.36 (s, 3 H, -OMe), 3.73 (s, 3 H, -CO2Me), 3.78-4.11 (m, 4 H, -OCH2CH2O-), 4.20 
(dq, J = 10.76, 7.15 Hz, 1 H, CH2CO2Et), 4.25 (dq, J = 10.76, 7.15 Hz, 1 H, 
CH2CO2Et), 4.56 (d, J = 11.32 Hz, 1 H, 1´-H), 4.68 (d, J = 4.53 Hz, 1 H, 2-H), 5.09 (d, 
J = 5.64 Hz, 1 H, 5-H), 5.18 (d, J = 3.48 Hz, 1 H, 2´´-H); 13C NMR (75.5 MHz, 
CDCl3): δ = 13.9 (+, CH2CH3), 43.5 (+, C-3), 47.4 (+, C-4), 51.9 (+, OMe), 53.4 (+, C-
1´), 56.7 (+, CO2Me), 62.4 (−, CH2CH3), 64.9 (−, -OCH2CH2O-), 65.3 (−, -OCH2CH2O-
), 75.8 (+, C-2), 100.9 (+, C-5), 106.6 (+, C-2´´), 168.37 (Cquat, CO2Me), 169.70 (Cquat, 
CO2Et); IR (KBr): ~ν  = 3073, 2982, 2955, 2894, 2772, 2255, 2053, 2200, 1747, 1720, 
1603, 1414, 1367, 1302, 1211, 1179, 1117, 1059, 979, 939, 879, 854, 814, 733 cm-1; 
MS (EI, NH3): m/z (%) = 396.9 [M - H.]+, 395.0 [M - H.]+, 73.0 (100.0); MS (HR-EI, 
70 eV): 395.0341 (C14H20BrO8: calc. 394.0342  [M+]); elemental analysis calcd (%) 
for C14H21BrO8 (397.22): C 42.33, H 5.33, Br 20.12, O 32.22; found C 42.32, H 5.25. 
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(1´R,2R,3S,4S,5R)-(+)-4-(Azido-ethoxycarbonyl-methyl)-3-[1´´,3´´]dioxolan-2´´-yl-
5-methoxy-tetrahydro-furan-2-carboxylic acid methyl ester (222): To a solution of 
220 (0.315 g, 0.79 mmol, 1 equiv.) in DMF (10 mL) was added sodium azide (0.093 g, 
1.43 mmol, 1.8 equiv.). The mixture was stirred at room temperature for 24 h and the 
reaction was quenched with water (10 mL). After extraction with EtOAc (3 × 15 mL), 
the organic layers were dried over anhydrous MgSO4 and filtered. The EtOAc was 
removed in vacuo. The residue was purified by column chromatography on silica 
(hexanes/ethyl acetate 7:3) to provide 222 as colorless oil (0.278 g, 97%).  
 
Rf (SiO2, hexanes/ethyl acetate 1:1) = 0.34; [ ]α D20  = +17.2 (c 1.0, CH2Cl2); 1H NMR 
(300 MHz, CDCl3): δ = 1.33 (t, J = 7.10 Hz, 3 H, CH2CH3), 3.05 (ddd, J = 10.29, 7.15, 
4.53 Hz, 1 H, 4-H), 3.10 (ddd, J = 7.15, 5.21, 4.53 Hz, 1 H, 3-H), 3.46 (s, 3 H, OMe), 
3.77 (s, 3 H, CO2Me), 3.78-3.92 (m, 4 H, -OCH2CH2O-), 4.19 (d, J = 10.29 Hz, 1 H, 1´-
H), 4.27 (q, J = 7.10 Hz, 2 H, CH2CH3), 4.73 (d, J = 5.21 Hz, 1 H, 2´´-H), 4.90 (d, J = 
5.21 Hz, 1 H, 2-H), 5.16 (d, J = 4.53 Hz, 1 H, 5-H); 13C NMR (75.5 MHz, CDCl3): δ = 
14.2 (+, CH2CH3), 46.9 (+, C-4), 48.7 (+, C-3), 52.1 (+, OMe), 56.5 (+, C-1´), 60.5 (+, 
CO2Me), 61.9 (−, CH2CH3), 64.2 (−, -OCH2CH2O-), 65.0 (−, -OCH2CH2O-), 76.7 (+, 
C-2), 101.4 (+, C-5), 106.9 (+, C-2´´), 168.6 (Cquat, CO2Me), 169.6 (Cquat, CO2Et); IR 
(film): ~ν  = 2901, 2498, 2109, 2200, 1739, 1628, 1441, 1372, 1259, 1215, 1102, 1055, 
1027, 943, 861, 732 cm-1; MS (EI, NH3): m/z (%) = 358.2 [M - H.]+, 73.0 (100.0); MS 
(HR-EI, 70 eV): 358.1251 (C14H20N3O8: calc. 358.1250 [M+]). 
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(1´R,2R,3S,4S,5R)-(−)-4-(tert-Butoxycarbonylamino-ethoxycarbonyl-methyl)-3-
[1´´,3´´]dioxolan-2´´-yl-5-methoxy-tetrahydro-furan-2-carboxylic acid methyl ester 
(223): A solution of the 222 (0.111 g, 0.31 mmol, 1 equiv.) and Boc2O (.074 g, 0.34 
mmol, 1.1 equiv.) in MeOH (6 mL) was treated with 10% Pd/C (0.016 g) and purged 
with hydrogen for 10 minutes followed by vigorous stirring in an atmosphere of 
hydrogen (via balloon) for 15 h. The reaction mixture was filtered through a pad of 
celite. The solvent was removed in vacuo. The residue was purified by column 
chromatography on silica (hexanes/ethyl acetate 1:1) to provide 223 as colorless oil 
(0.113 g, 84%). 
 
Rf (SiO2, hexanes/ethyl acetate 1:1) = 0.24; [ ]α D20  = −7.1 (c 1.0, CH2Cl2); 1H NMR 
(300 MHz, CDCl3): δ = 1.27 (t, J = 7.15 Hz, 3 H, CH2CH3), 1.44 (s, 9 H, -C(CH3)3), 
2.72 (ddd, J = 8.74, 7.62, 4.37, 1 H, 4-H), 2.96-3.01 (m, 1 H, 3-H), 3.39 (s, 3 H, OMe), 
3.75 (s, 3 H, CO2Me), 3.77-4.26 (m, 6 H, -OCH2CH2O and CH2CH3), 4.59-4.65 (m, 1 
H, 1´-H), 4.69 (d, J = 6.21 Hz, 1 H, 2-H), 5.01 (d, J = 4.94 Hz, 1 H, 2´´-H), 5.12 (d, J = 
4.37 Hz, 1 H, 5-H), 5.30-5.31 (d, J = 7.68 Hz, 1 H, NHBoc); 13C NMR (75.5 MHz, 
CDCl3): δ = 14.2 (+, CH2CH3), 28.3 (+, C(CH3)3), 46.5 (+, C-3), 48.9 (+, C-4), 51.8 (+, 
C-1´), 52.1 (+, OMe), 56.2 (+, CO2Me), 61.4 (−,CH2CH3), 64.7 (−,-OCH2CH2O-), 65.1 
(−,-OCH2CH2O-), 76.5 (+, C-2), 79.9 (Cquat, -C(CH3)3), 101.5 (+, C-5), 106.9 (+, C-2´´), 
155.3 (Cquat, COtBu), 169.7 (Cquat, CO2Me) , 171.5 (Cquat, CO2Et); IR (film): ~ν  = 3371, 
2978, 2425, 2199, 1738, 1721, 1512, 1443, 1368, 1284, 1219, 1165, 1105, 1060, 1027, 
943, 863, 755, 663 cm-1; MS (EI, NH3): m/z (%) = 433.3 [M]+, 360.1 (12.4) [M+ − 
CO2CH2CH3], 200.0 (100.0) ; MS (HR-EI, 70 eV): 433.1949 (C19H31NO10: calc. 
433.1949 [M+•]). 
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(1´R,2R,3S,4S,5R)-(+)-4-(tert-Butoxycarbonylamino-ethoxycarbonyl-methyl)-3-
[1´´,3´´]dioxolan-2´´-yl-5-methoxy-tetrahydro-furan-2-carboxylic acid (224): To a 
solution of 223 (0.100 g, 0.23 mmol, 1 equiv.) in THF (3 mL) cooled to 0 oC was added 
a solution of LiOH (0.055 g, 0.23 mmol, 1 equiv.) in water (1 mL) slowly. The solution 
was then warmed to room temperature overnight (15 h) and quenched with HOAc (1 
mL). After extracting with EtOAc (4 × 3 mL), the organic layer was dried over 
anhydrous MgSO4 and filtered. The EtOAc was removed in vacuo. The residue was 
dried on high vaccum pump for 48 h to afford 224 as low melting amorphous white 
solid (0.080 g, 83%). 
 
Rf (SiO2, dichloromethane/Methanol 5:1) = 0.30; [ ]α D20  = + 15.6 (c 1.0, CH2Cl2); 1H 
NMR (300 MHz, CDCl3): δ = 1.21 (t, J = 7.15 Hz, 3 H, CH2CH3), 1.38 (s, 9 H, -
C(CH3)3), 2.67 (m, 1 H, 4-H), 2.98-3.04 (m, 1 H, 3-H), 3.35 (s, 3 H, OMe), 3.69-4.19, 
m, 6 H, -OCH2CH2O and CH2CH3), 4.54-4.60 (m, 1 H,1´-H), 4.66 (d, J = 5.83 Hz, 1 H, 
2-H), 4.98 (d, J = 3.60 Hz, 1 H, 2´´-H), 5.07 (d, J = 4.84 Hz, 1 H, 5-H), 5.18 (d, J = 8.23 
Hz, 1 H, NHBoc); 7.53 (bs, 1 H, CO2H); 13C NMR (75.5 MHz, CDCl3): δ = 13.1 (+, 
CH2CH3), 27.3 (+, C(CH3)3), 44.9 (+, C-3), 48.2 (+, C-1´), 50.6 (+, C-4), 55.5 (+, OMe), 
60.5 (−,CH2CH3), 63.5 (−,-OCH2CH2O-), 64.0 (−,-OCH2CH2O-), 75.4 (+, C-2), 79.9 
(Cquat, -C(CH3)3), 100.4 (+, C-5), 106.3 (+, C-2´´), 154.3 (Cquat, COtBu), 170.2 (Cquat, 
CO2Et), 171.8 (Cquat, CO2H); IR (KBr): ~ν  = 3558, 2978, 2199, 1730, 1700, 1255, 1164, 
1101, 1052, 862, 802, 755 cm-1; MS (EI, NH3): m/z (%) = 420.0 [MH]+, 404.1 (12) [M 
− •CH3], 346.0 (12.2), 230.0 (24.6), 186.0 (76.4), 73.0 (100.0) ; MS (HR-EI, 70 eV): 
419.1790 (C18H29NO10: calc. 419.1791 [M+•]). 
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(1S,3R,4S,5S,6S)-4-Formyl-2-oxa-bicyclo[3.1.0]hexane-3,6-dicarboxylic acid 6-
ethyl ester 3-methyl ester (237): To a solution of 190 (3.0 g, 9.48 mmol, 1 equiv.) in 
CH2Cl2 (60 mL) was added at room temperature formic acid (72 mL, 1.89 mol, 200 
equiv.). After being stirred for 5 minutes, the mixture was neutralized with solid 
Na2CO3 and diluted with saturated Na2CO3 solution. The layers were separated and the 
aqueous phase was extracted with Et2O (3 × 30 mL). The combined organic layers were 
dried over anhydrous MgSO4 and filtered. The solvent was removed in vacuo to provide 
crude 237 as colorless oil (2.29 g., quant.). The crude 237 was further carried for the 
next reaction without purification. 
 
1H NMR (300 MHz, CDCl3): δ = 1.25 (t, J = 7.15 Hz, 3 H, CH2CH3), 2.40-2.46 (m, 2 
H, 5-H and 6-H), 3.75 (s, 3 H, CO2Me), 3.84 (ddd, J = 10.21, 5.57, 2.21 Hz, 1 H, 4-H), 
4.05-4.17 (m, 2 H, CH2CH3), 4.40-4.43 (m, 1 H, 1-H), 4.98 (d, J = 10.21 Hz, 1 H, 3-H), 
9.63 (d, J = 2.21 Hz, CHO); 13C NMR (75.5 MHz, CDCl3): δ = 14.3 (+, CH2CH3), 26.2 
(+, C-6), 26.6 (+, C-5), 52.8 (+, CO2Me), 53.9 (+, C-4), 61.1 (−, CH2CH3), 66.7 (+, C-
1), 79.7 (+, C-3), 169.7 (Cquat, CO2Me), 170.9 (Cquat, CO2Et), 196.5 (Cquat, CHO). 
 
 
 
 
 
(2R,5R)-(+)-5-Ethoxycarbonylmethyl-3-formyl-2,5-dihydro-furan-2-carboxylic 
acid methyl ester (239): To a solution of 237 (1.0 g., 4.12 mmol, 1 equiv.) in diethyl 
ether (50 mL) was added silica gel (20 g, Merck 60–230 mesh) and the heterogeneous 
mixture was stirred at room temperature for 72 h, after which time TLC indicated 
disappearance of the substrate. The silica gel was filtered off and washed with diethyl 
ether (2 × 20 mL). The solvent was removed in vacuo. The residue was purified by 
column chromatography on silica (hexanes/ethyl acetate 1:1) to provide 239 as colorless 
oil (0.600 g., 60%). 
O
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Rf (SiO2, hexanes/ethyl acetate 1:1) = 0.40; [ ]α D20  = +12.8 (c 1.0, CH2Cl2); 1H NMR 
(300 MHz, CDCl3): δ = 1.28 (t, J = 7.14 Hz, 3 H, CH2CH3), 2.78 (dd, J = 16.40, 7.31 
Hz, 1 H, CH2CO2Et), 2.97 (dd, J = 16.40, 6.83 Hz, 1 H, CH2CO2Et), 3.77 (s, 3 H, 
CO2Me), 4.19 (q, J = 7.14 Hz, 2 H, CH2CH3), 5.39 (ddd, J = 2.64, 1.85, 0.48 Hz, 1 H, 
2-H), 5.48 (dddd, J = 2.64, 1.81, 7.30, 6.83 Hz, 1 H, 5-H), 7.15 (dd, J = 1.85, 1.81 Hz, 1 
H, 4-H), 9.81 (d, J = 0.48 Hz, 1 H, CHO); 13C NMR (75.5 MHz, CDCl3): δ = 14.3 (+, 
CH2CH3), 40.3 (−, CH2CO2Et), 52.8 (+, CO2Me), 61.1 (−, CH2CH3), 82.4 (+, C-5), 84.0 
(+, C-2), 141.1 (Cquat, C-3), 148.4 (+, C-4), 170.2 (Cquat, CO2Me), 170.4 (Cquat, CO2Et), 
185.9 (+, CHO); IR (film): ~ν  = 2957, 2848, 2733, 1746, 1683, 1629, 1437, 1376, 1285, 
1180, 1082, 926, 852, 765 cm-1; MS (EI, 70 eV): m/z (%) = 242.0 (4) [M+•], 183.0 
(100), 155.0 (60), 109.0.0 (54); MS (HR-EI, 70 eV): 242.0789 (C11H14O6: calc. 
242.0790 [M+•]). 
 
 
 
 
 
 
(2R,5R)-(+)-5-Ethoxycarbonylmethyl-2,5-dihydro-furan-2,3-dicarboxylic acid 2-
methyl ester (240): A solution of NaClO2 (0.225 g, 2.49 mmol, 3 equiv.) in water (1 
mL) was added dropwise to a stirred mixture of 5-methyl-furfural 239 (0.100 g, 0.83 
mmol, 1 equiv.) in acetonitrile (2 mL), KH2PO4 (0.107 g, 0.79 mmol, 0.95 equiv.) in 
water (2 mL) and of 30% H2O2 (0.13 mL, 1.25 mmol, 1.5 equiv.), keeping the 
temperature at 0 oC. Oxygen evolved from the solution until the end of the reaction (12 
hours) with a bubbler connected to the apparatus. A small amount of Na2SO3 (0.157 g, 
1.25 mmol, 1.5 equiv.) was added to destroy the unreacted HOCl and H2O2. After 
acidification with HCl 6 N, the mixture was extracted with dichloromethane (3 × 30 
mL). The combined organic layers were washed with water (1 × 10 mL), dried over 
anhydrous Na2SO4 and concentrated in vacuo. The residue was purified by column 
chromatography on silica (hexanes/ethyl acetate 9:1) to provide 240 as a white 
crystalline solid (0.088 g, 83%). 
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Rf (SiO2, hexanes/ethyl acetate 1:1) = 0.1; m.p. = 79 oC; [ ]α D20  = +30.8 (c 1.0, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ = 1.27 (t, J = 7.14 Hz, 3 H, CH2CH3), 2.73 (dd, J = 
16.33, 6.72 Hz, 1 H, CH2CO2Et), 2.90 (dd, J = 16.33, 7.27 Hz, 1 H, CH2CO2Et), 3.77 (s, 
3 H, CO2Me), 4.17 (q, J = 7.14 Hz, 2 H, CH2CH3), 5.33 (dd, J = 2.74, 2.20 Hz, 1 H, 2-
H), 5.45 (dddd, J = 2.74, 1.78, 7.00, 7.00 Hz, 1 H, 5-H), 7.15 (dd, J = 1.78, 1.781 Hz, 1 
H, 4-H), 8.69-9.49 (bs, 1 H, CO2H); 13C NMR (75.5 MHz, CDCl3): δ = 14.3 (+, 
CH2CH3), 40.3 (−, CH2CO2Et), 52.9 (+, CO2Me), 61.1 (−, CH2CH3), 83.3 (+, C-5), 84.3 
(+, C-2), 131.7 (Cquat, C-3), 145.5 (+, C-4), 166.4 (Cquat, CO2H), 170.2 (Cquat, CO2Me), 
170.5(Cquat, CO2Et); IR (KBr): ~ν  = 2987, 1745, 1703, 1405, 1278, 1181, 1115, 1081, 
1021, 749 cm-1; MS (PI-LSIMS, Glycerin/MeOH): m/z (%) = 351.2 [MH++glyc.], 
259.1 [MH+]; MS (HR- PI-LSIMS, Glycerin/MeOH): 259.0815 (C11H15O7: calc. 
259.0818 [M+]); elemental analysis calcd (%) for C11H14rO7 (258.22): C 51.16, H 5.46, 
O 43.37; found C 50.92, H 4.95. 
 
 
 
 
 
(2R,3R,5S)-(+)-5-Ethoxycarbonylmethyl-3-formyl-tetrahydro-furan-2-carboxylic 
acid methyl ester (243): A solution of 239 (0.100 g, 0.41 mmol, 1 equiv.) in MeOH (5 
mL) was treated with 10% Pd/C (0.010 g) and purged with hydrogen for 10 minutes 
followed by vigorous stirring in an atmosphere of hydrogen (via balloon) for 2 h (tlc 
control). The reaction mixture was filtered through a pad of celite. The solvent was 
removed in vacuo. The residue was purified by column chromatography on silica 
(hexanes/ethyl acetate 1:1) to provide 243 as colorless oil (0.070 g., 69%). 
 
Rf (SiO2, hexanes/ethyl acetate 1:1) = 0.30; [ ]α D20  = +5.5 (c 1.0, CH2Cl2); 1H NMR 
(300 MHz, CDCl3): δ = 1.20 (t, J = 7.17 Hz, 1 H, CH2CH3), 1.86 (ddd, J = 12.97, 9.09, 
8.78 Hz, 1 H, 4-CH2), 2.48 (ddd, J = 12.96, 6.18, 3.40 Hz, 1 H, 4-CH2), 2.52 (dd, J = 
15.92, 6.72 Hz, 1 H, CH2CO2Et), 2.78 (dd, J = 15.98, 6.52 Hz, 1 H, CH2CO2Et), 3.25 
(ddd, J = 9.09, 4.19, 3.40 Hz, 1 H, 3-H), 3.71 (s, 3 H, CO2Me), 4.09 (q, J = 7.17 Hz, 2 
H, CH2CH3), 4.33 (dddd, J = 8.78, 6.72, 6.52, 6.17 Hz, 1 H, 5-H), 4.75 (d, J = 4.19 Hz, 
1 H, 2-H), 9.69 (d, J = 0.89 Hz, 1 H, CHO); 13C NMR (75.5 MHz, CDCl3): δ = 14.2 (+, 
O
MeO2C
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H
H
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CH2CH3), 31.3 (−, C-4), 40.3 (−, CH2CO2Et), 52.6 (+, C-3), 55.3 (+, CO2Me), 60.8 (−, 
CH2CH3), 76.3 (+, C-5), 76.7 (+, C-2), 170.6 (Cquat, CO2Me), 172.0 (Cquat, CO2Et), 
198.4 (Cquat, CHO); IR (KBr): ~ν  = 3463, 2981, 2740, 2199, 2092, 1734, 1439, 1394, 
1370, 1206, 1096, 846, 702 cm-1; MS (EI, 70 eV): m/z (%) = 245.2 (4) [MH+], 226.1 
(10), 185.1 (100). 
 
 
 
 
 
(1S,2R,3S)-Oxalic acid 2-acetyl-3-ethoxycarbonyl-cyclopropyl ester methyl ester 
(250): A solution of 176 (0.500 g, 2.2 mmol) in dry CH2Cl2 (25 mL) was cooled to –78 
°C and treated with ozone until the mixture turned blue. Excess ozone was expelled by 
passing oxygen through the solution, followed by addition of dimethyl sulfide (0.3 mL, 
4.42 mmol, 5.0 equiv.). The reaction mixture was allowed to warm to room temperature 
and stirring was continued for 24 hours. Saturated NaHCO3 (10 mL) was added and 
layers were separated. The organic layer was washed with water (2 x 10 mL), dried, 
filtered and evaporated to yield 250 as the colorless oil (0.468 g, 82%). 
 
1H NMR (300 MHz, CDCl3): δ = 1.27 (t, J = 7.14 Hz, 3 H, CH2CH3), 2.34 (s, 3 H, 
C(O)CH3), 2.86-2.94 (m, 2 H, 2-H and 3-H), 3.88 (s, 3 H, CO2Me), 4.17 (dq, J = 7.14, 
1.23 Hz, 2 H, CH2CH3), 4.54 (dd, J = 7.27, 3.98 Hz, 1 H, 1-H); 13C NMR (75.5 MHz, 
CDCl3): δ = 14.2 (+, CH2CH3), 26.6 (+, C(O)CH3), 31.6 (+, C-3), 34.8 (+, C-2), 53.9 (+, 
CO2Me),58.9 (+, C-1), 61.7 (−, CH2CH3), 156.8 (Cquat, -OC(O)C(O)OMe), 157.2 (Cquat, 
-OC(O)C(O)OMe), 169.1 (Cquat, CO2Et), 198.6 (Cquat, C(O)Me); MS (CI, NH3): m/z 
(%) = 276.3 (100) [M+NH4+]. 
 
 
 
 
 
(1S,2R,3S)-Oxalic acid-2-(2-bromo-acetyl)-3-ethoxycarbonyl-cyclopropyl ester 
methyl ester (251): 251 was synthesized from 177 using the similar procedure and 
scale as in the synthesis of 250. The product obtained was the colorless oil in 86% yield. 
CO2Et
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1H NMR (300 MHz, CDCl3): δ = 1.28 (t, J = 7.27 Hz, 3 H, CH2CH3), 2.92 (dd, J = 
6.31, 3.84 Hz, 1 H, 2-H), 3.19 (dd, J = 7.55, 6.31 Hz, 1 H, 3-H), 3.19 (s, 3 H, CO2Me), 
3.99 (d, J = 12.35, 1 H, CH2Br), 4.08 (d, J = 12.35, 1 H, CH2Br), 4.17 (dq, J = 7.27, 
1.23 Hz, 2 H, CH2CH3), 4.61 (dd, J = 7.55, 3.84 Hz, 1 H, 1-H); 13C NMR (75.5 MHz, 
CDCl3): δ = 14.2 (+, CH2CH3), 27.3 (+, C-2), 32.2 (+, C-3), 34.6 (−, CH2Br), 54.1 (+, 
CO2Me), 59.5 (+, C-1), 62.1 (−, CH2CH3), 156.7 (Cquat, -OC(O)C(O)OMe), 157.2 (Cquat, 
-OC(O)C(O)OMe), 168.7 (Cquat, CO2Et), 192.5 (Cquat, C(O)Me); MS (CI, NH3): m/z 
(%) = 354.0 (94) [M+NH4+], 355.9 (100) [M+NH4+]. 
 
 
 
 
 
(1S,2R,3S)-Oxalic acid 2-(1`-bromomethyl-1`-hydroxy-pent-4-enyl)-3-
ethoxycarbonyl-cyclopropyl ester methyl ester (252): A solution of 251 (200 mg, 
0.59 mmol, 1 equiv.) in dichloromethane (10 mL) was added dropwise to a stirred 
solution of boron trifluoride diethyl etherate (0.11 mL, 0.89 mmol, 1.5 equiv.) in 
dichloromethane (4 mL) at 0 °C. After 5 min, allyltributyltin (0.22 mL, 0.71 mmol, 1.2 
equiv.) was added, and the mixture was stirred for 24 h at 0 °C. Saturated aqueous 
NaHCO3 (10 mL) was added, and the mixture was allowed to warm to room 
temperature before being partitioned between dichloromethane and water. The organic 
extract was washed with brine, dried over MgSO4, filtered and concentrated under 
reduced pressure to yield 252 as the colorless oil (0.225 g., quant.). The crude product 
was carried for the next reaction without chromatography, as it is not stable on silica. 
 
1H NMR (300 MHz, CDCl3): δ = 1.28 (t, J = 7.14 Hz, 3 H, CH2CH3), 2.33 (bs, 1 H, 
OH), 2.36 (dd, J = 7.14, 3.02 Hz, 1 H; 2-H), 2.46 (dd, J = 6.72, 2.88 Hz, 1 H, 3-H), 
2.50-2.67 (m, 2 H, 2`-CH2), 3.49-3.54 (m, 2 H, CH2Br), 3.90 (s, 3 H, CO2Me), 4.16 (dq, 
J = 7.14, 1.10 Hz, 2 H, CH2CH3), 4.76-4.82 (m, 1 H, 1-H), 5.11-5.27 (m, 2 H, 4`-CH2), 
5.76-5.91 (m, 1 H, 3`-H); MS (CI, NH3): m/z (%) = 396.1 (100) [M+NH4+], 398.0 (99) 
[M+NH4+]. Note: As tri-butyl tin hydride impurities were also present in the crude 
product, it was cumbersome to analyze 13C NMR spectrum. Hence, after confirming the 
structure on the basis of 1H NMR and mass, the product was carried further for the next 
reaction.
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6.0 Appendix  
6.1 NMR Spectra 
 
(–)-(S,S)-Bis(4-isopropyloxazoline) (164): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
 
O
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5-Methyl-furan-2-carboxylic acid methyl ester (171): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, CDCl3)  
(ppm)
0102030405060708090100110120130140150160170180190
 
 
O CH3
MeO2C
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3-Methyl-furan-2-carboxylic acid methyl ester (154): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
 
 
O
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(1S,5R,6S)-(−)-4-Methyl-2-oxa-bicyclo[3.1.0]hex-3-ene-3,6-dicarboxylic acid 6-ethyl 
ester 3-methyl ester (176): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
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(1S,5R,6S)-(−)-4-Bromomethyl-2-oxa-bicyclo[3.1.0]hex-3-ene-3,6-dicarboxylic acid 
6-ethyl ester 3-methyl ester (177): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
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4-(Bromo-ethoxy-carbonyl-methyl)-3-methyl-furan-2-carboxylic acid methyl ester 
(178): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
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(1S,5R,6S)-(−)-4-(4-Methoxy-phenoxymethyl)-2-oxa-bicyclo[3.1.0]hex-3-ene-3,6-
dicarboxylic acid 6-ethyl ester 3-methyl ester (179): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
 
O
H
H
CO2EtMeO2C
O
MeO
Section 6. Appendix 119 
 
(1S,5R,6S)-(−)-4-Hydroxymethyl-2-oxa-bicyclo[3.1.0]hex-3-ene-3,6-dicarboxylic 
acid 6-ethyl ester 3-methyl ester (180): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
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(1S,5R,6S)-(−)-4-Formyl-2-oxa-bicyclo[3.1.0]hex-3-ene-3,6-dicarboxylic acid 6-
ethyl ester 3-methyl ester (181): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
(ppm)
10
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
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(1S,5R,6S)-4-(1`-Hydroxy-but-3`-enyl)-2-oxa-bicyclo[3.1.0]hex-3-ene-3,6-
dicarboxylic acid 6-ethyl ester 3-methyl ester (182): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
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(1S,5R,6S)-(−)-4-[1´,3´]Dioxolan-2´-yl-2-oxa-bicyclo[3.1.0]hex-3-ene-3,6-
dicarboxylic acid 6-ethyl ester 3-methyl ester (185): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
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(1S,5R,6S)-(−)-4-Diethoxymethyl-2-oxa-bicyclo[3.1.0]hex-3-ene-3,6-dicarboxylic 
acid 6-ethyl ester 3-methyl ester (186): 
1H NMR (300 MHz, DMSO-d6) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, DMSO-d6) 
(ppm)
020406080100120140160180
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2-Hydroxy-3-methyl-heptanedioic acid 7-ethyl ester 1-methyl ester (187): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
 
 
OH
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(1S,3R,4R,5R,6S)-(−)4-(4`-Methoxy-phenoxymethyl)-2-oxa-bicyclo[3.1.0]hexane-
3,6-dicarboxylic acid 6-ethyl ester 3-methyl ester (188): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
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(1S,3R,4S,5S,6S)-(+)-4-[1´´,3´´]Dioxolan-2´-yl-2-oxa-bicyclo[3.1.0]hexane-3,6-
dicarboxylic acid 6-ethyl ester 3-methyl ester (189): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
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(1S,3R,4S,5S,6S)-(+)-4-Diethoxymethyl-2-oxa-bicyclo[3.1.0]hexane-3,6-dicarboxylic 
acid 6-ethyl ester 3-methyl ester (190): 
1H NMR (300 MHz, DMSO-d6) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, DMSO-d6) 
(ppm)
020406080100120140160180
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(1S,3R,4S,5S,6S)-(−)4-[1`,3`]Dithian-2-yl-2-oxa-bicyclo[3.1.0]hexane-3,6-
dicarboxylic acid 6-ethyl ester 3-methyl ester (191): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
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(2R,3S,3aR,6aR)-(−)-3-[1`,3`]Dithian-2-yl-5-oxo-hexahydro-furo[2,3-b]furan-2-
carboxylic acid methyl ester (192): 
1H NMR (300 MHz, DMSO-d6) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, DMSO-d6) 
(ppm)
020406080100120140160180
 
O
MeO2C
S S
O
H
H
O
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(2R,3S,3aR,6aR)-(−)-3-[1`,3`]Dithian-2-yl-5-oxo-hexahydro-furo[2,3-b]furan-2-
carboxylic acid (193): 
1H NMR (300 MHz, DMSO-d6) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
(ppm)
1314
 
13C NMR (75.5 MHz, DMSO-d6) 
(ppm)
020406080100120140160180
 
O
HO2C
S S
O
H
H
O
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(2R,3S,3aR,6aR)-(+)-3-[1`,3`]Dithian-2-yl-5-oxo-hexahydro-furo[2,3-b]furan-2-
carboxylic acid benzyl ester (195): 
1H NMR (300 MHz, DMSO-d6) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, DMSO-d6) 
(ppm)
020406080100120140160180
 
O
BnO2C
S
S
O
H
H
O
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(2R,3S,3aR,6aR)-(−)-3-Dimethoxymethyl-5-oxo-hexahydro-furo[2,3-b]furan-2-
carboxylic acid benzyl ester (196): 
1H NMR (300 MHz, DMSO-d6) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, DMSO-d6) 
(ppm)
020406080100120140160180
 
O
BnO2C
MeO
OMe
O
H
H
O
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(2R,3R,3aR,6aR)-(−)-3-Formyl-5-oxo-hexahydro-furo[2,3-b]furan-2-carboxylic 
acid benzyl ester (197): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
(ppm)
10.0
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
 
O
BnO2C
OHC
O
H
H
O
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(1`S,2R,3S,4R,,5R)-(−)-4-(Bromo-ethoxycarbonyl-methyl)-3-[1´´,3´´]dioxolan-2´´-
yl-5-methoxy-tetrahydro-furan-2-carboxylic acid methyl ester (220): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
 
O
MeO2C
OMe
H
CO2Et
BrO O
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(1´R,2R,3S,4S,5R)-(+)-4-(Azido-ethoxycarbonyl-methyl)-3-[1´´,3´´]dioxolan-2´´-yl-
5-methoxy-tetrahydro-furan-2-carboxylic acid methyl ester (222): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
 
O
MeO2C
OMe
H
CO2Et
N3O O
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(1´R,2R,3S,4S,5R)-(−)-4-(tert-Butoxycarbonylamino-ethoxycarbonyl-methyl)-3-
[1´´,3´´]dioxolan-2´´-yl-5-methoxy-tetrahydro-furan-2-carboxylic acid methyl ester 
(223): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
 
O OMe
H
CO2Et
HN
MeO2C
O
O
O
O
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(1´R,2R,3S,4S,5R)-(+)-4-(tert-Butoxycarbonylamino-ethoxycarbonyl-methyl)-3-
[1´´,3´´]dioxolan-2´´-yl-5-methoxy-tetrahydro-furan-2-carboxylic acid (224): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
020406080100120140160180
 
O OMe
H
CO2Et
HN
HO2C
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(1S,3R,4S,5S,6S)-4-Formyl-2-oxa-bicyclo[3.1.0]hexane-3,6-dicarboxylic acid 6-
ethyl ester 3-methyl ester (237): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
(ppm)
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
 
O
MeO2C
OHC
H
H
CO2Et
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(2R,5R)-(+)-5-Ethoxycarbonylmethyl-3-formyl-2,5-dihydro-furan-2-carboxylic 
acid methyl ester (239): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
(ppm)
10.0
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
 
O
MeO2C
OHC
H
H
CO2Et
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(2R,5R)-(+)-5-Ethoxycarbonylmethyl-2,5-dihydro-furan-2,3-dicarboxylic acid 2-
methyl ester (240): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
(ppm)
910
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
 
O
MeO2C
HO2C
H
H
CO2Et
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(2R,5R)-(+)-5-Ethoxycarbonylmethyl-3-formyl-tetrahydro-furan-2-carboxylic acid 
methyl ester (243): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
(ppm)
10
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
 
O
MeO2C
H
H
OHC
CO2Et
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(1S,2R,3S)-Oxalic acid 2-acetyl-3-ethoxycarbonyl-cyclopropyl ester methyl ester 
(250): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
 
CO2Et
OCOCO2Me
O
H3C
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(1S,2R,3S)-Oxalic acid 2-(2-bromo-acetyl)-3-ethoxycarbonyl-cyclopropyl ester 
methyl ester (251): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
 
CO2Et
OCOCO2Me
OBr
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(1S,2R,3S)-Oxalic acid 2-(1-bromomethyl-1-hydroxy-pent-4-enyl)-3-
ethoxycarbonyl-cyclopropyl ester methyl ester (252): 
1H NMR (300 MHz, CDCl3) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
 
13C NMR (75.5 MHz, CDCl3) 
(ppm)
0102030405060708090100110120130140150160170180190
 
CO2Et
OCOCO2Me
OHBr
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6.2 X-ray Data:  
6.2.1 (1S,5R,6S)-(−)-4-Bromomethyl-2-oxa-bicyclo[3.1.0]hex-3-ene-3,6-
dicarboxylic acid 6-ethyl ester 3-methyl ester (177): 
 
6.2.1a Crystal data and structure refinement for 177: 
 
Crystal Data: 
Empirical formula   C11 H13 Br O5  
Formula weight   305.11  
Crystal size    0.40 x 0.12 x 0.04 mm  
Crystal description   stick  
Crystal colour    colorless  
Crystal system   Monoclinic  
Space group    P 21  
Unit cell dimensions   a = 8.7496(12) Å  α = 90 deg.  
b = 8.4611(9) Å  β = 116.659(16) deg.  
c = 9.5715(16) Å  γ = 90 deg.  
Volume    633.26(18) Å3  
Z, Calculated density   2, 1.600 Mg/m3  
Absorption coefficient  3.252 mm-1  
F(000)     308 
Data Collection: 
Measurement device type  STOE-IPDS diffractometer  
Measurement method   rotation  
Temperature    173(1) K  
Wavelength    0.71073 Å  
Monochromator   graphite  
Theta range for data collection 2.38 to 25.64 deg.  
Index ranges    -10<=h<=10, -10<=k<=10, -11<=l<=11  
Reflections collected / unique 4681 / 2211 [R(int) = 0.0378]  
Reflections greater I>2\\s(I)  1865  
Absorption correction  Numerical  
Max. and min. transmission  0.7462 and 0.3977  
Refinement: 
Refinement method   Full-matrix least-squares on F2  
Hydrogen treatment   : 
Data / restraints / parameters  2211 / 1 / 154  
Goodness-of-fit on F2   0.969  
Final R indices [I>2sigma(I)] R1 = 0.0346, wR2 = 0.0750 
O
H
H
CO2EtMeO2C
Br
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R indices (all data)   R1 = 0.0438, wR2 = 0.0772 
Absolute structure parameter  -0.013(10)  
Largest diff. peak and hole  0.413 and -0.312 e.Å-3 
 
6.2.1b Atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (A2 x 103) for 177. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor: 
 
 x y z U(eq) 
Br(1) 6047(1) 8164(1) 3103(1) 59(1) 
O(1) 1326(3) 4774(3) 2667(3) 32(1) 
O(2) 673(3) 9191(3) 4687(3) 34(1) 
O(3) -330(4) 9982(3) 2180(3) 35(1) 
O(4) 4731(4) 3473(4) 1903(4) 56(1) 
O(5) 2093(4) 2549(3) 1218(4) 43(1) 
C(1) 2937(5) 4812(4) 2775(4) 30(1) 
C(2) 3951(5) 5969(4) 3696(5) 31(1) 
C(3) 2899(5) 6921(4) 4243(4) 31(1) 
C(4) 1202(5) 6094(4) 3535(4) 30(1) 
C(5) 1339(5) 7717(3) 2907(4) 28(1) 
C(6) 538(5) 9015(4) 3380(4) 28(1) 
C(7) -1148(5) 11352(4) 2524(5) 34(1) 
C(8) -2139(7) 12193(5) 1017(6) 52(2) 
C(9) 5763(5) 6261(5) 4150(5) 40(1) 
C(10) 3368(6) 3556(4) 1920(5) 35(1) 
C(11) 2400(7) 1270(5) 380(6) 54(2) 
 
6.2.1c Bond lengths [Å] and angles [deg] for 177: 
 
Br(1)-C(9) 1.970(4) 
O(1)-C(1) 1.367(6) 
O(1)-C(4) 1.425(4) 
O(2)-C(6) 1.212(4) 
O(3)-C(6) 1.335(4) 
O(3)-C(7) 1.475(5) 
O(4)-C(10) 1.202(7) 
O(5)-C(10) 1.323(6) 
O(5)-C(11) 1.442(6) 
C(1)-C(2) 1.349(5) 
C(1)-C(10) 1.489(6) 
C(2)-C(3) 1.484(6) 
C(2)-C(9) 1.465(7) 
C(3)-C(4) 1.500(6) 
C(3)-C(5) 1.545(5) 
C(4)-C(5) 1.525(5) 
C(5)-C(6) 1.479(5) 
C(7)-C(8) 1.489(6) 
C(3)-H(3) 1.0001 
C(4)-H(4) 1.0000 
C(5)-H(5) 1.0001 
C(7)-H(7A) 0.9903 
C(7)-H(7B) 0.9901 
C(8)-H(8A) 0.9798 
C(8)-H(8B) 0.9811 
C(8)-H(8C) 0.9796 
C(9)-H(9A) 0.9895 
C(9)-H(9B) 0.9897 
C(11)-H(11A) 0.9800 
C(11)-H(11B) 0.9800 
C(11)-H(11C) 0.9800 
  
C(1)-O(1)-C(4) 106.5(3) 
C(6)-O(3)-C(7) 115.8(3) 
C(10)-O(5)-C(11) 116.2(4) 
O(1)-C(1)-C(2) 114.8(4) 
O(1)-C(1)-C(10) 116.6(3) 
C(2)-C(1)-C(10) 128.5(4) 
C(1)-C(2)-C(3) 107.1(4) 
C(1)-C(2)-C(9) 128.5(4) 
C(3)-C(2)-C(9) 124.3(3) 
C(2)-C(3)-C(4) 103.4(3) 
C(2)-C(3)-C(5) 113.7(3) 
C(4)-C(3)-C(5) 60.1(2) 
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O(1)-C(4)-C(3) 108.1(3) 
O(1)-C(4)-C(5) 115.8(3) 
C(3)-C(4)-C(5) 61.4(3) 
C(3)-C(5)-C(4) 58.5(2) 
C(3)-C(5)-C(6) 115.8(3) 
C(4)-C(5)-C(6) 114.6(4) 
O(2)-C(6)-O(3) 124.5(4) 
O(2)-C(6)-C(5) 124.6(3) 
O(3)-C(6)-C(5) 110.9(3) 
O(3)-C(7)-C(8) 106.8(4) 
Br(1)-C(9)-C(2) 110.7(3) 
O(4)-C(10)-O(5) 124.8(4) 
O(4)-C(10)-C(1) 123.1(4) 
O(5)-C(10)-C(1) 112.0(4) 
C(2)-C(3)-H(3) 121.02 
C(4)-C(3)-H(3) 121.09 
C(5)-C(3)-H(3) 121.11 
O(1)-C(4)-H(4) 119.27 
C(3)-C(4)-H(4) 119.22 
C(5)-C(4)-H(4) 119.18 
C(3)-C(5)-H(5) 118.12 
C(4)-C(5)-H(5) 118.11 
C(6)-C(5)-H(5) 118.12 
O(3)-C(7)-H(7A) 110.40 
O(3)-C(7)-H(7B) 110.41 
C(8)-C(7)-H(7A) 110.37 
C(8)-C(7)-H(7B) 110.34 
H(7A)-C(7)-H(7B) 108.51 
C(7)-C(8)-H(8A) 109.48 
C(7)-C(8)-H(8B) 109.45 
C(7)-C(8)-H(8C) 109.50 
H(8A)-C(8)-H(8B) 109.44 
H(8A)-C(8)-H(8C) 109.51 
H(8B)-C(8)-H(8C) 109.44 
Br(1)-C(9)-H(9A) 109.55 
Br(1)-C(9)-H(9B) 109.50 
C(2)-C(9)-H(9A) 109.49 
C(2)-C(9)-H(9B) 109.48 
H(9A)-C(9)-H(9B) 108.05 
O(5)-C(11)-
H(11A) 
109.46 
O(5)-C(11)-
H(11B) 
109.45 
O(5)-C(11)-
H(11C) 
109.49 
H(11A)-C(11)-
H(11B) 
109.48 
H(11A)-C(11)-
H(11C) 
109.46 
H(11B)-C(11)-
H(11C) 
109.49 
 
6.2.1d Anisotropic displacement parameters (A2 x 103) for 177. The anisotropic 
displacement factor exponent takes the form: -2 pi2 [h2 a*2 U11 + + 2 h k a* b* 
U12]: 
 
 U11 U22 U33 U23 U13 U12 
Br(1) 50(1) 50(1) 79(1) -3(1) 31(1) -15(1)  
O(1) 33(2) 21(1) 43(2) -4(1) 19(1) -3(1)  
O(2) 37(2) 31(1) 33(2) 0(1) 16(1) 4(1)  
O(3) 47(2) 25(1) 39(2) 2(1) 24(1) 7(1)  
O(4) 39(2) 63(2) 66(2) -26(2) 25(2) 3(2)  
O(5) 49(2) 26(1) 53(2) -11(1) 20(2) 2(1)  
C(1) 29(2) 21(2) 38(2) 3(2) 15(2) 3(1)  
C(2) 31(2) 26(2) 35(2) 3(2) 13(2) 5(2)  
C(3) 33(2) 28(2) 31(2) 0(1) 14(2) 2(2)  
C(4) 34(2) 22(2) 39(2) -1(1) 22(2) -1(1)  
C(5) 30(2) 22(2) 35(2) 0(1) 17(2) -1(1)  
C(6) 26(2) 21(2) 36(2) 0(2) 12(2) -2(1)  
C(7) 41(2) 24(2) 41(2) 1(2) 22(2) 8(2)  
C(8) 65(3) 44(2) 56(3) 8(2) 35(3) 20(2)  
C(9) 32(2) 36(2) 45(2) -4(2) 12(2) 2(2)  
C(10) 40(2) 28(2) 35(2) 3(1) 14(2) 7(2)  
C(11) 64(3) 35(2) 52(3) -13(2) 16(3) 11(2) 
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6.2.1e Hydrogen coordinates (x 104) and isotropic displacement parameters (A2 x 
103) for 177:  
 
 x y z U(eq) 
H(3) 3395 7344 5334 37 
H(4) 550 5983 4161 35 
H(5) 1308 7775 1851 33 
H(7A) -271 12061 3289 41 
H(7B) -1918 10997 2967 41 
H(8A) -2970 11466 259 62 
H(8B) -1355 12575 613 62 
H(8C) -2742 13092 1186 62 
H(9A) 6257 5337 3864 47 
H(9B) 6386 6401 5297 47 
H(11A) 3375 642 1105 65 
H(11B) 2652 1702 -444 65 
H(11C) 1382 597 -90 65 
 
6.2.1f Torsion angles [deg] for 177: 
 
C(4)-O(1)-C(1)-
C(2) 
3.5(4) 
C(4)-O(1)-C(1)-
C(10) 
-178.6(3) 
C(1)-O(1)-C(4)-
C(5) 
64.2(4) 
C(1)-O(1)-C(4)-
C(3) 
-2.1(3) 
C(7)-O(3)-C(6)-
C(5) 
-178.4(3) 
C(6)-O(3)-C(7)-
C(8) 
-175.9(4) 
C(7)-O(3)-C(6)-
O(2) 
0.6(6) 
C(11)-O(5)-
C(10)-C(1) 
-178.9(3) 
C(11)-O(5)-
C(10)-O(4) 
0.0(6) 
O(1)-C(1)-C(2)-
C(9) 
175.0(4) 
C(10)-C(1)-C(2)-
C(3) 
179.1(3) 
C(10)-C(1)-C(2)-
C(9) 
-2.7(7) 
O(1)-C(1)-C(2)-
C(3) 
-3.3(4) 
O(1)-C(1)-C(10)-
O(5) 
-2.2(5) 
C(2)-C(1)-C(10)-
O(5) 
175.4(4) 
O(1)-C(1)-C(10)- 178.9(4) 
O(4) 
C(2)-C(1)-C(10)-
O(4) 
-3.5(7) 
C(9)-C(2)-C(3)-
C(5) 
120.4(4) 
C(1)-C(2)-C(3)-
C(4) 
1.7(4) 
C(9)-C(2)-C(3)-
C(4) 
-176.7(4) 
C(1)-C(2)-C(3)-
C(5) 
-61.3(4) 
C(3)-C(2)-C(9)-
Br(1) 
-73.1(4) 
C(1)-C(2)-C(9)-
Br(1) 
108.8(4) 
C(2)-C(3)-C(5)-
C(6) 
-163.4(3) 
C(2)-C(3)-C(4)-
O(1) 
0.3(4) 
C(2)-C(3)-C(5)-
C(4) 
92.3(3) 
C(2)-C(3)-C(4)-
C(5) 
-109.9(3) 
C(5)-C(3)-C(4)-
O(1) 
110.1(3) 
C(4)-C(3)-C(5)-
C(6) 
104.3(4) 
C(3)-C(4)-C(5)-
C(6) 
-106.3(4) 
O(1)-C(4)-C(5)-
C(3) 
-97.4(4) 
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O(1)-C(4)-C(5)-
C(6) 
156.4(3) 
C(4)-C(5)-C(6)-
O(3) 
-137.6(4) 
C(3)-C(5)-C(6)- 157.0(3) 
O(3) 
C(3)-C(5)-C(6)-
O(2) 
-21.9(6) 
C(4)-C(5)-C(6)-
O(2) 
43.4(6) 
 
6.2.1g Hydrogen-bonds for 177 [Å and deg.]: 
 
D-H   A d(D-H) d(H   A) d(D   A)  (DHA) 
C(3)-H(3)   
O(4) 1 
1.0000 2.5900 3.573(5) 168.00 
C(4)-H(4)   
O(2) 2 
1.0000 2.3900 3.269(5) 146.00 
C(9)-H(9A)   
O(4) 
0.9900 2.3500 3.044(5) 126.00 
C(9)-H(9A)   
O(2) 3 
0.9900 2.6000 3.304(5) 129.00 
 
6.2.2 (1S,3R,4S,5S,6S)-(+)-4-[1´´,3´´]Dioxolan-2´-yl-2-oxa-bicyclo[3.1.0]hexane-
3,6-dicarboxylic acid 6-ethyl ester 3-methyl ester (189): 
 
6.2.2a Crystal data and structure refinement for 189: 
 
Crystal Data: 
Empirical formula   C13 H18 O7 
Formula weight   286.27 
Crystal size    0.480 x 0.200 x 0.060 mm 
Crystal description   rod 
Crystal colour    colourless 
Crystal system   Monoclinic 
Space group    P 21  
Unit cell dimensions   a = 8.6307(9) Å  α = 90 deg. 
b = 7.9396(6) Å  β = 108.157(12) deg. 
c = 10.5006(11) Å  γ = 90 deg. 
Volume    683.72(12) A3  
Z, Calculated density   2, 1.391 Mg/m3 
Absorption coefficient  0.114 mm-1 
F(000)     304  
Data Collection: 
O
H
H
CO2EtMeO2C
O
O
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Measurement device type  STOE-IPDS diffractometer 
Measurement method   rotation 
Temperature    123(1) K 
Wavelength    0.71073 Å 
Monochromator   graphite 
Theta range for data collection 3.57 to 26.91 deg. 
Index ranges    -10<=h<=10, -10<=k<=10, -13<=l<=13 
Reflections collected / unique 8682 / 2923 [R(int) = 0.0249] 
Reflections greater I>2\s(I)  2760 
Absorption correction  None 
Max. and min. transmission  0.993 and 0.947 
Refinement: 
Refinement method   Full-matrix least-squares on F2 
Hydrogen treatment   : 
Data / restraints / parameters  2923 / 1 / 253 
Goodness-of-fit on F2   1.069 
Final R indices [I>2sigma(I)] R1 = 0.0292, wR2 = 0.0708 
R indices (all data)   R1 = 0.0310, wR2 = 0.0714 
Absolute structure parameter  -0.1(6) 
Largest diff. peak and hole  0.252 and -0.138 e.A-3 
 
6.2.2b Atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (A2 x 103) for 189. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor: 
 
 x y z U(eq) 
O(1) 1568(1) 2829(1) 2124(1) 31(1) 
O(2) 5785(1) 1715(1) 3322(1) 28(1) 
O(3) 3913(1) 1585(2) 4415(1) 33(1) 
O(4) -375(1) -1978(1) 3582(1) 26(1) 
O(5) -1929(1) -1357(1) 1461(1) 26(1) 
O(6) 4114(1) -1547(1) 2507(1) 22(1) 
O(7) 3415(1) -1900(1) 224(1) 26(1) 
C(1) 361(2) 1564(2) 1676(1) 26(1) 
C(2) 729(1) -144(2) 2375(1) 22(1) 
C(3) 959(1) 183(2) 1001(1) 22(1) 
C(4) 2663(1) 707(2) 1003(1) 22(1) 
C(5) 3081(2) 2212(2) 2013(1) 25(1) 
C(6) 4264(1) 1787(2) 3404(1) 25(1) 
C(7) 7022(2) 1170(2) 4537(2) 36(1) 
C(8) -675(1) -1206(2) 2390(1) 22(1) 
C(9) -1642(2) -3098(2) 3749(1) 33(1) 
C(10) -1510(2) -4829(2) 3201(2) 41(1) 
C(11) 3936(1) -688(2) 1269(1) 21(1) 
C(12) 3714(2) -3288(2) 2202(1) 26(1) 
C(13) 3984(2) -3489(2) 847(1) 28(1) 
 
6.2.2c Bond lengths [Å] and angles [deg] for 189: 
 
O(1)-C(1) 1.4174(17) 
O(1)-C(5) 1.4330(17) 
O(2)-C(6) 1.3437(16) 
O(2)-C(7) 1.4513(18) 
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O(3)-C(6) 1.2022(15) 
O(4)-C(8) 1.3436(15) 
O(4)-C(9) 1.4622(17) 
O(5)-C(8) 1.2161(14) 
O(6)-C(11) 1.4330(14) 
O(6)-C(12) 1.4361(17) 
O(7)-C(11) 1.4232(15) 
O(7)-C(13) 1.4356(17) 
C(1)-C(2) 1.5275(18) 
C(1)-C(3) 1.4828(18) 
C(2)-C(3) 1.5386(17) 
C(2)-C(8) 1.4807(17) 
C(3)-C(4) 1.5273(18) 
C(4)-C(5) 1.5641(18) 
C(4)-C(11) 1.5235(18) 
C(5)-C(6) 1.5358(18) 
C(9)-C(10) 1.508(2) 
C(12)-C(13) 1.5204(18) 
C(1)-H(1) 0.926(18) 
C(2)-H(2) 0.946(17) 
C(3)-H(3) 0.925(15) 
C(4)-H(4) 0.941(16) 
C(5)-H(5) 0.942(17) 
C(7)-H(7A) 0.966(18) 
C(7)-H(7B) 0.97(2) 
C(7)-H(7C) 1.00(2) 
C(9)-H(9A) 0.936(16) 
C(9)-H(9B) 0.923(18) 
C(10)-H(10A) 0.93(3) 
C(10)-H(10B) 0.98(3) 
C(10)-H(10C) 0.91(2) 
C(11)-H(11) 0.974(17) 
C(12)-H(12A) 0.960(18) 
C(12)-H(12B) 0.948(17) 
C(13)-H(13A) 0.955(18) 
C(13)-H(13B) 0.92(2) 
  
C(1)-O(1)-C(5) 108.94(10) 
C(6)-O(2)-C(7) 114.94(10) 
C(8)-O(4)-C(9) 117.06(10) 
C(11)-O(6)-C(12) 107.77(9) 
C(11)-O(7)-C(13) 105.13(9) 
O(1)-C(1)-C(2) 116.64(10) 
O(1)-C(1)-C(3) 110.70(11) 
C(2)-C(1)-C(3) 61.45(8) 
C(1)-C(2)-C(3) 57.84(8) 
C(1)-C(2)-C(8) 117.52(11) 
C(3)-C(2)-C(8) 116.84(10) 
C(1)-C(3)-C(2) 60.70(8) 
C(1)-C(3)-C(4) 106.05(10) 
C(2)-C(3)-C(4) 116.77(10) 
C(3)-C(4)-C(5) 103.13(10) 
C(3)-C(4)-C(11) 116.17(11) 
C(5)-C(4)-C(11) 115.49(10) 
O(1)-C(5)-C(4) 107.04(10) 
O(1)-C(5)-C(6) 110.54(11) 
C(4)-C(5)-C(6) 114.93(11) 
O(2)-C(6)-O(3) 124.81(12) 
O(2)-C(6)-C(5) 108.80(10) 
O(3)-C(6)-C(5) 126.37(12) 
O(4)-C(8)-O(5) 124.55(11) 
O(4)-C(8)-C(2) 110.39(10) 
O(5)-C(8)-C(2) 125.06(11) 
O(4)-C(9)-C(10) 111.14(12) 
O(6)-C(11)-O(7) 107.28(10) 
O(6)-C(11)-C(4) 112.35(10) 
O(7)-C(11)-C(4) 108.24(9) 
O(6)-C(12)-C(13) 102.32(10) 
O(7)-C(13)-C(12) 101.76(10) 
O(1)-C(1)-H(1) 113.0(10) 
C(2)-C(1)-H(1) 120.4(10) 
C(3)-C(1)-H(1) 125.5(10) 
C(1)-C(2)-H(2) 116.6(10) 
C(3)-C(2)-H(2) 119.2(10) 
C(8)-C(2)-H(2) 116.2(10) 
C(1)-C(3)-H(3) 121.9(10) 
C(2)-C(3)-H(3) 118.3(10) 
C(4)-C(3)-H(3) 119.2(10) 
C(3)-C(4)-H(4) 109.5(10) 
C(5)-C(4)-H(4) 107.7(10) 
C(11)-C(4)-H(4) 104.7(10) 
O(1)-C(5)-H(5) 109.9(10) 
C(4)-C(5)-H(5) 107.2(10) 
C(6)-C(5)-H(5) 107.2(11) 
O(2)-C(7)-H(7A) 105.3(10) 
O(2)-C(7)-H(7B) 108.3(12) 
O(2)-C(7)-H(7C) 112.3(11) 
H(7A)-C(7)-
H(7B) 
110.5(15) 
H(7A)-C(7)-
H(7C) 
109.8(15) 
H(7B)-C(7)-
H(7C) 
110.5(17) 
O(4)-C(9)-H(9A) 102.5(10) 
O(4)-C(9)-H(9B) 108.1(11) 
C(10)-C(9)-
H(9A) 
112.0(10) 
C(10)-C(9)-
H(9B) 
112.7(10) 
H(9A)-C(9)-
H(9B) 
110.0(15) 
C(9)-C(10)- 109.7(15) 
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H(10A) 
C(9)-C(10)-
H(10B) 
108.8(14) 
C(9)-C(10)-
H(10C) 
114.0(15) 
H(10A)-C(10)-
H(10B) 
112(2) 
H(10A)-C(10)-
H(10C) 
105.3(18) 
H(10B)-C(10)-
H(10C) 
106.9(17) 
O(6)-C(11)-H(11) 107.3(9) 
O(7)-C(11)-H(11) 111.1(9) 
C(4)-C(11)-H(11) 110.6(9) 
O(6)-C(12)-
H(12A) 
111.4(14) 
O(6)-C(12)- 106.6(10) 
H(12B) 
C(13)-C(12)-
H(12A) 
109.2(10) 
C(13)-C(12)-
H(12B) 
118.3(11) 
H(12A)-C(12)-
H(12B) 
108.9(16) 
O(7)-C(13)-
H(13A) 
109.2(10) 
O(7)-C(13)-
H(13B) 
109.6(13) 
C(12)-C(13)-
H(13A) 
110.4(10) 
C(12)-C(13)-
H(13B) 
114.7(12) 
H(13A)-C(13)-
H(13B) 
110.7(15) 
 
6.2.2d Anisotropic displacement parameters (A2 x 103) for 189. The anisotropic 
displacement factor exponent takes the form: -2 pi2 [ h2 a*2 U11 ++ 2 h k a* b* 
U12]: 
 
 U11 U22 U33 U23 U13 U12 
O(1) 26(1) 20(1) 46(1) -4(1) 8(1) 1(1) 
O(2) 22(1) 32(1) 30(1) -4(1) 7(1) -6(1) 
O(3) 27(1) 45(1) 28(1) -12(1) 9(1) -6(1) 
O(4) 21(1) 35(1) 23(1) 4(1) 5(1) -2(1) 
O(5) 20(1) 29(1) 26(1) 2(1) 2(1) -1(1) 
O(6) 26(1) 21(1) 18(1) 0(1) 5(1) 1(1) 
O(7) 29(1) 27(1) 19(1) -3(1) 5(1) 0(1) 
C(1) 22(1) 22(1) 32(1) 0(1) 4(1) 2(1) 
C(2) 19(1) 23(1) 23(1) 0(1) 4(1) 0(1) 
C(3) 20(1) 23(1) 21(1) 2(1) 2(1) 0(1) 
C(4) 24(1) 22(1) 20(1) 3(1) 5(1) -2(1) 
C(5) 24(1) 19(1) 32(1) 2(1) 8(1) -2(1) 
C(6) 23(1) 21(1) 30(1) -8(1) 8(1) -6(1) 
C(7) 25(1) 47(1) 32(1) -5(1) 4(1) -5(1) 
C(8) 20(1) 22(1) 23(1) -1(1) 6(1) 3(1) 
C(9) 22(1) 47(1) 29(1) 8(1) 8(1) -4(1) 
C(10) 38(1) 37(1) 41(1) 11(1) 2(1) -7(1) 
C(11) 21(1) 23(1) 19(1) -1(1) 6(1) -3(1) 
C(12) 27(1) 23(1) 25(1) 0(1) 5(1) -1(1) 
C(13) 27(1) 26(1) 27(1) -5(1) 4(1) 3(1) 
 
6.2.2e Hydrogen coordinates (x 104) and isotropic displacement parameters (A2 x 
103) for 189: 
 
 x y z U(eq) 
H(1) -690(20) 1990(20) 1411(16) 26(4) 
H(2) 1657(19) -200(20) 3146(16) 24(4) 
H(3) 280(17) -369(19) 262(15) 16(3) 
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H(4) 2609(18) 1130(20) 153(16) 19(3) 
H(5) 3580(20) 3050(20) 1639(17) 30(4) 
H(7A) 8020(20) 1110(20) 4308(17) 29(4) 
H(7B) 7110(20) 2010(30) 5220(20) 44(5) 
H(7C) 6770(20) 40(30) 4850(20) 42(5) 
H(9A) -1421(18) -3110(20) 4680(16) 20(3) 
H(9B) -2640(20) -2600(20) 3345(18) 31(4) 
H(10A) -2310(30) -5530(30) 3340(20) 50(5) 
H(10B) -410(30) -5260(30) 3630(20) 51(6) 
H(10C) -1680(20) -4850(30) 2300(20) 43(5) 
H(11) 4999(19) -230(20) 1318(15) 21(4) 
H(12A) 2590(20) -3510(30) 2108(17) 32(4) 
H(12B) 4380(20) -3920(20) 2935(17) 25(4) 
H(13A) 5120(20) -3600(20) 956(16) 29(4) 
H(13B) 3400(20) -4350(30) 326(19) 36(4) 
 
6.2.2f Torsion angles [deg] for 189: 
 
C(5)-O(1)-C(1)-
C(2) 
56.38(14) 
C(5)-O(1)-C(1)-
C(3) 
-11.17(14) 
C(1)-O(1)-C(5)-
C(4) 
19.57(13) 
C(1)-O(1)-C(5)-
C(6) 
-106.27(12) 
C(7)-O(2)-C(6)-
O(3) 
6.9(2) 
C(7)-O(2)-C(6)-
C(5) 
-174.58(11) 
C(9)-O(4)-C(8)-
O(5) 
1.22(18) 
C(8)-O(4)-C(9)-
C(10) 
83.93(15) 
C(9)-O(4)-C(8)-
C(2) 
-179.08(11) 
C(12)-O(6)-
C(11)-C(4) 
119.44(11) 
C(12)-O(6)-
C(11)-O(7) 
0.61(12) 
C(11)-O(6)-
C(12)-C(13) 
22.49(12) 
C(13)-O(7)-
C(11)-O(6) 
-25.21(12) 
C(13)-O(7)-
C(11)-C(4) 
-146.67(10) 
C(11)-O(7)-
C(13)-C(12) 
38.22(12) 
O(1)-C(1)-C(3)-
C(2) 
109.88(11) 
O(1)-C(1)-C(3)- -2.20(13) 
C(4) 
C(2)-C(1)-C(3)-
C(4) 
-112.08(11) 
O(1)-C(1)-C(2)-
C(3) 
-100.22(12) 
O(1)-C(1)-C(2)-
C(8) 
153.90(11) 
C(3)-C(1)-C(2)-
C(8) 
-105.89(12) 
C(8)-C(2)-C(3)-
C(1) 
107.08(12) 
C(1)-C(2)-C(3)-
C(4) 
94.14(12) 
C(8)-C(2)-C(3)-
C(4) 
-158.79(11) 
C(1)-C(2)-C(8)-
O(5) 
39.11(18) 
C(3)-C(2)-C(8)-
O(5) 
-26.75(18) 
C(1)-C(2)-C(8)-
O(4) 
-140.59(11) 
C(3)-C(2)-C(8)-
O(4) 
153.55(11) 
C(2)-C(3)-C(4)-
C(5) 
-51.63(13) 
C(1)-C(3)-C(4)-
C(11) 
140.58(10) 
C(1)-C(3)-C(4)-
C(5) 
13.21(12) 
C(2)-C(3)-C(4)-
C(11) 
75.74(14) 
C(5)-C(4)-C(11)-
O(7) 
-176.68(10) 
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C(3)-C(4)-C(11)-
O(7) 
62.34(13) 
C(5)-C(4)-C(11)-
O(6) 
65.04(14) 
C(3)-C(4)-C(11)-
O(6) 
-55.93(14) 
C(3)-C(4)-C(5)-
O(1) 
-20.05(12) 
C(11)-C(4)-C(5)-
O(1) 
-147.86(11) 
C(11)-C(4)-C(5)-
C(6) 
-24.69(16) 
C(3)-C(4)-C(5)-
C(6) 
103.11(12) 
C(4)-C(5)-C(6)-
O(3) 
-104.18(16) 
O(1)-C(5)-C(6)-
O(3) 
17.10(19) 
O(1)-C(5)-C(6)-
O(2) 
-161.44(11) 
C(4)-C(5)-C(6)-
O(2) 
77.29(14) 
O(6)-C(12)-
C(13)-O(7) 
-37.10(12) 
 
6.2.2g Hydrogen-bonds for 189 [Å and deg.]: 
 
D-H   A d(D-H) d(H   A) d(D   A) (DHA) 
C(1)-H(1)   O(7) 
1 
0.926(18) 2.596(17) 3.4692(16) 157.5(14) 
C(2)-H(2)   O(3) 0.946(17) 2.441(16) 3.2178(16) 139.3(13) 
C(4)-H(4)   O(5) 
1 
0.941(16) 2.565(16) 3.3928(16) 146.9(13) 
C(11)-H(11)   
O(2) 
0.974(17) 2.526(15) 2.9474(16) 106.1(11) 
C(13)-H(13B)   
O(5) 2 
0.92(2) 2.49(2) 3.3951(16) 168.3(17) 
 
6.2.3 (1`S,2R,3S,4R,,5R)-(−)-4-(Bromo-ethoxycarbonyl-methyl)-3-
[1´´,3´´]dioxolan-2´´-yl-5-methoxy-tetrahydro-furan-2-carboxylic acid methyl ester 
(220): 
 
6.2.3a Crystal data and structure refinement for 220: 
 
Crystal Data: 
Empirical formula   C14 H21 Br O8 
Formula weight   397.25 
Crystal size    0.47 x 0.31 x 0.19 mm 
Crystal description   prism 
Crystal colour    colourless 
Crystal system   Monoclinic 
O
MeO2C
OMe
H
CO2Et
BrO O
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Space group    P 21  
Unit cell dimensions   a = 8.8944(14) Å  α = 90 deg. 
b = 8.1736(9) Å  β = 96.977(18) deg. 
c = 11.6433(18) Å  γ = 90 deg. 
Volume    840.2(2) A3 
Z, Calculated density   2, 1.570 Mg/m3 
Absorption coefficient  2.484 mm-1 
F(000)     408 
Data Collection: 
Measurement device type  STOE-IPDS diffractometer 
Measurement method   rotation 
Temperature    173(1) K 
Wavelength    0.71073 Å 
Monochromator   graphite 
Theta range for data collection 2.73 to 25.76 deg. 
Index ranges    -10<=h<=10, -9<=k<=9, -14<=l<=14 
Reflections collected / unique 10361 / 3176 [R(int) = 0.0654] 
Reflections greater I>2\s(I)  2981 
Absorption correction  Analytical 
Max. and min. transmission  0.6629 and 0.4726 
Refinement: 
Refinement method   Full-matrix least-squares on F2  
Hydrogen treatment   : 
Data / restraints / parameters  3176 / 1 / 218 
Goodness-of-fit on F2   1.032  
Final R indices [I>2sigma(I)] R1 = 0.0333, wR2 = 0.0812  
R indices (all data)   R1 = 0.0353, wR2 = 0.0823 
Absolute structure parameter  -0.011(8) 
Largest diff. peak and hole  0.546 and -0.322 e.A-3 
 
6.2.3b Atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (A2 x 103) for 220. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor: 
 
 x y z U(eq) 
Br(1) 8659(1) 10600(1) -55(1) 42(1) 
O(1) 8856(2) 6553(3) 3376(2) 35(1) 
O(2) 5168(2) 7048(3) 1428(2) 34(1) 
O(3) 6342(3) 8895(3) 2721(2) 38(1) 
O(4) 11738(3) 11094(3) 1544(2) 38(1) 
O(5) 10329(5) 12345(6) 2759(4) 34(1) 
O(7) 11154(2) 7966(3) 3474(2) 38(1) 
O(8) 6282(3) 4658(3) 3314(2) 37(1) 
O(9) 6631(3) 3772(3) 1526(2) 35(1) 
C(1) 9122(3) 10271(3) 1623(2) 31(1) 
C(2) 9253(3) 8425(4) 1874(2) 28(1) 
C(3) 9579(3) 8068(4) 3183(2) 32(1) 
C(4) 8244(3) 5867(4) 2287(2) 29(1) 
C(5) 7865(3) 7352(4) 1474(2) 26(1) 
C(6) 6356(4) 8195(4) 1595(3) 31(1) 
C(7) 4962(4) 8370(4) 3146(3) 44(1) 
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C(8) 4032(4) 7672(5) 2101(3) 44(1) 
C(9) 10599(4) 11143(4) 2015(3) 41(1) 
C(10) 11613(8) 13426(9) 3144(6) 38(2) 
C(11) 12718(9) 12627(10) 4057(7) 46(2) 
C(14) 11592(4) 7934(6) 4704(3) 51(1) 
C(15) 6925(3) 4741(4) 2464(3) 31(1) 
C(16) 5277(4) 2772(4) 1495(3) 42(1) 
C(12) 12017(10) 12179(10) 3807(6) 38(2) 
C(13) 12181(10) 13962(11) 3602(8) 46(2) 
O(6) 10591(6) 11547(6) 3193(4) 34(1) 
 
6.2.3c Bond lengths [Å] and angles [deg] for 220: 
 
Br(1)-C(1) 1.966(2) 
O(1)-C(3) 1.426(4) 
O(1)-C(4) 1.432(3) 
O(2)-C(6) 1.408(4) 
O(2)-C(8) 1.445(4) 
O(3)-C(6) 1.432(4) 
O(3)-C(7) 1.443(4) 
O(4)-C(9) 1.210(4) 
O(5)-C(9) 1.351(6) 
O(5)-C(10) 1.470(9) 
O(6)-C(12) 1.472(10) 
O(6)-C(9) 1.412(6) 
O(7)-C(3) 1.403(3) 
O(7)-C(14) 1.438(4) 
O(8)-C(15) 1.204(4) 
O(9)-C(15) 1.349(4) 
O(9)-C(16) 1.452(4) 
C(1)-C(9) 1.515(4) 
C(1)-C(2) 1.539(4) 
C(2)-C(5) 1.540(4) 
C(2)-C(3) 1.544(3) 
C(4)-C(15) 1.525(4) 
C(4)-C(5) 1.551(4) 
C(5)-C(6) 1.530(5) 
C(7)-C(8) 1.499(5) 
C(10)-C(11) 1.506(11) 
C(12)-C(13) 1.487(12) 
C(1)-H(1) 1.0000 
C(2)-H(2) 1.0004 
C(3)-H(3) 1.0002 
C(4)-H(4) 1.0002 
C(5)-H(5) 0.9999 
C(6)-H(6) 1.0000 
C(7)-H(7A) 0.9902 
C(7)-H(7B) 0.9895 
C(8)-H(8A) 0.9906 
C(8)-H(8B) 0.9902 
C(10)-H(10A) 0.9903 
C(10)-H(10B) 0.9899 
C(11)-H(11A) 0.9793 
C(11)-H(11B) 0.9795 
C(11)-H(11C) 0.9798 
C(14)-H(14A) 0.9795 
C(14)-H(14B) 0.9798 
C(14)-H(14C) 0.9806 
C(16)-H(16A) 0.9802 
C(16)-H(16B) 0.9801 
C(16)-H(16C) 0.9796 
  
C(3)-O(1)-C(4) 109.3(2) 
C(6)-O(2)-C(8) 104.6(3) 
C(6)-O(3)-C(7) 107.3(3) 
C(9)-O(5)-C(10) 116.2(4) 
C(9)-O(6)-C(12) 116.6(5) 
C(3)-O(7)-C(14) 112.5(2) 
C(15)-O(9)-C(16) 115.4(2) 
Br(1)-C(1)-C(9) 107.71(19) 
C(2)-C(1)-C(9) 111.2(2) 
Br(1)-C(1)-C(2) 108.94(16) 
C(1)-C(2)-C(3) 111.9(2) 
C(3)-C(2)-C(5) 103.8(2) 
C(1)-C(2)-C(5) 117.5(2) 
O(1)-C(3)-O(7) 111.5(2) 
O(7)-C(3)-C(2) 108.2(2) 
O(1)-C(3)-C(2) 106.6(2) 
O(1)-C(4)-C(5) 105.4(2) 
O(1)-C(4)-C(15) 109.4(2) 
C(5)-C(4)-C(15) 116.2(2) 
C(2)-C(5)-C(4) 98.9(2) 
C(2)-C(5)-C(6) 113.3(3) 
C(4)-C(5)-C(6) 115.1(2) 
O(2)-C(6)-C(5) 109.8(3) 
O(3)-C(6)-C(5) 111.7(3) 
O(2)-C(6)-O(3) 107.6(3) 
O(3)-C(7)-C(8) 104.1(3) 
O(2)-C(8)-C(7) 102.8(3) 
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O(4)-C(9)-O(5) 122.6(4) 
O(4)-C(9)-C(1) 126.2(3) 
O(5)-C(9)-C(1) 108.7(3) 
O(6)-C(9)-C(1) 107.2(3) 
O(4)-C(9)-O(6) 123.5(4) 
O(5)-C(10)-C(11) 111.8(6) 
O(6)-C(12)-C(13) 111.2(7) 
O(9)-C(15)-C(4) 108.8(3) 
O(8)-C(15)-O(9) 124.6(3) 
O(8)-C(15)-C(4) 126.5(3) 
Br(1)-C(1)-H(1) 109.63 
C(2)-C(1)-H(1) 109.66 
C(9)-C(1)-H(1) 109.69 
C(1)-C(2)-H(2) 107.73 
C(3)-C(2)-H(2) 107.71 
C(5)-C(2)-H(2) 107.74 
O(1)-C(3)-H(3) 110.11 
O(7)-C(3)-H(3) 110.20 
C(2)-C(3)-H(3) 110.19 
O(1)-C(4)-H(4) 108.56 
C(5)-C(4)-H(4) 108.58 
C(15)-C(4)-H(4) 108.49 
C(2)-C(5)-H(5) 109.68 
C(4)-C(5)-H(5) 109.71 
C(6)-C(5)-H(5) 109.69 
O(2)-C(6)-H(6) 109.26 
O(3)-C(6)-H(6) 109.20 
C(5)-C(6)-H(6) 109.21 
O(3)-C(7)-H(7A) 110.90 
O(3)-C(7)-H(7B) 110.96 
C(8)-C(7)-H(7A) 110.92 
C(8)-C(7)-H(7B) 110.96 
H(7A)-C(7)-
H(7B) 
108.97 
O(2)-C(8)-H(8A) 111.16 
O(2)-C(8)-H(8B) 111.20 
C(7)-C(8)-H(8A) 111.18 
C(7)-C(8)-H(8B) 111.25 
H(8A)-C(8)-
H(8B) 
109.17 
O(5)-C(10)-
H(10A) 
109.29 
O(5)-C(10)-
H(10B) 
109.27 
C(11)-C(10)-
H(10A) 
109.24 
C(11)-C(10)-
H(10B) 
109.29 
H(10A)-C(10)-
H(10B) 
107.91 
C(10)-C(11)-
H(11A) 
109.46 
C(10)-C(11)-
H(11B) 
109.44 
C(10)-C(11)-
H(11C) 
109.42 
H(11A)-C(11)-
H(11B) 
109.55 
H(11A)-C(11)-
H(11C) 
109.47 
H(11B)-C(11)-
H(11C) 
109.49 
O(7)-C(14)-
H(14A) 
109.47 
O(7)-C(14)-
H(14B) 
109.50 
O(7)-C(14)-
H(14C) 
109.43 
H(14A)-C(14)-
H(14B) 
109.48 
H(14A)-C(14)-
H(14C) 
109.51 
H(14B)-C(14)-
H(14C) 
109.44 
O(9)-C(16)-
H(16A) 
109.43 
O(9)-C(16)-
H(16B) 
109.45 
O(9)-C(16)-
H(16C) 
109.44 
H(16A)-C(16)-
H(16B) 
109.52 
H(16A)-C(16)-
H(16C) 
109.53 
H(16B)-C(16)-
H(16C) 
109.46 
 
6.2.3d Anisotropic displacement parameters (A2 x 103) for 220. The anisotropic 
displacement factor exponent takes the form: -2 pi2 [ h2 a*2 U11 ++ 2 h k a* b* 
U12]: 
 
 U11   U22   U33    U23    U13  U12  
Br(1) 47(1) 41(1) 39(1) 9(1) 11(1) -8(1)  
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O(1) 35(1) 38(1) 31(1) 5(1) 6(1) -2(1)  
O(2) 26(1) 31(1) 44(1) 3(1) 8(1) 0(1)  
O(3) 31(1) 40(1) 45(1) -8(1) 16(1) -1(1)  
O(4) 35(1) 37(1) 46(1) -3(1) 18(1) -4(1)  
O(5) 37(2) 28(2) 39(2) -6(1) 12(2) -4(2)  
O(7) 27(1) 57(2) 31(1) 0(1) 7(1) 0(1)  
O(8) 39(1) 37(1) 36(1) 6(1) 11(1) 1(1)  
O(9) 39(1) 28(1) 41(1) -2(1) 13(1) -1(1)  
C(1) 36(2) 27(2) 33(1) -2(1) 12(1) -1(1)  
C(2) 27(1) 27(2) 31(1) -4(1) 11(1) 2(1)  
C(3) 28(2) 38(2) 31(1) -3(1) 8(1) -2(1)  
C(4) 29(1) 26(2) 32(1) 1(1) 7(1) 3(1)  
C(5) 29(2) 25(2) 26(1) 1(1) 8(1) 2(1)  
C(6) 31(2) 28(2) 35(2) 1(1) 6(1) 0(1)  
C(7) 40(2) 39(2) 59(2) -1(2) 28(2) 4(2)  
C(8) 29(2) 40(2) 67(2) 3(2) 20(2) 4(1)  
C(9) 42(2) 36(2) 48(2) -10(1) 20(1) -6(1)  
C(10) 41(3) 35(3) 37(3) -1(2) 6(2) -1(2)  
C(11) 44(3) 43(3) 50(3) -2(2) 8(3) -1(3)  
C(14) 38(2) 79(3) 35(2) 1(2) 4(1) -4(2)  
C(15) 32(2) 26(2) 36(2) 5(1) 9(1) 7(1)  
C(16) 44(2) 34(2) 49(2) -1(2) 11(2) -6(2)  
C(12) 41(3) 35(3) 37(3) -1(2) 6(2) -1(2)  
C(13) 44(3) 43(3) 50(3) -2(2) 8(3) -1(3)  
O(6) 37(2) 28(2) 39(2) -6(1) 12(2) -4(2) 
 
6.2.3e Hydrogen coordinates (x 104) and isotropic displacement parameters (A2 x 
103) for 220: 
 
 x y z U(eq) 
H(3) 9155 8960 3636 38 
H(5) 7892 7011 652 32 
H(6) 6176 9077 999 37 
H(4) 9050 5202 1979 34 
H(1) 8293 10748 2026 38 
H(2) 10126 7997 1497 34 
H(8B) 3407 8527 1671 53 
H(10A) 11229 14449 3459 45 
H(10B) 12142 13718 2472 45 
H(11A) 12181 12258 4696 54 
H(11B) 13502 13417 4346 54 
H(11C) 13189 11686 3721 54 
H(14A) 11279 8955 5046 61 
H(14B) 12694 7817 4863 61 
H(14C) 11101 7006 5041 61 
H(16A) 5322 2129 2209 50 
H(16B) 5215 2033 828 50 
H(16C) 4382 3480 1427 50 
H(7A) 4437 9306 3462 53 
H(7B) 5173 7531 3757 53 
H(8A) 3363 6784 2318 53 
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H(12A) 12881 11589 3539 45 
H(12B) 12036 11977 4647 45 
H(13A) 12144 14166 2770 54 
H(13B) 13154 14341 3998 54 
H(13C) 11355 14553 3904 54 
 
6.2.3f Torsion angles [deg] for 220: 
 
C(3)-O(1)-C(4)-
C(15) 
-154.7(2) 
C(4)-O(1)-C(3)-
O(7) 
-112.1(2) 
C(4)-O(1)-C(3)-
C(2) 
5.8(3) 
C(3)-O(1)-C(4)-
C(5) 
-29.1(3) 
C(8)-O(2)-C(6)-
O(3) 
30.0(3) 
C(8)-O(2)-C(6)-
C(5) 
151.8(3) 
C(6)-O(2)-C(8)-
C(7) 
-37.1(3) 
C(7)-O(3)-C(6)-
C(5) 
-130.8(3) 
C(6)-O(3)-C(7)-
C(8) 
-12.9(3) 
C(7)-O(3)-C(6)-
O(2) 
-10.2(3) 
C(10)-O(5)-C(9)-
C(1) 
-174.3(4) 
C(9)-O(5)-C(10)-
C(11) 
-77.7(7) 
C(10)-O(5)-C(9)-
O(4) 
-11.3(7) 
C(14)-O(7)-C(3)-
O(1) 
-73.7(3) 
C(14)-O(7)-C(3)-
C(2) 
169.4(3) 
C(16)-O(9)-
C(15)-C(4) 
-172.4(2) 
C(16)-O(9)-
C(15)-O(8) 
10.7(5) 
C(2)-C(1)-C(9)-
O(5) 
-123.8(3) 
Br(1)-C(1)-C(2)-
C(3) 
-178.65(17) 
Br(1)-C(1)-C(2)-
C(5) 
-58.7(2) 
C(9)-C(1)-C(2)-
C(3) 
62.8(3) 
Br(1)-C(1)-C(9)- -45.3(4) 
O(4) 
C(2)-C(1)-C(9)-
O(4) 
74.0(4) 
Br(1)-C(1)-C(9)-
O(5) 
116.9(3) 
C(9)-C(1)-C(2)-
C(5) 
-177.2(2) 
C(1)-C(2)-C(3)-
O(7) 
-92.5(3) 
C(3)-C(2)-C(5)-
C(4) 
-34.8(3) 
C(1)-C(2)-C(5)-
C(4) 
-159.0(2) 
C(5)-C(2)-C(3)-
O(7) 
139.8(2) 
C(3)-C(2)-C(5)-
C(6) 
87.5(3) 
C(1)-C(2)-C(3)-
O(1) 
147.5(2) 
C(5)-C(2)-C(3)-
O(1) 
19.8(3) 
C(1)-C(2)-C(5)-
C(6) 
-36.6(3) 
C(15)-C(4)-C(5)-
C(6) 
39.7(3) 
C(15)-C(4)-C(5)-
C(2) 
160.7(2) 
O(1)-C(4)-C(5)-
C(6) 
-81.6(3) 
O(1)-C(4)-C(15)-
O(9) 
-163.3(2) 
O(1)-C(4)-C(15)-
O(8) 
13.5(4) 
O(1)-C(4)-C(5)-
C(2) 
39.4(2) 
C(5)-C(4)-C(15)-
O(9) 
77.6(3) 
C(5)-C(4)-C(15)-
O(8) 
-105.6(4) 
C(4)-C(5)-C(6)-
O(2) 
-56.0(3) 
C(2)-C(5)-C(6)-
O(3) 
-49.4(3) 
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C(2)-C(5)-C(6)-
O(2) 
-168.8(2) 
C(4)-C(5)-C(6)- 63.4(3) 
O(3) 
O(3)-C(7)-C(8)-
O(2) 
30.5(3) 
 
6.2.3g Hydrogen-bonds for 220 [Å and deg.]: 
 
D-H   A d(D-H) d(H   A) d(D   A) (DHA) 
C(1)-H(1)   O(3) 1.0000 2.5100 3.127(4) 120.00 
C(2)-H(2)   
Br(1) 1 
1.0000 2.8700 3.771(3) 149.00 
C(3)-H(3)   O(3) 1.0000 2.6000 2.943(4) 100.00 
C(8)-H(8B)   
O(4) 2 
0.9900 2.5600 3.476(5) 153.00 
C(11)-H(11A)   
O(1) 3 
0.9800 2.5900 3.561(8) 170.00 
 
6.2.4 2R,5R-(+)-5-Ethoxycarbonylmethyl-2,5-dihydro-furan-2,3-dicarboxylic acid 
2-methyl ester (240): 
 
6.2.4a Crystal data and structure refinement for 240: 
 
Crystal Data: 
Empirical formula   C11 H14 O7 
Formula weight   258.22 
Crystal size    0.30 x 0.12 x 0.08 mm 
Crystal description   rod 
Crystal colour    colourless 
Crystal system   Monoclinic 
Space group    P 21 
Unit cell dimensions   a = 8.9228(6) Å  α = 90 deg. 
b = 4.5629(3) Å  β = 97.005(8) deg. 
c = 14.7692(11) Å  γ = 90 deg. 
Volume    596.82(7) A3 
Z, Calculated density   2, 1.437 Mg/m3 
Absorption coefficient  0.122 mm-1 
F(000)     272 
Data Collection: 
Measurement device type  STOE-IPDS diffractometer  
Measurement method   rotation 
O
MeO2C
HO2C
H
H
CO2Et
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Temperature    123(1) K 
Wavelength    0.71073 Å 
Monochromator   graphite 
Theta range for data collection 2.30 to 26.83 deg. 
Index ranges    -11<=h<=11, -5<=k<=5, -18<=l<=18 
Reflections collected / unique 5209 / 2543 [R(int) = 0.0162] 
Reflections greater   I>2\s(I);2404 
Absorption correction  : 
Refinement: 
Refinement method   Full-matrix least-squares on F2 
Hydrogen treatment   : 
Data / restraints / parameters  2543 / 1 / 184 
Goodness-of-fit on F2   1.065 
Final R indices [I>2sigma(I)] R1 = 0.0262, wR2 = 0.0675 
R indices (all data)   R1 = 0.0280, wR2 = 0.0684 
Absolute structure parameter  -0.5(6)  
Largest diff. peak and hole  0.234 and -0.139 e.A-3 
 
6.2.4b Atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (A2 x 103) for 240. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor: 
 
 x y z U(eq) 
O(1) 7335(1) 4146(2) 6918(1) 22(1) 
O(2) 6223(1) 6373(2) 9579(1) 26(1) 
O(3) 4662(1) 9686(2) 8822(1) 28(1) 
O(4) 6768(1) 4600(2) 4590(1) 24(1) 
O(5) 8606(1) 8024(2) 4702(1) 22(1) 
O(6) 9715(1) 5124(2) 8909(1) 32(1) 
O(7) 9389(1) 8413(2) 7774(1) 38(1) 
C(1) 7458(1) 4734(3) 7872(1) 18(1) 
C(2) 6131(1) 6734(3) 7975(1) 17(1) 
C(3) 5452(1) 7494(3) 7157(1) 19(1) 
C(4) 6200(1) 6023(3) 6422(1) 19(1) 
C(5) 6927(1) 8152(3) 5810(1) 19(1) 
C(6) 7410(1) 6673(3) 4977(1) 18(1) 
C(7) 9108(1) 6962(3) 3854(1) 23(1) 
C(8) 8146(1) 8220(3) 3032(1) 27(1) 
C(9) 8965(1) 6327(3) 8168(1) 20(1) 
C(10) 11135(2) 6548(4) 9240(1) 41(1) 
C(11) 5681(1) 7567(3) 8871(1) 19(1) 
 
6.2.4c Bond lengths [Å] and angles [deg] for 240: 
 
O(1)-C(1) 1.4266(13) 
O(1)-C(4) 1.4540(14) 
O(2)-C(11) 1.2251(14) 
O(3)-C(11) 1.3233(15) 
O(4)-C(6) 1.2125(15) 
O(5)-C(6) 1.3376(14) 
O(5)-C(7) 1.4634(14) 
O(6)-C(9) 1.3295(15) 
O(6)-C(10) 1.4538(17) 
O(7)-C(9) 1.2010(16) 
O(3)-H(3O) 0.841(18) 
C(1)-C(2) 1.5176(17) 
C(1)-C(9) 1.5437(16) 
C(2)-C(11) 1.4786(15) 
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C(2)-C(3) 1.3294(15) 
C(3)-C(4) 1.4994(16) 
C(4)-C(5) 1.5253(17) 
C(5)-C(6) 1.5116(16) 
C(7)-C(8) 1.5117(17) 
C(1)-H(1) 0.950(17) 
C(3)-H(3) 0.935(16) 
C(4)-H(4) 1.0003 
C(5)-H(5A) 0.949(15) 
C(5)-H(5B) 0.944(16) 
C(7)-H(7A) 0.947(18) 
C(7)-H(7B) 0.933(17) 
C(8)-H(8A) 0.9803 
C(8)-H(8B) 0.9801 
C(8)-H(8C) 0.9799 
C(10)-H(10A) 0.9797 
C(10)-H(10B) 0.9803 
C(10)-H(10C) 0.9800 
  
C(1)-O(1)-C(4) 110.58(8) 
C(6)-O(5)-C(7) 116.48(9) 
C(9)-O(6)-C(10) 114.99(10) 
C(11)-O(3)-
H(3O) 
109.8(12) 
O(1)-C(1)-C(9) 109.16(9) 
C(2)-C(1)-C(9) 110.62(11) 
O(1)-C(1)-C(2) 104.15(8) 
C(1)-C(2)-C(11) 122.94(9) 
C(3)-C(2)-C(11) 127.11(11) 
C(1)-C(2)-C(3) 109.92(10) 
C(2)-C(3)-C(4) 110.33(10) 
O(1)-C(4)-C(5) 110.65(9) 
C(3)-C(4)-C(5) 113.76(11) 
O(1)-C(4)-C(3) 104.11(8) 
C(4)-C(5)-C(6) 112.50(11) 
O(4)-C(6)-C(5) 124.52(10) 
O(5)-C(6)-C(5) 111.01(10) 
O(4)-C(6)-O(5) 124.43(10) 
O(5)-C(7)-C(8) 110.99(10) 
O(6)-C(9)-C(1) 111.86(10) 
O(7)-C(9)-C(1) 123.40(11) 
O(6)-C(9)-O(7) 124.74(11) 
O(2)-C(11)-C(2) 121.89(11) 
O(3)-C(11)-C(2) 113.47(10) 
O(2)-C(11)-O(3) 124.63(10) 
O(1)-C(1)-H(1) 109.4(10) 
C(2)-C(1)-H(1) 113.2(9) 
C(9)-C(1)-H(1) 110.1(9) 
C(2)-C(3)-H(3) 126.3(9) 
C(4)-C(3)-H(3) 123.3(9) 
O(1)-C(4)-H(4) 109.39 
C(3)-C(4)-H(4) 109.40 
C(5)-C(4)-H(4) 109.37 
C(4)-C(5)-H(5A) 109.0(9) 
C(4)-C(5)-H(5B) 109.1(9) 
C(6)-C(5)-H(5A) 110.3(9) 
C(6)-C(5)-H(5B) 105.0(9) 
H(5A)-C(5)-
H(5B) 
110.9(13) 
O(5)-C(7)-H(7A) 108.3(10) 
O(5)-C(7)-H(7B) 102.8(10) 
C(8)-C(7)-H(7A) 110.2(10) 
C(8)-C(7)-H(7B) 110.2(10) 
H(7A)-C(7)-
H(7B) 
114.2(14) 
C(7)-C(8)-H(8A) 109.49 
C(7)-C(8)-H(8B) 109.45 
C(7)-C(8)-H(8C) 109.46 
H(8A)-C(8)-
H(8B) 
109.48 
H(8A)-C(8)-
H(8C) 
109.48 
H(8B)-C(8)-
H(8C) 
109.48 
O(6)-C(10)-
H(10A) 
109.48 
O(6)-C(10)-
H(10B) 
109.47 
O(6)-C(10)-
H(10C) 
109.45 
H(10A)-C(10)-
H(10B) 
109.47 
H(10A)-C(10)-
H(10C) 
109.45 
H(10B)-C(10)-
H(10C) 
109.50 
 
6.2.4d Anisotropic displacement parameters (A2 x 103) for 240. The anisotropic 
displacement factor exponent takes the form: -2 pi2 [ h2 a*2 U11 ++ 2 h k a* b* 
U12]: 
 
 U11 U22 U33 U23 U13 U12 
O(1) 29(1) 21(1) 15(1) -2(1) 4(1) 6(1) 
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O(2) 27(1) 36(1) 15(1) 3(1) 6(1) 0(1) 
O(3) 31(1) 38(1) 15(1) -3(1) 7(1) 9(1) 
O(4) 29(1) 26(1) 18(1) -6(1) 6(1) -6(1) 
O(5) 21(1) 27(1) 20(1) -5(1) 7(1) -4(1) 
O(6) 28(1) 46(1) 20(1) 5(1) -5(1) -4(1) 
O(7) 26(1) 37(1) 48(1) 16(1) -4(1) -8(1) 
C(1) 23(1) 17(1) 14(1) 0(1) 3(1) 1(1) 
C(2) 17(1) 19(1) 17(1) -2(1) 4(1) -3(1) 
C(3) 18(1) 23(1) 16(1) -2(1) 5(1) 0(1) 
C(4) 19(1) 21(1) 15(1) -2(1) 2(1) 0(1) 
C(5) 22(1) 18(1) 16(1) -1(1) 3(1) 1(1) 
C(6) 19(1) 19(1) 15(1) 2(1) 2(1) 2(1) 
C(7) 22(1) 29(1) 21(1) -4(1) 9(1) 0(1) 
C(8) 32(1) 27(1) 22(1) 1(1) 9(1) -2(1) 
C(9) 20(1) 22(1) 19(1) -1(1) 5(1) 5(1) 
C(10) 30(1) 62(1) 28(1) -3(1) -8(1) -6(1) 
C(11) 17(1) 23(1) 16(1) -1(1) 4(1) -6(1) 
 
6.2.4e Hydrogen coordinates (x 104) and isotropic displacement parameters (A2 x 
103) for 240: 
 
 x y z U(eq) 
H(1) 7424(16) 2940(40) 8196(10) 22 
H(3) 4597(17) 8680(40) 7038(10) 22 
H(3O) 4475(18) 10130(40) 9349(12) 33 
H(4) 5443 4785 6040 22 
H(5A) 7767(17) 9060(30) 6155(10) 22 
H(5B) 6205(16) 9560(40) 5578(10) 22 
H(7A) 9046(17) 4890(40) 3849(11) 28 
H(7B) 10090(18) 7690(40) 3887(10) 28 
H(8A) 7087 7686 3055 32 
H(8B) 8483 7430 2474 32 
H(8C) 8244 10359 3035 32 
H(10A) 11819 6445 8770 49 
H(10B) 11596 5554 9793 49 
H(10C) 10945 8605 9379 49 
 
6.2.3f Torsion angles [deg] for 240: 
 
C(4)-O(1)-C(1)-
C(2) 
9.78(12) 
C(4)-O(1)-C(1)-
C(9) 
-108.38(11) 
C(1)-O(1)-C(4)-
C(3) 
-8.67(12) 
C(1)-O(1)-C(4)-
C(5) 
113.92(10) 
C(7)-O(5)-C(6)-
O(4) 
2.72(17) 
C(6)-O(5)-C(7)-
C(8) 
80.54(13) 
C(7)-O(5)-C(6)-
C(5) 
-174.91(9) 
C(10)-O(6)-C(9)-
C(1) 
-178.82(10) 
C(10)-O(6)-C(9)-
O(7) 
0.70(18) 
C(2)-C(1)-C(9)-
O(6) 
114.21(11) 
C(9)-C(1)-C(2)-
C(3) 
109.84(12) 
O(1)-C(1)-C(2)-
C(11) 
170.97(11) 
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O(1)-C(1)-C(9)-
O(7) 
48.71(16) 
C(2)-C(1)-C(9)-
O(7) 
-65.31(15) 
C(9)-C(1)-C(2)-
C(11) 
-71.88(14) 
O(1)-C(1)-C(9)-
O(6) 
-131.77(10) 
O(1)-C(1)-C(2)-
C(3) 
-7.32(14) 
C(1)-C(2)-C(11)-
O(3) 
169.55(11) 
C(3)-C(2)-C(11)-
O(3) 
-12.47(19) 
C(1)-C(2)-C(11)-
O(2) 
-10.35(19) 
C(11)-C(2)-C(3)- -176.08(12) 
C(4) 
C(1)-C(2)-C(3)-
C(4) 
2.11(15) 
C(3)-C(2)-C(11)-
O(2) 
167.63(13) 
C(2)-C(3)-C(4)-
C(5) 
-116.69(12) 
C(2)-C(3)-C(4)-
O(1) 
3.83(14) 
C(3)-C(4)-C(5)-
C(6) 
-169.26(9) 
O(1)-C(4)-C(5)-
C(6) 
73.97(11) 
C(4)-C(5)-C(6)-
O(5) 
-150.31(10) 
C(4)-C(5)-C(6)-
O(4) 
32.06(16) 
 
6.2.3g Hydrogen-bonds for 240 [Å and deg.]: 
 
D-H   A d(D-H) d(H   A) d(D   A) (DHA) 
     
O(3)-H(3O)   
O(2)#1 
0.841(18) 1.859(17) 2.6921(12) 170.8(16) 
C(3)-H(3)   
O(4) 2 
0.935(16) 2.593(15) 3.2023(14) 123.2(12) 
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